,Date,Title,Url
0,2017-01-02,IPO주관한투證삼성바이오로직스잡고1위등극,http://news.einfomax.co.kr/news/articleView.html?idxno=288572
1,2017-01-02,삼성바이오로직스뛰고vs한미약품추락왜,http://www.choicenews.co.kr/news/articleView.html?idxno=30694
2,2017-01-04,삼성바이오로직스의약품위탁생산1위넘본다,http://news.mk.co.kr/newsRead.php?no=6888&year=2017
3,2017-01-04,특징주삼성바이오로직스외인러브콜16만원선눈앞,http://www.g-enews.com/ko-kr/news/article/news_all/201701040921275878634_1/article.html
4,2017-01-09,매일장보는남녀삼성바이오로직스207940,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002679024
5,2017-01-11,삼성바이오로직스바이오CMO시장확대고객만족도극대화,http://www.readersnews.com/news/articleView.html?idxno=69062
6,2017-01-11,삼성바이오로직스바이오CMO시장확대고객만족도극대화,http://www.ajunews.com/view/20170111085510281
7,2017-01-11,삼성바이오로직스CMO시장확대로매출극대화,http://www.dailypharm.com/News/220950
8,2017-01-11,김태한삼성바이오로직스사장3조원이상공급계약체결,http://www.ebn.co.kr/news/view/871340
9,2017-01-11,삼성바이오로직스15개제약사와위탁생산협상중,http://www.edaily.co.kr/news/newspath.asp?newsid=02102486615796736
10,2017-01-11,삼성바이오로직스바이오제약산업패러다임바꾼다,http://www.dt.co.kr/contents.html?article_no=2017011102109976029001
11,2017-01-11,삼성바이오로직스JP모건헬스케어컨퍼런스에서글로벌투자자대상IR실시,http://www.fnnews.com/news/201701110923397487
12,2017-01-11,특징주삼성바이오로직스매출확대기대사흘만에날갯짓,http://www.g-enews.com/ko-kr/news/article/news_all/201701110926151853631_1/article.html
13,2017-01-11,특징주삼성바이오로직스글로벌투자자대상IR소식에강세,http://www.asiatoday.co.kr/view.php?key=20170111010006562
14,2017-01-11,삼성바이오로직스美서IR진행15곳과계약협상중,http://view.asiae.co.kr/news/view.htm?idxno=2017011109353981434
15,2017-01-11,특징주삼성바이오로직스강세15개기업과협상중,http://stock.hankyung.com/news/app/newsview.php?aid=2017011138906
16,2017-01-11,특징주삼성바이오로직스기업설명회효과4대상승,http://www.etoday.co.kr/news/section/newsview.php?idxno=1439977
17,2017-01-11,특징주삼성바이오로직스공급계약협상진행소식에상승,http://biz.chosun.com/site/data/html_dir/2017/01/11/2017011100887.html
18,2017-01-11,김태한삼성바이오로직스사장15개제약사와30개이상제품공급계약협상”,http://biz.chosun.com/site/data/html_dir/2017/01/11/2017011100891.html
19,2017-01-11,삼성바이오로직스반도체같이생산전문업체들이주도해나가도록시장패러다임변화선도,http://www.g-enews.com/ko-kr/news/article/news_all/201701110941371960137_1/article.html
20,2017-01-11,김태한삼성바이오로직스사장바이오CMO확대,http://www.ajunews.com/view/20170111090826301
21,2017-01-11,김태한삼성바이오로직스사장바이오CMO시장확대패러다임바꿀것”,http://news.heraldcorp.com/view.php?ud=20170111000218
22,2017-01-11,특징주삼성바이오로직스공급계약체결소식에강세,http://www.newsway.co.kr/view.php?tp=1&ud=2017011109573762330
23,2017-01-11,특징주삼성바이오로직스강세15개기업과공급계약협상중,http://www.ebn.co.kr/news/view/871362
24,2017-01-11,삼성바이오로직스바이오CMO시장확대고객만족도극대화”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1439959
25,2017-01-11,삼성바이오로직스생산전문업체가주도하는시장으로전환할것,http://www.enewstoday.co.kr/news/articleView.html?idxno=676381
26,2017-01-11,삼성바이오로직스김태한사장글로벌제약사15곳과제품공급협상중,http://www.newsis.com/view/?id=NISX20170111_0014633257&cID=10434&pID=13000
27,2017-01-11,특징주삼성바이오로직스29억달러공급계약소식에장초반강세,http://www.fnnews.com/news/201701111014451929
28,2017-01-11,특징주삼성바이오로직스제품공급계약체결기대감에급등세,http://www.cstimes.com/news/articleView.html?idxno=235592
29,2017-01-11,삼성바이오로직스바이오CMO시장확대15개기업과공급협상중,http://www.newspim.com/news/view/20170111000129
30,2017-01-11,김태한삼성바이오로직스사장15개이상기업과제품공급협상중,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201701110161
31,2017-01-11,삼성바이오로직스29억달러계약체결소식에상승세,http://www.newsprime.co.kr/news/article.html?no=361018
32,2017-01-11,김태한삼성바이오로직스사장CMO가바이오미래주도,http://www.mt.co.kr/view/mtview.php?type=1&no=2017011110153192030&outlink=1
33,2017-01-11,삼성바이오로직스바이오CMO시장확대고객만족극대화,http://www.m-i.kr/news/articleView.html?idxno=282451
34,2017-01-11,삼성바이오로직스바이오의약품CMO시장확대고객만족극대화,http://www.dailian.co.kr/news/view/606051/?sc=naver
35,2017-01-11,삼성바이오로직스CMO산업의진화이끌겠다,http://news.mk.co.kr/newsRead.php?no=24731&year=2017
36,2017-01-11,삼성바이오로직스JP모건헬스케어콘퍼런스참석,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170111140900017&did=1196m
37,2017-01-11,삼성바이오로직스미국서기업설명회개최,http://news.heraldcorp.com/view.php?ud=20170111000435
38,2017-01-11,삼성바이오로직스15개글로벌기업과위탁생산협상중,http://www.m-i.kr/news/articleView.html?idxno=282537
39,2017-01-11,美IR서도대접받는삼성바이오로직스국내업체첫메인트랙배정,http://www.newsis.com/view/?id=NISX20170111_0014633571&cID=10434&pID=13000
40,2017-01-11,삼성바이오로직스CMO도경쟁우위가능할듯,http://www.choicenews.co.kr/news/articleView.html?idxno=30876
41,2017-01-11,특징주삼성바이오로직스글로벌제약사와계약기대감에↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03404646615796736
42,2017-01-11,삼성바이오로직스바이오CMO시장확대고객만족도극대화,http://www.gukjenews.com/news/articleView.html?idxno=629530
43,2017-01-11,삼성바이오로직스김태한대표현재15개이상기업들과제품공급협상중”,http://www.viva100.com/main/view.php?key=20170111010003854
44,2017-01-11,삼성바이오로직스6개사와29억달러공급계약체결,http://news.mk.co.kr/newsRead.php?no=25669&year=2017
45,2017-01-11,삼성바이오로직스바이오CMO시장확대할것,http://www.sporbiz.co.kr/news/articleView.html?idxno=67940
46,2017-01-11,삼성바이오로직스글로벌제약15곳과생산계약협상중,http://news.mk.co.kr/newsRead.php?no=26231&year=2017
47,2017-01-11,삼성바이오로직스미국서기업설명회열어,http://www.fnnews.com/news/201701111726039479
48,2017-01-11,김태한삼성바이오로직스15개기업과제품공급협상,http://www.businesspost.co.kr/news/articleView.html?idxno=40605
49,2017-01-11,삼성바이오로직스15곳과의약품공급협상,http://www.hankyung.com/news/app/newsview.php?aid=2017011156941
50,2017-01-11,삼성바이오로직스15개업체와약품수출협상,http://www.segye.com/content/html/2017/01/11/20170111003656.html?OutUrl=naver
51,2017-01-11,김태한삼성바이오로직스사장바이오CMO시장확대고객만족도↑,http://www.asiatoday.co.kr/view.php?key=20170111010007311
52,2017-01-11,김태한삼성바이오로직스사장미국기업공개행사CMO가바이오산업미래주도해나갈것”,http://news.kmib.co.kr/article/view.asp?arcid=0923676752&code=11110000&cp=nv
53,2017-01-11,삼성바이오로직스고객만족도극대화,http://www.kgnews.co.kr/news/articleView.html?idxno=470978
54,2017-01-11,글로벌투자자앞으로삼성바이오로직스몸집키우기잰걸음,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=680599
55,2017-01-11,삼성바이오로직스기업15개이상과위탁생산협상,http://www.kyeongin.com/main/view.php?key=20170111010003673
56,2017-01-11,삼성바이오로직스10일샌프란시스코JP모건헬스케어컨퍼런스에서투자설명회,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1297118
57,2017-01-12,더벨삼성바이오로직스15곳협상유력파트너는,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201701110100021310001270
58,2017-01-12,삼성바이오로직스15개이상다국적제약사와의약품공급협상중,http://biz.newdaily.co.kr/news/article.html?no=10123362
59,2017-01-12,삼성바이오로직스6개사와29억달러어치공급계약체결”,http://www.mdtoday.co.kr/mdtoday/index.html?no=277699
60,2017-01-12,삼성바이오로직스바이오시장서지속성장자신”,http://www.docdocdoc.co.kr/?p=239470
61,2017-01-13,삼성바이오로직스2017년시장패러다임변화선도,http://www.kormedi.com/news/news/drug_dist/1221546_2906.html
62,2017-01-18,더벨위기의삼성삼성바이오로직스CMO계약직간접피해생기나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201701170100032670001958
63,2017-01-18,삼성바이오로직스이달24일결산실적공시예고,http://www.mt.co.kr/view/mtview.php?type=1&no=2017011815510073295&outlink=1
64,2017-01-18,삼성바이오로직스24일결산실적공시예정,http://view.asiae.co.kr/news/view.htm?idxno=2017011816022103818
65,2017-01-18,삼성바이오로직스오는24일결산실적공시예정,http://stock.hankyung.com/news/app/newsview.php?aid=2017011836966
66,2017-01-18,삼성바이오로직스24일결산실적공시예고,http://www.ekn.kr/news/article.html?no=262536
67,2017-01-19,인베스트조선삼성의새로운이슈어로부상한삼성바이오로직스,http://www.investchosun.com/2017/01/19/3207876
68,2017-01-19,주요공시삼성바이오로직스롯데케미칼한솔로지스틱스등,http://www.intn.co.kr/news/articleView.html?idxno=794454
69,2017-01-19,특징주삼성바이오로직스사흘째상승랠리이달24일실적발표,http://www.g-enews.com/ko-kr/news/article/news_all/201701190923464469303_1/article.html
70,2017-01-21,셀트리온삼성바이오로직스대표연임할까3월임기만료,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170120169600017&did=1195m
71,2017-01-21,셀트리온삼성바이오로직스대표연임에관심↑,http://www.cstimes.com/news/articleView.html?idxno=236555
72,2017-01-21,셀트리온삼성바이오로직스대표연임유력,http://www.ebn.co.kr/news/view/872909
73,2017-01-22,김태한삼성바이오로직스의위탁생산물량확보총력전,http://www.businesspost.co.kr/news/articleView.html?idxno=41245
74,2017-01-22,셀트리온헬스케어상장하면삼성바이오로직스따라잡을까,http://www.businesspost.co.kr/news/articleView.html?idxno=41246
75,2017-01-24,삼성바이오로직스적정주가도달투자의견↓메리츠,http://stock.hankyung.com/news/app/newsview.php?aid=2017012468676
76,2017-01-24,삼성바이오로직스작년영업손실304억원,http://www.mt.co.kr/view/mtview.php?type=1&no=2017012415560143212&outlink=1
77,2017-01-24,삼성바이오로직스지난해4Q영업손7억원전년比축소,http://www.edaily.co.kr/news/newspath.asp?newsid=03535846615801000
78,2017-01-24,삼성바이오로직스2016년매출223증가영업손익85개선,http://www.gukjenews.com/news/articleView.html?idxno=638490
79,2017-01-24,삼성바이오로직스작년매출액2946억원영업적자304억원,http://www.ebn.co.kr/news/view/873426
80,2017-01-24,삼성바이오로직스지난해영업손실304억원기록,http://www.sedaily.com/NewsView/1OAXZLGGRR
81,2017-01-24,삼성바이오로직스지난해매출2946억전년比337증가1보,http://news1.kr/articles/?2894732
82,2017-01-24,공시삼성바이오로직스지난해영업손304억원,http://www.newsway.co.kr/view.php?tp=1&ud=2017012416154241595
83,2017-01-24,삼성바이오로직스지난해4Q영업손실7억전분기比적자폭945확대,http://view.asiae.co.kr/news/view.htm?idxno=2017012416193577853
84,2017-01-24,삼성바이오로직스지난해4분기영업손실7억전분기比945↓,http://www.newsis.com/view/?id=NISX20170124_0014662210&cID=10424&pID=10400
85,2017-01-24,삼성바이오로직스지난해매출2946억원영업손실304억원,http://www.asiatoday.co.kr/view.php?key=20170124010015922
86,2017-01-24,삼성바이오로직스지난해영업손실304억전년대비85감소,https://cnbc.sbs.co.kr/article_hub/10000844332?division=NAVER
87,2017-01-24,삼성바이오로직스작년영업손실304억매출은전년비223↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1446435
88,2017-01-24,삼성바이오로직스작년매출2946억원기록,http://www.dailypharm.com/News/221483
89,2017-01-24,삼성바이오로직스지난해영업손실304억2200만원,http://view.asiae.co.kr/news/view.htm?idxno=2017012416220200281
90,2017-01-24,삼성바이오로직스영업손실304억전년대비감소,http://www.newstomato.com/ReadNews.aspx?no=726870
91,2017-01-24,삼성바이오로직스작년4분기영업손실7억원,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170124164700008&did=1195m
92,2017-01-24,삼성바이오로직스지난해연결영업손실1002억전년比적자폭378축소,http://view.asiae.co.kr/news/view.htm?idxno=2017012416321881927
93,2017-01-24,삼성바이오로직스바이오CMO사업성과가시화,http://daily.hankooki.com/lpage/ittech/201701/dh20170124163005145630.htm
94,2017-01-24,공시삼성바이오로직스지난해영업손실304억원,http://www.newsprime.co.kr/news/article.html?no=362461
95,2017-01-24,삼성바이오로직스영업손실304억적자폭은개선,http://www.mt.co.kr/view/mtview.php?type=1&no=2017012416223747978&outlink=1
96,2017-01-24,삼성바이오로직스영업적자1700억줄였다,http://view.asiae.co.kr/news/view.htm?idxno=2017012416470372045
97,2017-01-24,삼성바이오로직스매출규모223급증영업손실은줄어,http://www.fnnews.com/news/201701241653169771
98,2017-01-24,삼성바이오로직스제1공장풀가동지난해매출4배껑충상보,http://news1.kr/articles/?2894785
99,2017-01-24,삼성바이오로직스2년연속적자적자규모는개선,http://www.dailian.co.kr/news/view/608508/?sc=naver
100,2017-01-24,삼성바이오로직스지난해매출2946억원선방,http://biz.newdaily.co.kr/news/article.html?no=10124369
101,2017-01-24,삼성바이오로직스지난해영업손실304억원적자지속,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170124168200017&did=1195m
102,2017-01-24,삼성바이오로직스작년매출2946억,http://www.dt.co.kr/contents.html?article_no=2017012502100976029001
103,2017-01-24,삼성바이오로직스작년매출3배급증CMO성장가도,http://www.newspim.com/news/view/20170124000407
104,2017-01-24,삼성바이오로직스지난해영업손실304억원,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201701240282
105,2017-01-24,종합삼성바이오로직스지난해영업손실304억원전년比85개선,http://www.newsis.com/view/?id=NISX20170124_0014662273&cID=10434&pID=13000
106,2017-01-24,삼성바이오로직스매출늘고영업손실줄고CMO실적개선,http://view.asiae.co.kr/news/view.htm?idxno=2017012417165076670
107,2017-01-24,삼성바이오로직스지난해304억원영업손실전년대비85손실감소,http://www.ekn.kr/news/article.html?no=263768
108,2017-01-24,상장후첫실적발표삼성바이오로직스작년영업손실304억원전년비85감소,http://biz.chosun.com/site/data/html_dir/2017/01/24/2017012402361.html
109,2017-01-24,삼성바이오로직스2016년영업적자304억원기록,http://www.g-enews.com/ko-kr/news/article/news_all/201701241722355250358_1/article.html
110,2017-01-24,삼성바이오로직스작년영업손304억적자지속,http://www.etoday.co.kr/news/section/newsview.php?idxno=1446503
111,2017-01-24,삼성바이오로직스2016년매출223증가영업손익85개선,http://www.kukinews.com/news/article.html?no=426925
112,2017-01-24,공시삼성바이오로직스지난해영업손실304억원,http://www.ajunews.com/view/20170124180212437
113,2017-01-24,삼성바이오로직스영업손실304억원적자축소,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017012417360932317
114,2017-01-24,삼성바이오로직스지난해1768억원당기순손실적자전환,http://www.etnews.com/20170124000488
115,2017-01-24,삼성바이오로직스작년매출액223↑적자개선뚜렷,http://www.viva100.com/main/view.php?key=20170124010008540
116,2017-01-24,삼성바이오로직스작년4분기영업손실7억원,http://www.viva100.com/main/view.php?key=20170124010008531
117,2017-01-24,삼성바이오로직스지난해영업손실304억원적자폭감소종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170124168251017&did=1195m
118,2017-01-24,삼성바이오로직스작년매출2946억손실304억,http://www.dailymedi.com/detail.php?number=815163&thread=22r05
119,2017-01-24,삼성바이오로직스매출223급증,http://stock.hankyung.com/news/app/newsview.php?aid=2017012491531
120,2017-01-24,삼성바이오로직스2016년도매출액2946억원기록전년比223↑,http://www.mediaus.co.kr/news/articleView.html?idxno=78566
121,2017-01-24,삼성바이오로직스지난해영업손실304억원전년대비85감소,http://www.mdtoday.co.kr/mdtoday/index.html?no=278217
122,2017-01-24,삼성바이오로직스상장후첫결산실적발표작년매출2946억선방,http://www.ajunews.com/view/20170124104437768
123,2017-01-24,삼성바이오로직스매출1년새3배↑,http://www.fnnews.com/news/201701241859394543
124,2017-01-24,삼성바이오로직스작년4분기영업손실7억원,http://www.cstimes.com/news/articleView.html?idxno=236826
125,2017-01-24,삼성바이오로직스위탁생산늘어분기흑자전환가시화,http://www.businesspost.co.kr/news/articleView.html?idxno=41445
126,2017-01-24,공시삼성바이오로직스지난해영업손실304억원‥적자폭감소,http://www.fnnews.com/news/201701242050430716
127,2017-01-24,매출223↑영업손실85↓삼성바이오로직스실적개선,http://www.kyeongin.com/main/view.php?key=20170124010008072
128,2017-01-24,삼성바이오로직스2016년매출223증가영업손익85개선,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1303354
129,2017-01-25,삼성바이오로직스영업적자감소세,http://www.joongboo.com/?mod=news&act=articleView&idxno=1139437
130,2017-01-25,메리츠종금증권삼성바이오로직스예상웃돈견조한2공장매출4분기실적전망치상회,http://www.g-enews.com/ko-kr/news/article/news_all/201701250811566072844_1/article.html
131,2017-01-25,삼성바이오로직스국내최다바이오시밀러허가기대삼성,http://www.edaily.co.kr/news/newspath.asp?newsid=01718726615801328
132,2017-01-25,삼성바이오로직스전년비적자폭감소–메리츠,http://www.cstimes.com/news/articleView.html?idxno=236854
133,2017-01-25,클릭e종목삼성바이오로직스4Q실적전망치상회목표가16만5000원,http://view.asiae.co.kr/news/view.htm?idxno=2017012508255900529
134,2017-01-25,삼성바이오로직스4Q실적예상웃돌아메리츠증권,http://www.newstomato.com/ReadNews.aspx?no=726997
135,2017-01-25,삼성바이오로직스최다바이오시밀러허가기대삼성,http://stock.hankyung.com/news/app/newsview.php?aid=2017012503126
136,2017-01-25,삼성바이오로직스작년4분기실적예상치상회,http://www.fnnews.com/news/201701250856249270
137,2017-01-25,특징주삼성바이오로직스실적전망치상회하루만에기지개,http://www.g-enews.com/ko-kr/news/article/news_all/201701250901446294509_1/article.html
138,2017-01-25,삼성바이오로직스가장많은바이오시밀러보유”삼성증권,http://www.dailian.co.kr/news/view/608607/?sc=naver
139,2017-01-25,삼성바이오로직스지난해매출2946억영업이익304억발표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038210
140,2017-01-25,삼성바이오로직스상장후첫실적공시,http://www.m-i.kr/news/articleView.html?idxno=285693
141,2017-01-25,삼성바이오로직스지난해매출2946억원337↑,http://www.polinews.co.kr/news/article.html?no=301970
142,2017-01-25,셀트리온삼성바이오로직스대표이사임기3월중만료,http://www.mdtoday.co.kr/mdtoday/index.html?no=278156
143,2017-01-25,삼성바이오로직스적자폭줄이며순항,http://www.newstomato.com/ReadNews.aspx?no=727126
144,2017-01-25,삼성바이오로직스3분기에적자행진마감할수도,http://www.businesspost.co.kr/news/articleView.html?idxno=41480
145,2017-01-25,유가증권시장공시삼성생명삼성바이오로직스현대산업,http://news.mk.co.kr/newsRead.php?no=61097&year=2017
146,2017-01-25,삼성바이오로직스86억원규모의약품위탁생산계약수주,http://www.edaily.co.kr/news/newspath.asp?newsid=04618246615801328
147,2017-01-25,삼성바이오로직스스위스제약회사와위탁생산계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170125199700008&did=1195m
148,2017-01-25,삼성바이오로직스스위스제약회사와86억원규모공급계약체결,http://www.asiatoday.co.kr/view.php?key=20170125010017027
149,2017-01-25,삼성바이오로직스스위스제약회사와85억규모의약품위탁생산계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1447312
150,2017-01-25,삼성바이오로직스85억규모의약품위탁생산계약,http://www.newspim.com/news/view/20170125000467
151,2017-01-25,삼성바이오로직스86억원규모의약품위탁생산계약체결,https://cnbc.sbs.co.kr/article_hub/10000844577?division=NAVER
152,2017-01-25,삼성바이오로직스4분기실적예상치상회,http://www.econovill.com/news/articleView.html?idxno=307823
153,2017-01-25,삼성바이오로직스86억규모의약품위탁생산계약체결,http://www.newsis.com/view/?id=NISX20170125_0014665538&cID=10424&pID=10400
154,2017-01-25,삼성바이오로직스스위스로슈와86억원규모의약품생산계약,http://news1.kr/articles/?2896201
155,2017-01-25,삼성바이오로직스스위스제약사와858억원규모위탁생산계약,http://www.newstomato.com/ReadNews.aspx?no=727355
156,2017-01-25,삼성바이오로직스스위스기업과85억규모공급계약,http://view.asiae.co.kr/news/view.htm?idxno=2017012521133223295
157,2017-01-26,유가증권기업공시25일삼성바이오로직스등,http://stock.hankyung.com/news/app/newsview.php?aid=2017012632261
158,2017-01-26,삼성바이오로직스스위스제약사위탁생산계약,http://www.dailymedi.com/detail.php?number=815205&thread=22r05
159,2017-01-26,기업분석삼성바이오로직스올해3분기분기최초흑자전환예상다수의파이프라인모멘텀기대,http://www.g-enews.com/ko-kr/news/article/news_all/201701251747368282541_1/article.html
160,2017-01-26,stockinside삼성바이오로직스주가다시날갯짓2공장가동률업,http://www.g-enews.com/ko-kr/news/article/news_all/201701251720048101452_1/article.html
161,2017-01-26,벼르는삼성바이오로직스주가반등하나,http://www.whitepaper.co.kr/news/articleView.html?idxno=80485
162,2017-01-26,특징주삼성바이오로직스스위스제약사와86억원공급계약에급등,http://view.asiae.co.kr/news/view.htm?idxno=2017012615092149608
163,2017-01-30,삼성바이오로직스매출223급증,http://www.kgnews.co.kr/news/articleView.html?idxno=472511
164,2017-01-31,삼성바이오로직스올영업흑자예상목표가↑유진,http://stock.hankyung.com/news/app/newsview.php?aid=2017013199266
165,2017-01-31,삼성바이오로직스예상보다빠른성장유진투자,http://www.newstomato.com/ReadNews.aspx?no=727819
166,2017-01-31,오늘의종목삼성바이오로직스올해흑자전환의원년으로만든다,http://www.sedaily.com/NewsView/1OB16IXY6N
167,2017-01-31,특징주삼성바이오로직스수익성개선기대외인매수16만원선안착하나,http://www.g-enews.com/ko-kr/news/article/news_all/201701310913380595567_1/article.html
168,2017-01-31,유진證삼성바이오로직스우호적시장환경목표가26상향,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201701310061
169,2017-02-02,특징주삼성바이오로직스고성장흑자전환기대이틀째상승행진,http://www.g-enews.com/ko-kr/news/article/news_all/201702020924340756206_1/article.html
170,2017-02-02,특징주삼성바이오로직스트럼프정책수혜기대에강세,http://www.ebn.co.kr/news/view/874624
171,2017-02-02,특징주삼성바이오로직스흑전전망트럼프발언강세,http://view.asiae.co.kr/news/view.htm?idxno=2017020210035460853
172,2017-02-02,삼성바이오로직스본격수익궤도들어섰나,http://www.choicenews.co.kr/news/articleView.html?idxno=31298
173,2017-02-02,fnRASSI삼성바이오로직스207940현재583,http://www.fnnews.com/news/201702021308458619
174,2017-02-02,특징주삼성바이오로직스흑자전환기대감에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=03319366615826584
175,2017-02-02,종목플러스삼성바이오로직스실적확인후고공비행,http://stock.hankyung.com/news/app/newsview.php?aid=2017020276446
176,2017-02-02,특징주삼성바이오로직스흑자전환기대감에이틀째강세트럼프발언도영향,http://biz.chosun.com/site/data/html_dir/2017/02/02/2017020202041.html
177,2017-02-02,코스피외국인순매수아모레퍼시픽삼성바이오로직스하나금융지주,http://www.newsway.co.kr/view.php?tp=1&ud=2017020216152739118
178,2017-02-02,코스피기관순매수LG전자LG화학삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2017020216164355347
179,2017-02-02,특징주UPDOWN한진해운기업회생절차폐지결정에급락아모레퍼시픽등화장품주美국방장관사드논의방한에약세삼성바이오로직스강세비트코인관련주약세,http://www.bithub.co.kr/news/articleView.html?idxno=11013
180,2017-02-03,특징주삼성바이오로직스외인러브콜18만원선넘을까,http://www.g-enews.com/ko-kr/news/article/news_all/201702030917070512045_1/article.html
181,2017-02-03,특징주삼성바이오로직스사흘째강세실적기대,http://stock.hankyung.com/news/app/newsview.php?aid=2017020395206
182,2017-02-03,로봇뉴스삼성바이오로직스_기관외국인쌍끌이매수로주가가탄력받아현재262,http://www.etnews.com/20170203000063
183,2017-02-03,특징주삼성바이오로직스트럼프정책수혜기대에사흘째강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=74094
184,2017-02-03,개장전특징주삼성바이오로직스207940,http://www.newstomato.com/ReadNews.aspx?no=728956
185,2017-02-03,특검금융위압수수색삼성바이오로직스상장특혜의혹조사,http://news.einfomax.co.kr/news/articleView.html?idxno=299826
186,2017-02-05,미국트럼프정부의료정책수혜셀트리온삼성바이오로직스등바이오시밀러주눈여겨볼만,http://stock.hankyung.com/news/app/newsview.php?aid=2017020528631
187,2017-02-06,바이오전공대학생취업선호도1위는삼성바이오로직스LG생활건강,http://www.rapportian.com/news/articleView.html?idxno=101794
188,2017-02-06,삼성바이오로직스공정감사관바이오의약품규제준수가장중요”,http://www.ebn.co.kr/news/view/875101
189,2017-02-06,출발UPDOWN우리은행삼성바이오로직스,http://www.newstomato.com/ReadNews.aspx?no=729378
190,2017-02-07,특징주삼성바이오로직스17만원선재탈환눈앞,http://www.g-enews.com/ko-kr/news/article/news_all/201702070913000622462_1/article.html
191,2017-02-07,삼성바이오로직스트럼프수혜본격기대,http://www.choicenews.co.kr/news/articleView.html?idxno=31389
192,2017-02-07,로봇뉴스제약주테마_삼성바이오로직스변동성대비상승률최대,http://www.etnews.com/20170207000158
193,2017-02-07,檢삼성그룹정조준악재에도삼성바이오로직스주가상승세,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=684193
194,2017-02-08,특검삼성바이오로직스삼성합병의혹연관성들여다본다,http://www.newspim.com/news/view/20170207000350
195,2017-02-09,특징주삼성바이오로직스하루만에날갯짓외인사자,http://www.g-enews.com/ko-kr/news/article/news_all/201702090906040432395_1/article.html
196,2017-02-10,단독청와대삼성바이오로직스상장도왔다,http://www.hankookilbo.com/v/cee345115ac1477e9430d156802031ba
197,2017-02-10,삼성바이오로직스상장에무슨일이궁지에몰린금융위,http://www.etoday.co.kr/news/section/newsview.php?idxno=1453343
198,2017-02-10,특징주삼성바이오로직스외인매수16만원선이탈,http://www.g-enews.com/ko-kr/news/article/news_all/201702100923230697097_1/article.html
199,2017-02-10,특징주상장특혜의혹삼성바이오로직스3거래일연속하락,http://view.asiae.co.kr/news/view.htm?idxno=2017021009334020924
200,2017-02-10,특검삼성바이오로직스주식상장에청와대개입,http://www.sisunnews.co.kr/news/articleView.html?idxno=48714
201,2017-02-10,특징주삼성바이오로직스상장특혜의혹약세,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017021010048057885&outlink=1
202,2017-02-10,삼성바이오로직스상장특혜의혹에연일하락세,http://www.newsprime.co.kr/news/article.html?no=364118
203,2017-02-10,청와대는삼성바이오로직스상장도우미,http://sports.khan.co.kr/news/sk_index.html?art_id=201702101030003&sec_id=560901&pt=nv
204,2017-02-10,靑상장특혜의혹삼성바이오로직스오전10시50분15만8000원으로뚝,http://news20.busan.com/controller/newsController.jsp?newsId=20170210000080
205,2017-02-10,삼성바이오로직스상장을청와대가도왔다고,http://www.kukinews.com/news/article.html?no=430924
206,2017-02-10,삼성그룹삼성바이오로직스상장특혜사실무근,http://news1.kr/articles/?2908742
207,2017-02-10,삼성바이오로직스상장특혜사실무근,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170210086000003&did=1195m
208,2017-02-10,삼성바이오로직스특혜상장의혹은사실아냐,http://www.asiatoday.co.kr/view.php?key=20170210010006748
209,2017-02-10,삼성바이오로직스상장금융당국특혜없었다반박,http://www.mt.co.kr/view/mtview.php?type=1&no=2017021011521867121&outlink=1
210,2017-02-10,삼성바이오로직스상장과정에서금융위등도움받은적없어,http://www.newsis.com/view/?id=NISX20170210_0014696605&cID=10406&pID=13000
211,2017-02-10,삼성바이오로직스상장특혜없었다반박,http://www.dailian.co.kr/news/view/611843/?sc=naver
212,2017-02-10,삼성바이오로직스금감위도움없었다,http://www.dailypharm.com/News/221996
213,2017-02-10,삼성바이오로직스상장특혜사실무근”,http://www.g-enews.com/ko-kr/news/article/news_all/201702101239221169877_1/article.html
214,2017-02-10,삼성바이오로직스청와대에상장로비나스닥가려했다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038825
215,2017-02-10,삼성바이오로직스청와대개입된상장특혜사실무근”,http://www.ajunews.com/view/20170210122508196
216,2017-02-10,삼성바이오로직스상장과정서특혜받은적없없다,http://view.asiae.co.kr/news/view.htm?idxno=2017021013093804208
217,2017-02-10,삼성바이오로직스상장특혜전혀사실아냐반박,http://biz.newdaily.co.kr/news/article.html?no=10125569
218,2017-02-10,삼성바이오로직스상장관련청와대도움없었다,http://news.mk.co.kr/newsRead.php?&year=2017&no=95778
219,2017-02-10,삼성바이오로직스상장관련지원특혜사실무근,http://www.ebn.co.kr/news/view/876220
220,2017-02-10,삼성삼성바이오로직스상장특혜없었다규정에따라진행”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1453579
221,2017-02-10,삼성바이오로직스상장서금융당국도움없었다,http://www.shinailbo.co.kr/news/articleView.html?idxno=557350
222,2017-02-10,상장특혜의혹에삼성바이오로직스사실무근,http://www.dt.co.kr/contents.html?article_no=2017021002109976029004
223,2017-02-10,삼성바이오로직스상장때금감위등도움없어,http://www.fnnews.com/news/201702101345250029
224,2017-02-10,삼성바이오로직스코스닥상장특혜사실아냐해명,http://www.kukinews.com/news/article.html?no=430999
225,2017-02-10,삼성바이오로직스상장금감위도움없었다”,http://www.econovill.com/news/articleView.html?idxno=308891
226,2017-02-10,삼성바이오로직스거래소권유로상장도움혜택없었다,http://view.asiae.co.kr/news/view.htm?idxno=2017021013570888972
227,2017-02-10,삼성바이오로직스상장과정서금융당국특혜없었다”,http://www.fntimes.com/paper/view.aspx?num=172937
228,2017-02-10,삼성바이오로직스상장특혜의혹전혀사실아냐,http://www.inews24.com/php/news_view.php?g_serial=1006013&g_menu=022100&rrf=nv
229,2017-02-10,삼성바이오로직스상장과정서금융위도움안받았다,http://www.newspim.com/news/view/20170210000230
230,2017-02-10,삼성삼성바이오로직스상장특혜의혹전혀사실아니다,http://www.anewsa.com/detail.php?number=1126867&thread=10r02
231,2017-02-10,삼성그룹삼성바이오로직스상장때금감위도움없었다”,http://www.newsway.co.kr/view.php?tp=1&ud=2017021015081837553
232,2017-02-10,삼성삼성바이오로직스상장특혜사실무근,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017021014348085505&outlink=1
233,2017-02-10,삼성바이오로직스상장논란왜뜨겁나,http://www.pressian.com/news/article.html?no=150510&ref=nav_search
234,2017-02-10,삼성바이오로직스정부상장지원은사실무근,http://www.koreaittimes.com/story/65238/%EC%82%BC%EC%84%B1%EB%B0%94%EC%9D%B4%EC%98%A4%EB%A1%9C%EC%A7%81%EC%8A%A4-%EC%A0%95%EB%B6%80-%EC%83%81%EC%9E%A5%EC%A7%80%EC%9B%90%EC%9D%80-%EC%82%AC%EC%8B%A4%EB%AC%B4%EA%B7%BC
235,2017-02-10,SK하이닉스삼성바이오로직스심상찮다,http://www.choicenews.co.kr/news/articleView.html?idxno=31488
236,2017-02-10,삼성바이오로직스상장청와대입김작용했나특혜의혹사실아니다”,http://www.mdtoday.co.kr/mdtoday/index.html?no=279082
237,2017-02-10,삼성바이오로직스상장과정서특혜없었다,http://www.nocutnews.co.kr/news/4731784
238,2017-02-10,삼성바이오로직스코스피상장금융위등도움받은바없다,http://www.fnnews.com/news/201702101720344324
239,2017-02-10,코스피기관순매도삼성바이오로직스한국항공우주LG유플러스,http://www.newsway.co.kr/view.php?tp=1&ud=2017021017384082263
240,2017-02-10,삼성바이오로직스상장특혜사실무근,http://www.obsnews.co.kr/news/articleView.html?idxno=1028538
241,2017-02-10,삼성바이오로직스상장특혜논란공방,http://www.sisafocus.co.kr/news/articleView.html?idxno=157231
242,2017-02-11,삼성바이오로직스상장청와대개입설부인설명들어보니,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20170211.99002012502
243,2017-02-11,삼성바이오로직스상장특혜없었다”해명,http://www.dailymedi.com/detail.php?number=815667&thread=22r05
244,2017-02-11,삼성바이오로직스상장특혜사실무근,http://www.ceoscoredaily.com/news/article.html?no=27115
245,2017-02-11,삼성바이오로직스이상한회계의혹빠른흑자전환배경,http://www.nocutnews.co.kr/news/4731996
246,2017-02-12,삼성바이오로직스특혜논란으로도마삼성그룹측사실무근반박,http://www.ekn.kr/news/article.html?no=267142
247,2017-02-13,클릭e종목삼성바이오로직스코스피200편입확정적,http://view.asiae.co.kr/news/view.htm?idxno=2017021306482711410
248,2017-02-13,인베스트조선국민들이삼성바이오로직스코스피상장을기대했나,http://www.investchosun.com/2017/02/13/3208887
249,2017-02-13,삼성바이오로직스코스피200편입관심높아져유안타증권,http://www.ebn.co.kr/news/view/876412
250,2017-02-13,삼성바이오로직스코스피200편입확정적시기의문제,http://news.einfomax.co.kr/news/articleView.html?idxno=303366
251,2017-02-13,삼성바이오로직스코스피200편입확정적유안타증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017021308311869122
252,2017-02-13,삼성바이오로직스약만팔아먹고”트럼프엄포어쩌나,http://www.koreaittimes.com/story/65301/%EC%82%BC%EC%84%B1%EB%B0%94%EC%9D%B4%EC%98%A4%EB%A1%9C%EC%A7%81%EC%8A%A4-%ED%8A%B8%EB%9F%BC%ED%94%84-%EC%97%84%ED%8F%AC-%EC%96%B4%EC%A9%8C%EB%82%98
253,2017-02-13,stock톡유안타證삼성바이오로직스코스피200편입은확정적”,http://www.newsway.co.kr/view.php?tp=1&ud=2017021308530788838
254,2017-02-13,이슈진단삼성바이오로직스악재호재팽팽어느쪽이이길까주가도힘겨루기,http://www.g-enews.com/ko-kr/news/article/news_all/201702131024220814531_1/article.html
255,2017-02-13,심상정대표삼성바이오로직스특혜상장관련회견,http://news1.kr/photos/view/?2382629
256,2017-02-13,삼성바이오로직스특혜상장의혹제기하는심상정대표,http://news1.kr/photos/view/?2382627
257,2017-02-13,심상정청와대의삼성바이오로직스특혜상장의혹,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170213125400013&did=1196m
258,2017-02-13,심상정청와대의삼성바이오로직스특혜상장의혹,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170213126000013&did=1196m
259,2017-02-13,심상정청와대의삼성바이오로직스특혜상장의혹,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170213126500013&did=1196m
260,2017-02-13,심상정청와대의삼성바이오로직스특혜상장의혹,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170213126100013&did=1196m
261,2017-02-13,심상정삼성바이오로직스특혜상장의혹,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170213126200013&did=1196m
262,2017-02-13,삼성바이오로직스당초나스닥상장추진이제와서문제삼다니,http://www.metroseoul.co.kr/news/newsview?newscd=2017021300106
263,2017-02-13,삼성바이오로직스코스피200지수편입언제쯤,http://www.edaily.co.kr/news/newspath.asp?newsid=03870406615830192
264,2017-02-13,포토심상정정의당대표삼성바이오로직스특혜상장과편법회계의혹,http://www.newsway.co.kr/view.php?tp=1&ud=2017021316231115474
265,2017-02-13,포토심상정대표삼성바이오로직스특혜상장관련회견,http://www.newsway.co.kr/view.php?tp=1&ud=2017021316270558726
266,2017-02-13,거래소깔아준판에응했을뿐인데삼성바이오로직스상장재구성,http://news1.kr/articles/?2909202
267,2017-02-13,삼성바이오로직스상장뜯어보니수상한회계,http://www.hani.co.kr/arti/economy/finance/782496.html
268,2017-02-14,심상정송도삼성바이오로직스특혜의혹특검조사촉구,http://www.joongboo.com/?mod=news&act=articleView&idxno=1143802
269,2017-02-14,삼성바이오로직스에특혜상장의혹이수그러들지않는이유는,http://www.nocutnews.co.kr/news/4733147
270,2017-02-14,상장특혜의혹삼성바이오로직스나스닥진출더원했었다,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20170214002322
271,2017-02-14,상장특혜논란에코스피200공염불되나방향타잃은삼성바이오로직스,http://www.ebn.co.kr/news/view/876745
272,2017-02-14,삼성바이오로직스상장특혜의혹논란재점화,http://www.sisafocus.co.kr/news/articleView.html?idxno=157337
273,2017-02-14,삼성바이오로직스해외상장겨우막았더니”,http://www.munhwa.com/news/view.html?no=2017021401070221305001
274,2017-02-14,삼성바이오로직스편법회계논란,http://www.naeil.com/news_view/?id_art=227369
275,2017-02-14,삼성바이오로직스상장과정에특혜없었다부인,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170214178900017&did=1195m
276,2017-02-14,삼성바이오로직스상장과정서특혜없었다,http://www.viva100.com/main/view.php?key=20170214010004776
277,2017-02-14,삼성바이오로직스상장과정뿐아니라상장후에도특혜없어,http://www.newsis.com/view/?id=NISX20170214_0014704711&cID=10434&pID=13000
278,2017-02-14,삼성바이오로직스상장과정특혜없었다의혹부인,http://www.etnews.com/20170214000319
279,2017-02-14,삼성바이오로직스상장과정에특혜없었다”부인,http://news.kbs.co.kr/news/view.do?ncd=3428824&ref=A
280,2017-02-14,삼성바이오로직스자회사회계인식변경상장에영향없었다,http://www.mt.co.kr/view/mtview.php?type=1&no=2017021419262340235&outlink=1
281,2017-02-14,삼성바이오로직스상장특혜없었다공식입장밝혀,http://biz.chosun.com/site/data/html_dir/2017/02/14/2017021403154.html
282,2017-02-15,특징주삼성바이오로직스상장과정및상장후에도어떤특혜도받은바없다6거래일만에기지개,http://www.g-enews.com/ko-kr/news/article/news_all/201702150923530697097_1/article.html
283,2017-02-15,김태한사장삼성바이오로직스상장특혜없었다,http://www.newspim.com/news/view/20170215000137
284,2017-02-15,삼성바이오로직스상장과삼성물산합병연관관계없어”,http://www.ebn.co.kr/news/view/877023
285,2017-02-15,삼성바이오로직스세금낼형편안되는데기업가치5조,http://www.hani.co.kr/arti/economy/stock/782774.html
286,2017-02-16,특검朴대통령삼성바이오로직스지원지시정황포착,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170215202500008&did=1195m
287,2017-02-16,삼성바이오로직스국민연금투자유치나섰다,http://www.mt.co.kr/view/mtview.php?type=1&no=2017021316064353543&outlink=1
288,2017-02-16,임종룡금융위원장삼성바이오로직스상장관련청와대압력없었다,http://www.ajunews.com/view/20170216113933384
289,2017-02-16,진웅섭삼성바이오로직스분식회계의혹감리협의하겠다,http://www.newsis.com/view/?id=NISX20170216_0014709218&cID=10301&pID=10300
290,2017-02-16,진웅섭삼성바이오로직스특별감리논의해볼것,http://news1.kr/articles/?2913520
291,2017-02-16,사진진웅섭삼성바이오로직스특별감리논의할것,http://www.mt.co.kr/view/mtview.php?type=1&no=2017021613252942525&outlink=1
292,2017-02-16,朴대통령삼성바이오로직스지원지시정황,http://www.joongdo.co.kr/jsp/article/article_view.jsp?pq=201702161932
293,2017-02-16,적자기업삼성바이오로직스는어떻게10조원기업이됐나,http://www.edaily.co.kr/news/newspath.asp?newsid=03257046615831176
294,2017-02-16,삼성바이오로직스특별감리유관기관과협의후결정할것,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170216110400008&did=1195m
295,2017-02-16,임종룡삼성바이오로직스코스피상장위해규제완화시사,http://www.ajunews.com/view/20170216121918417
296,2017-02-16,진웅섭특혜의혹삼성바이오로직스특별감리논의하겠다”,http://www.fntimes.com/paper/view.aspx?num=173433
297,2017-02-16,진웅섭삼성바이오로직스특별감리검토할것”,http://www.viva100.com/main/view.php?key=20170216010005451
298,2017-02-16,삼성바이오로직스특별감리유관기관과협의후결정할것,http://news.sbs.co.kr/news/endPage.do?news_id=N1004047461&plink=ORI&cooper=NAVER
299,2017-02-16,진웅섭삼성바이오로직스특별감리금융위와협의해결정,http://www.ajunews.com/view/20170216150402677
300,2017-02-16,진웅섭삼성바이오로직스특혜의혹특별감리검토하겠다,http://www.asiatoday.co.kr/view.php?key=20170216010010969
301,2017-02-16,삼성바이오로직스편법회계주장은바이오업계이해못한탓,http://www.metroseoul.co.kr/news/newsview?newscd=2017021600164
302,2017-02-16,진웅섭원장삼성바이오로직스특별감리여부검토할것,http://www.newsprime.co.kr/news/article.html?no=364918
303,2017-02-16,임종룡삼성바이오로직스관련청와대지시압력없었다종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170216163400002&did=1195m
304,2017-02-16,진웅섭금감원장삼성바이오로직스특별감리협의,http://www.sisafocus.co.kr/news/articleView.html?idxno=157479
305,2017-02-16,삼성바이오로직스분식회계의혹금감원특별감리실시검토키로,http://www.cstimes.com/news/articleView.html?idxno=238759
306,2017-02-16,임종룡삼성바이오로직스관련특혜없었다,http://www.sporbiz.co.kr/news/articleView.html?idxno=78504
307,2017-02-16,삼성바이오로직스회계감리다시이뤄지나,http://www.hani.co.kr/arti/economy/finance/782938.html
308,2017-02-16,금감원장삼성바이오로직스특별감리논의해보겠다,http://www.fnnews.com/news/201702161727054017
309,2017-02-16,종합금감원편법회계의혹삼성바이오로직스감리검토,http://www.newsis.com/view/?id=NISX20170216_0014710056&cID=10201&pID=10200
310,2017-02-16,진웅섭삼성바이오로직스특별감리논의해볼것,http://www.ebn.co.kr/news/view/877308
311,2017-02-16,삼성바이오로직스분식회계특혜진실공방,http://www.intn.co.kr/news/articleView.html?idxno=794950
312,2017-02-16,특검朴대통령삼성바이오로직스지원지시정황포착종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170215202551008&did=1195m
313,2017-02-16,제윤경금융위삼성바이오로직스상장에혜택˝,http://www.sisaon.co.kr/news/articleView.html?idxno=52332
314,2017-02-16,특검朴대통령삼성바이오로직스지원지시정황포착종합,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10202478
315,2017-02-16,특검朴대통령삼성바이오로직스지원지시정황포착,http://www.ebn.co.kr/news/view/877330
316,2017-02-16,진웅섭금감원장삼성바이오로직스특별감리금융위등과논의,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017021616123153437
317,2017-02-17,꺼지지않는삼성바이오로직스특혜상장의혹오얏나무밑에서갓끈고쳐맸다,http://www.nocutnews.co.kr/news/4735181
318,2017-02-17,특검박근혜대통령삼성바이오로직스지원정황포착,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0100&key=20170217.99002003055
319,2017-02-17,금감원편법회계의혹삼성바이오로직스감리검토,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002717710
320,2017-02-17,글로벌6위삼성바이오로직스IPO아시아우수상수상,http://news1.kr/articles/?2914777
321,2017-02-17,삼성바이오로직스특혜상장의혹재부각,https://cnbc.sbs.co.kr/article_hub/10000847662?division=NAVER
322,2017-02-17,李구속에삼성바이오로직스특혜상장등의혹재부각,https://cnbc.sbs.co.kr/article_hub/10000847677?division=NAVER
323,2017-02-19,CJCGV녹십자홀딩스GS건설LIG넥스원동서삼성바이오로직스코스피200지수편입땐수백억자금유입,http://stock.hankyung.com/news/app/newsview.php?aid=2017021900691
324,2017-02-20,이재용옭아맨삼성바이오로직스논란두쟁점,http://www.seoul.co.kr/news/newsView.php?id=20170220017012&wlog_tag3=naver
325,2017-02-20,금감원삼성바이오로직스의혹조사,http://www.naeil.com/news_view/?id_art=228165
326,2017-02-21,특징주삼성바이오로직스사흘째상승행진외인러브콜,http://www.g-enews.com/ko-kr/news/article/news_all/201702210925070708071_1/article.html
327,2017-02-21,삼성바이오로직스3월코스피200지수편입가능성희박,http://www.choicenews.co.kr/news/articleView.html?idxno=31689
328,2017-02-21,금감원삼성바이오로직스의혹감리검토,http://www.ytn.co.kr/_ln/0102_201702211539031941
329,2017-02-21,삼성바이오로직스는왜2011년에설립했나,http://www.viva100.com/main/view.php?key=20170221010006951
330,2017-02-21,금감원상장특혜의혹삼성바이오로직스감리착수검토,http://www.kukinews.com/news/article.html?no=433928
331,2017-02-22,특징주삼성바이오로직스나흘째오름세17만원도전,http://www.g-enews.com/ko-kr/news/article/news_all/201702220913190663581_1/article.html
332,2017-02-23,이슈진단삼성바이오로직스IFRS의무이행특혜없었다,http://www.g-enews.com/ko-kr/news/article/news_all/201702221627042353354_1/article.html
333,2017-02-23,삼성바이오로직스매수가170500원비중80,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201702230015
334,2017-02-23,사진삼성바이오로직스최우수IB기업수상,http://www.mt.co.kr/view/mtview.php?type=1&no=2017022316005260084&outlink=1
335,2017-02-27,기자수첩영업적자304억원에편법회계의혹의삼성바이오로직스,http://www.kukinews.com/news/article.html?no=435237
336,2017-02-27,삼성바이오로직스내달24일주총개최,http://www.mt.co.kr/view/mtview.php?type=1&no=2017022715555147724&outlink=1
337,2017-02-27,삼성바이오로직스3월24일정기주총소집,http://www.newstomato.com/ReadNews.aspx?no=735115
338,2017-02-27,삼성바이오로직스내달24일주총김태한대표재선임,http://www.ebn.co.kr/news/view/879116
339,2017-02-27,삼성바이오로직스김태한대표이사세번째연임결정,http://news1.kr/articles/?2923034
340,2017-02-28,특징주삼성바이오로직스17만원넘나이틀째오름세,http://www.g-enews.com/ko-kr/news/article/news_all/201702280926230706284_1/article.html
341,2017-02-28,말한마디로2조7천억원삼성바이오로직스의마법,http://newstapa.org/38392
342,2017-03-06,삼성바이오로직스휴미라특허소송첫승소긍정적동부,http://www.edaily.co.kr/news/newspath.asp?newsid=01603926615860696
343,2017-03-06,삼성바이오로직스바이오시밀러사업긍정적전망동부증권,http://www.fntimes.com/paper/view.aspx?num=174782
344,2017-03-06,동부증권삼성바이오로직스유럽출시시기가앞당겨질수있다자회사삼성바이오에피스영국휴리마특허무효소송승소,http://www.g-enews.com/ko-kr/news/article/news_all/201703060841040259205_1/article.html
345,2017-03-06,삼성바이오로직스휴미라특허소송첫승소호재동부,http://www.cstimes.com/news/articleView.html?idxno=240205
346,2017-03-06,특징주삼성바이오로직스휴미라특허무효소송승소에↑,http://view.asiae.co.kr/news/view.htm?idxno=2017030611115456590
347,2017-03-08,이슈진단10일DDay시총규모별지수변경삼성바이오로직스두산밥캣등대형주지수신규편입체급따라수익률도희비,http://www.g-enews.com/ko-kr/news/article/news_all/201703071555241824682_1/article.html
348,2017-03-10,삼성바이오로직스자회사단기차입금462억증가결정,http://www.mt.co.kr/view/mtview.php?type=1&no=2017031015593216431&outlink=1
349,2017-03-10,삼성바이오로직스삼성바이오에피스2143억원규모유상증자결정,http://www.mt.co.kr/view/mtview.php?type=1&no=2017031016054777635&outlink=1
350,2017-03-10,삼성바이오로직스삼성바이오에피스에2143억규모유상증자결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1466223
351,2017-03-10,삼성바이오로직스유상증자삼성바이오에피스자금조달,http://www.ebn.co.kr/news/view/881104
352,2017-03-10,유가증권시장공시동원FB삼성바이오로직스SOil,http://news.mk.co.kr/newsRead.php?&year=2017&no=167086
353,2017-03-11,삼성바이오로직스이유있는外人순매수,http://www.choicenews.co.kr/news/articleView.html?idxno=32024
354,2017-03-13,주요공시삼성바이오로직스포스코바른손등,http://www.intn.co.kr/news/articleView.html?idxno=795379
355,2017-03-13,유가증권시장공시삼성바이오로직스쌍방울한전KPS등,http://news.mk.co.kr/newsRead.php?&year=2017&no=172081
356,2017-03-13,삼성바이오로직스불성실공시법인으로지정예고,http://www.newsis.com/view/?id=NISX20170313_0014761476&cID=10401&pID=10400
357,2017-03-13,한국거래소삼성바이오로직스불성실공시법인지정예고,http://www.edaily.co.kr/news/newspath.asp?newsid=04201686615862992
358,2017-03-13,삼성바이오로직스불성실공시법인지정예고,http://www.mt.co.kr/view/mtview.php?type=1&no=2017031318024695088&outlink=1
359,2017-03-13,삼성바이오로직스불성실공시법인지정예고,http://www.asiatoday.co.kr/view.php?key=20170313010008335
360,2017-03-13,삼성바이오로직스공시불이행사유로불성실공시법인지정예고,http://view.asiae.co.kr/news/view.htm?idxno=2017031318222030946
361,2017-03-13,삼성바이오로직스불성실공시법인지정예고,http://www.etoday.co.kr/news/section/newsview.php?idxno=1467183
362,2017-03-13,삼성바이오로직스불성실공시법인지정예고,http://www.ebn.co.kr/news/view/881450
363,2017-03-13,삼성바이오로직스불성실공시법인지정예고,http://www.newspim.com/news/view/20170313000324
364,2017-03-13,삼성바이오로직스지연공시지정에업무착오해명,http://news1.kr/articles/?2935183
365,2017-03-13,삼성바이오로직스불성실공시법인지정예고,http://www.dt.co.kr/contents.html?article_no=2017031302109976029007
366,2017-03-13,삼성바이오로직스자회사지연공시단순업무착오,http://www.ebn.co.kr/news/view/881461
367,2017-03-13,한국거래소삼성바이오로직스불성실공시법인지정예고,https://cnbc.sbs.co.kr/article_hub/10000850910?division=NAVER
368,2017-03-14,장마감후공시삼성바이오로직스불성실공시법인으로지정예고外,http://www.newsis.com/view/?id=NISX20170313_0014761478&cID=10401&pID=10400
369,2017-03-14,특징주삼성바이오로직스외인잇단러브콜불성실공시법인지정예고에도사흘째날갯짓,http://www.g-enews.com/ko-kr/news/article/news_all/201703140923470711928_1/article.html
370,2017-03-14,삼성바이오로직스불성실공시법인지정예고왜,http://www.hankyung.com/news/app/newsview.php?aid=201703147677A
371,2017-03-14,외국인의힘분위기탄삼성바이오로직스,http://www.mt.co.kr/view/mtview.php?type=1&no=2017031409194999810&outlink=1
372,2017-03-14,삼성바이오로직스시총셀트리온역전코앞,http://news.mk.co.kr/newsRead.php?&year=2017&no=174910
373,2017-03-14,셀트리온시총턱밑삼성바이오로직스대장주바뀔까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1467698
374,2017-03-14,삼성바이오로직스감사보고지연KRX불성실공시법인지정예고,http://www.kyeongin.com/main/view.php?key=20170314010005054
375,2017-03-15,매일장보는남녀삼성바이오로직스207940,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002744759
376,2017-03-15,삼성바이오로직스바이오대장주셀트리온추월임박,http://www.newsis.com/view/?id=NISX20170315_0014765483&cID=10401&pID=10400
377,2017-03-15,삼성바이오로직스셀트리온시가총액앞질렀다,http://www.choicenews.co.kr/news/articleView.html?idxno=32112
378,2017-03-15,셀트리온제친삼성바이오로직스자리바뀐바이오대장株,http://www.mt.co.kr/view/mtview.php?type=1&no=2017031515481294445&outlink=1
379,2017-03-15,바이오대장주7년만에정권교체삼성바이오로직스시총1위,http://www.etoday.co.kr/news/section/newsview.php?idxno=1468150
380,2017-03-15,삼성바이오로직스시가총액에서셀트리온제쳐,http://www.businesspost.co.kr/news/articleView.html?idxno=44917
381,2017-03-16,삼성바이오로직스시총셀트리온넘어바이오대장자리변경,http://www.g-enews.com/ko-kr/news/article/news_all/201703151758122712500_1/article.html
382,2017-03-17,삼성바이오로직스시총셀트리온역전코앞,http://premium.mk.co.kr/view.php?no=18089
383,2017-03-17,특징주삼성바이오로직스사흘째상승외인러브콜,http://www.g-enews.com/ko-kr/news/article/news_all/201703170911580498410_1/article.html
384,2017-03-21,특징주삼성바이오로직스19만원넘었다닷새연속상승랠리,http://www.g-enews.com/ko-kr/news/article/news_all/201703210915331565c642673384_1/article.html
385,2017-03-21,삼성바이오로직스5거래일연속상승세이틀연속신고가행진,http://news.heraldcorp.com/view.php?ud=20170321000289
386,2017-03-21,개장전특징주삼성바이오로직스207940,http://www.newstomato.com/ReadNews.aspx?no=740003
387,2017-03-21,fnRASSI삼성바이오로직스207940현재507↑,http://www.fnnews.com/news/201703211401394979
388,2017-03-21,바이오업종대장주자리꿰찬삼성바이오로직스시총13조육박,http://www.mdtoday.co.kr/mdtoday/index.html?no=281705
389,2017-03-22,특징주삼성바이오로직스주가20만원시대열리나6거래일연속상승랠리,http://www.g-enews.com/ko-kr/news/article/news_all/201703220931089317c642673384_1/article.html
390,2017-03-22,삼성바이오로직스바이오대장주꿰차고쑥쑥,http://view.asiae.co.kr/news/view.htm?idxno=2017032211112434176
391,2017-03-23,특징주삼성바이오로직스외인매수하루만에19만원회복,http://www.g-enews.com/ko-kr/news/article/news_all/201703230912204451c642673384_1/article.html
392,2017-03-23,삼성바이오로직스헬스케어대장株굳히기트럼프케어변수,http://www.ebn.co.kr/news/view/883212
393,2017-03-23,삼성바이오로직스CMO리더십4회연속수상,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170323092400017&did=1195m
394,2017-03-23,삼성바이오로직스CMO리더십4회연속수상,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170323164600017&did=1196m
395,2017-03-23,삼성바이오로직스CMO리더십어워즈서6개부문석권,http://www.fnnews.com/news/201703231259449540
396,2017-03-23,삼성바이오로직스CMO리더십전부문석권,http://www.sedaily.com/NewsView/1ODHE7Y5CO
397,2017-03-23,삼성바이오로직스글로벌CMO평가전부분석권,http://news.mk.co.kr/newsRead.php?&year=2017&no=197758
398,2017-03-23,삼성바이오로직스글로벌CMO리더십전관왕,http://www.seoulfn.com/news/articleView.html?idxno=275315
399,2017-03-23,삼성바이오로직스CMO리더십어워드4년연속수상,http://www.hankyung.com/news/app/newsview.php?aid=201703232716i
400,2017-03-23,세계적인상받고도보도자료못낸삼성바이오로직스,http://www.hankyung.com/news/app/newsview.php?aid=201703233672i
401,2017-03-23,삼성바이오로직스CMO리더십4회연속수상,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=691038
402,2017-03-24,기업삼성바이오로직스바이오의약품위탁생산기업상수상,http://www.ytn.co.kr/_ln/0102_201703240201486758
403,2017-03-24,삼성바이오로직스글로벌제약사고객세계최대CMO허브노려,http://news.mk.co.kr/newsRead.php?&year=2017&no=199302
404,2017-03-24,삼성바이오로직스바이오의약품위탁생산기업상수상,http://www.ytnscience.co.kr/program/program_view.php?s_mcd=0082&s_hcd=&key=201703241108318808
405,2017-03-24,주총김태한삼성바이오로직스대표세번째연임성공,http://news1.kr/articles/?2946219
406,2017-03-24,김태한삼성바이오로직스사장사내이사재선임,http://www.asiatoday.co.kr/view.php?key=20170324010016123
407,2017-03-24,삼성바이오로직스상장후첫주주총회김태한사장세번째선임,http://www.fnnews.com/news/201703241654470867
408,2017-03-24,주총현장김태한삼성바이오로직스사장재연임성공,http://www.ebn.co.kr/news/view/883597
409,2017-03-24,바이오산업고도화규모의경제노리는삼성바이오로직스,http://www.newspim.com/news/view/20170323000219
410,2017-03-26,삼성전자삼성바이오로직스주가급등이재용부회장재판영향미치나,http://www.fnnews.com/news/201703261914082056
411,2017-03-27,제약톡톡셀트리온제친삼성바이오로직스1위굳히기가능할까,http://news.heraldcorp.com/view.php?ud=20170327000071
412,2017-03-27,삼성바이오로직스15개제약사와30종이상수주협상진행,http://www.ebn.co.kr/news/view/883790
413,2017-03-27,여의도Talk삼성바이오로직스대장주는나요나”,http://news.mk.co.kr/newsRead.php?&year=2017&no=206269
414,2017-03-29,삼성바이오로직스공장가동률상승으로내년흑자예상,http://www.asiatoday.co.kr/view.php?key=20170329010018733
415,2017-03-29,삼성바이오로직스코스피200지수편입될듯,http://news.mk.co.kr/newsRead.php?&year=2017&no=213796
416,2017-03-29,삼성바이오로직스공장정기보수로올해도적자불가피,http://www.businesspost.co.kr/news/articleView.html?idxno=45930
417,2017-03-30,금감원삼성바이오로직스특별감리착수,http://view.asiae.co.kr/news/view.htm?idxno=2017033007432653214
418,2017-03-30,금감원삼성바이오로직스특별감리착수상보,http://view.asiae.co.kr/news/view.htm?idxno=2017033007450764039
419,2017-03-30,삼성바이오로직스분식회계논란금감원특별감리,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170330027000008&did=1195m
420,2017-03-30,삼성바이오로직스금감원특별감리실시되면사실확인명백히하겠다,http://www.fnnews.com/news/201703300816504992
421,2017-03-30,코스피200CJCGV삼성바이오로직스등신규편입될듯하나금투,http://www.ekn.kr/news/article.html?no=277550
422,2017-03-30,금감원삼성바이오로직스특별감리착수키로,http://news.sbs.co.kr/news/endPage.do?news_id=N1004120162&plink=ORI&cooper=NAVER
423,2017-03-30,금감원삼성바이오로직스특별감리착수,http://stock.hankyung.com/news/app/newsview.php?aid=2017033099256
424,2017-03-30,금감원분식논란삼성바이오로직스특별감리종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170330027051008&did=1195m
425,2017-03-30,금감원삼성바이오로직스분식회계혐의특별감리,http://www.cstimes.com/news/articleView.html?idxno=242276
426,2017-03-30,금융당국삼성바이오로직스분식회계논란규명,http://www.whitepaper.co.kr/news/articleView.html?idxno=83805
427,2017-03-30,금감원삼성바이오로직스특별감리한다,http://www.viva100.com/main/view.php?key=20170330010010417
428,2017-03-30,금감원삼성바이오로직스특별감리나선다,http://www.smedaily.co.kr/news/articleView.html?idxno=67691
429,2017-03-30,금감원삼성바이오로직스특별감리한다,http://news1.kr/articles/?2951626
430,2017-03-30,금감원분식회계의혹삼성바이오로직스특별감리,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201703300901001&code=920100
431,2017-03-30,삼성바이오로직스특별감리받는다바이오업계정치감리반발,http://www.ebn.co.kr/news/view/884414
432,2017-03-30,특징주삼성바이오로직스약세금감원특별감리착수,http://stock.hankyung.com/news/app/newsview.php?aid=2017033001106
433,2017-03-30,특징주삼성바이오로직스특별감리결정주가흔들,http://www.g-enews.com/ko-kr/news/article/news_all/201703300902475059c642673384_1/article.html
434,2017-03-30,금감원분식논란삼성바이오로직스특별감리,http://www.newsis.com/view/?id=NISX20170330_0014797877&cID=10401&pID=10400
435,2017-03-30,금감원삼성바이오로직스특별감리착수,http://www.mt.co.kr/view/mtview.php?type=1&no=2017033008480597735&outlink=1
436,2017-03-30,금감원삼성바이오로직스분식회계논란특별감리,http://www.etoday.co.kr/news/section/newsview.php?idxno=1474188
437,2017-03-30,삼성바이오로직스금융당국특별감리착수소식에장초반급락,http://www.sedaily.com/NewsView/1ODKL1JSSG
438,2017-03-30,특징주삼성바이오로직스금감원특별감리착수소식에하락세,http://www.dailian.co.kr/news/view/622105/?sc=naver
439,2017-03-30,특징주삼성바이오로직스특별감리소식에급락,http://www.mt.co.kr/view/mtview.php?type=1&no=2017033009111790276&outlink=1
440,2017-03-30,특징주삼성바이오로직스금감원특별감리소식에약세,http://biz.chosun.com/site/data/html_dir/2017/03/30/2017033000774.html
441,2017-03-30,특징주삼성바이오로직스금감원특별감리착수에약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1474216
442,2017-03-30,특징주삼성바이오로직스금감원특별감리착수에급락,http://www.viva100.com/main/view.php?key=20170330010010450
443,2017-03-30,금감원분식회계논란삼성바이오로직스특별감리,http://www.ajunews.com/view/20170330091242141
444,2017-03-30,금감원삼성바이오로직스특별감리착수,http://www.ebn.co.kr/news/view/884430
445,2017-03-30,삼성바이오로직스금감원특별감리착수소식에약세,http://www.newsprime.co.kr/news/article.html?no=369664
446,2017-03-30,특징주삼성바이오로직스금감원특별감리착수소식에하락세,http://www.cstimes.com/news/articleView.html?idxno=242293
447,2017-03-30,특징주삼성바이오로직스금감원특별감리소식에약세,http://www.newsis.com/view/?id=NISX20170330_0014797926&cID=10401&pID=10400
448,2017-03-30,HotLine삼성바이오로직스금감원특별감리소식에약세,http://news.mk.co.kr/newsRead.php?&year=2017&no=214856
449,2017-03-30,삼성바이오로직스금감원특별감리소식에5급락,http://news.heraldcorp.com/view.php?ud=20170330000185
450,2017-03-30,특징주삼성바이오로직스금감원특별감리약세,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017033009308054254&outlink=1
451,2017-03-30,삼성바이오로직스금감원특별감리실시되면사실확인명백히하겠다,http://www.fnnews.com/news/201703300910536684
452,2017-03-30,특징주삼성바이오로직스금감원특별감리착수소식에하락세,http://www.ekn.kr/news/article.html?no=277563
453,2017-03-30,특징주삼성바이오로직스특별감리착수소식에↓,http://www.edaily.co.kr/news/newspath.asp?newsid=02112326615868568
454,2017-03-30,삼성바이오로직스하락폭커져금감원특별감리앞둬,http://www.sedaily.com/NewsView/1ODKL3YRX5
455,2017-03-30,특징주삼성바이오로직스금감원특별감리소식에급락,http://www.asiatoday.co.kr/view.php?key=20170330010019716
456,2017-03-30,특징주특별감리결정에삼성바이오로직스약세,http://www.ebn.co.kr/news/view/884446
457,2017-03-30,금감원분식회계의혹삼성바이오로직스특별감리,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017033009150942259
458,2017-03-30,금감원삼성바이오로직스특별감리착수키로,https://cnbc.sbs.co.kr/article_hub/10000853260?division=NAVER
459,2017-03-30,금감원삼성바이오로직스특별감리착수,http://www.sedaily.com/NewsView/1ODKL5SR04
460,2017-03-30,과거박영수특검팀특혜의혹삼성바이오로직스금융감독원특별감리착수,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=3182414
461,2017-03-30,금감원삼성바이오로직스특별감리착수,http://www.newspim.com/news/view/20170330000104
462,2017-03-30,금감원삼성바이오로직스특별감리착수,http://www.ytn.co.kr/_ln/0102_201703300947210585
463,2017-03-30,금감원분식회계의혹삼성바이오로직스특별감리착수,http://www.ekn.kr/news/article.html?no=277575
464,2017-03-30,삼성바이오로직스금감원특별감리통보받은적없어해명,http://www.g-enews.com/ko-kr/news/article/news_all/201703300940092409e6a49afa8d_1/article.html
465,2017-03-30,금감원분식회계논란삼성바이오로직스특별감리,http://www.dailian.co.kr/news/view/622132/?sc=naver
466,2017-03-30,특징주삼성바이오로직스하락금감원특별감리,http://www.inews24.com/php/news_view.php?g_serial=1014443&g_menu=022310&rrf=nv
467,2017-03-30,삼성바이오로직스금감원특별감리없었다,http://biz.newdaily.co.kr/news/article.html?no=10129087
468,2017-03-30,금감원삼성바이오로직스특별감리착수결정,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10210259
469,2017-03-30,금감원삼성바이오로직스특별감리착수주가하락세,http://www.fntimes.com/paper/view.aspx?num=177175
470,2017-03-30,금감원삼성바이오로직스특별감리한다,http://www.shinailbo.co.kr/news/articleView.html?idxno=568023
471,2017-03-30,금감원분식회계파문삼성바이오로직스특별감리착수,http://www.sisajournal-e.com/biz/article/166811
472,2017-03-30,삼성바이오로직스금감원특별감리통보받은바없어,http://www.dailian.co.kr/news/view/622138/?sc=naver
473,2017-03-30,긴급점검삼성바이오로직스특별감리위기가기회회계처리적합성명백히밝힐것,http://www.g-enews.com/ko-kr/news/article/news_all/201703301013176652c642673384_1/article.html
474,2017-03-30,금감원특별감리삼성바이오로직스주가급락,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20170330.99002101814
475,2017-03-30,특징주삼성바이오로직스금감원특별감리소식에약세,http://www.mediapen.com/news/view/251443
476,2017-03-30,금감원삼성바이오로직스특별감리착수,http://www.edaily.co.kr/news/newspath.asp?newsid=02440326615868568
477,2017-03-30,삼성바이오로직스분식회계금감원특별감리불렀다,http://www.intn.co.kr/news/articleView.html?idxno=795795
478,2017-03-30,금감원삼성바이오로직스특별감리착수,http://news.kbs.co.kr/news/view.do?ncd=3454577&ref=A
479,2017-03-30,금융감독원삼성바이오로직스특별감리착수,http://www.sedaily.com/NewsView/1ODKL0XZ9F
480,2017-03-30,금감원분식회계의혹삼성바이오로직스특별감리,http://www.asiatoday.co.kr/view.php?key=20170330010019804
481,2017-03-30,출발UPDOWN일진디스플삼성바이오로직스,http://www.newstomato.com/ReadNews.aspx?no=742498
482,2017-03-30,삼성바이오로직스금감원특별감리통보없었다”,http://www.getnews.co.kr/view.php?ud=201703301040586046beeb3268c_16
483,2017-03-30,삼성바이오로직스분식회계논란금융당국특별감리착수,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017033010308047856&outlink=1
484,2017-03-30,삼성바이오로직스분식회계논란확전조짐상장특혜의혹등재점화,http://ilyo.co.kr/?ac=article_view&entry_id=239848
485,2017-03-30,금감원분식회계논란삼성바이오로직스특별감리한다,http://daily.hankooki.com/lpage/economy/201703/dh20170330105629138080.htm
486,2017-03-30,금감원삼성바이오로직스분식회계의혹특별감리,http://www.nocutnews.co.kr/news/4758792
487,2017-03-30,삼성바이오로직스2중3중검증회계처리문제없어,http://www.newspim.com/news/view/20170330000122
488,2017-03-30,삼성바이오로직스금감원특별감리소식에급락,http://daily.hankooki.com/lpage/economy/201703/dh20170330111429138110.htm
489,2017-03-30,특징주삼성바이오로직스특별감리착수에하락,http://view.asiae.co.kr/news/view.htm?idxno=2017033011204253592
490,2017-03-30,금감원삼성바이오로직스분식회계특별감리착수특혜의혹해소되나,http://www.etnews.com/20170330000138
491,2017-03-30,금감원삼성바이오로직스특별감리공식적통보받은바없다,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002762045
492,2017-03-30,삼성바이오로직스금감원특별감리공식통보없어,http://www.ajunews.com/view/20170330113422458
493,2017-03-30,삼성바이오로직스특별감리로회계적합성확인기대,http://www.mt.co.kr/view/mtview.php?type=1&no=2017033012042970402&outlink=1
494,2017-03-30,회계사기논란삼성바이오로직스특별감리,http://www.ytn.co.kr/_ln/0102_201703301214553250
495,2017-03-30,금감원삼성바이오로직스특별감리,http://www.naeil.com/news_view/?id_art=232510
496,2017-03-30,특징주삼성바이오로직스특별감리충격지분보유삼성전자삼성물산여파는,http://www.mediapen.com/news/view/251533
497,2017-03-30,분식회계특혜의혹삼성바이오로직스금감원특별감리,http://www.kormedi.com/news/news/drug_dist/1222647_2906.html
498,2017-03-30,삼성바이오로직스분식회계논란금감원특별감리착수,http://www.tfnews.co.kr/news/article.html?no=32377
499,2017-03-30,금감원삼성바이오로직스특별감리”주가는큰폭하락,http://www.hankookilbo.com/v/485483060bdb4f63b7afd9e760c11bba
500,2017-03-30,금감원삼성바이오로직스특별감리왜,http://www.seoulfn.com/news/articleView.html?idxno=275814
501,2017-03-30,금감원삼성바이오로직스특별감리착수결정,http://www.obsnews.co.kr/news/articleView.html?idxno=1036045
502,2017-03-30,삼성중공업삼성바이오로직스심상찮다,http://www.choicenews.co.kr/news/articleView.html?idxno=32453
503,2017-03-30,삼성바이오로직스특별감리소식에시총4000억증발,http://www.mt.co.kr/view/mtview.php?type=1&no=2017033015031945289&outlink=1
504,2017-03-30,특징주삼성바이오로직스금융당국특별감리소식에약세마감,http://www.ajunews.com/view/20170330162418885
505,2017-03-30,코스피외국인순매도삼성바이오로직스삼성전자우엔씨소프트,http://www.newsway.co.kr/view.php?tp=1&ud=2017033016305020831
506,2017-03-30,금감원삼성바이오로직스특별감리상장심사에문제없었나,http://www.fnnews.com/news/201703301635347793
507,2017-03-30,금감원삼성바이오로직스특별감리착수,http://www.hani.co.kr/arti/economy/finance/788652.html
508,2017-03-30,금감원분식회계논란삼성바이오로직스특별감리,http://news20.busan.com/controller/newsController.jsp?newsId=20170330000215
509,2017-03-30,삼성바이오로직스분식회계논란상장문제없었나,http://news.heraldcorp.com/view.php?ud=20170330000929
510,2017-03-30,삼성바이오로직스금감원특별감리성실히임할것,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201703300340
511,2017-03-30,삼성바이오로직스특별감리일파만파,http://www.viva100.com/main/view.php?key=20170330010010674
512,2017-03-30,특별감리받는삼성바이오로직스회계처리적합성밝혀질것”,http://www.viva100.com/main/view.php?key=20170330010010783
513,2017-03-30,금감원분식회계논란삼성바이오로직스특별감리나서,http://www.ntoday.co.kr/news/articleView.html?idxno=52255
514,2017-03-30,서울경제TV삼성바이오로직스분식회계의혹특별감리,http://www.sedaily.com/NewsView/1ODKMWJ2XP
515,2017-03-30,삼성바이오로직스주가하락금감원특별감리착수,http://www.businesspost.co.kr/news/articleView.html?idxno=46020
516,2017-03-30,심사감리합격한삼성바이오로직스다시한번들여다보겠다는금융당국,http://stock.hankyung.com/news/app/newsview.php?aid=2017033021421
517,2017-03-30,금감원분식회계논란삼성바이오로직스조사착수,https://cnbc.sbs.co.kr/article_hub/10000853379?division=NAVER
518,2017-03-30,상장전분식회계잇따른논란삼성바이오로직스특별감리,http://www.segye.com/content/html/2017/03/30/20170330003550.html?OutUrl=naver
519,2017-03-30,금감원상장전분식회계의혹삼성바이오로직스특별감리,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201703302134025&code=920301
520,2017-03-30,삼성바이오로직스특별감리착수,http://www.kyeongin.com/main/view.php?key=20170330010011245
521,2017-03-31,금감원삼성바이오로직스특별감리,http://www.hankookilbo.com/v/6e60c218e4014c77bea5d81d57b491b6
522,2017-03-31,삼성바이오로직스글로벌진출급제동,http://www.sedaily.com/NewsView/1ODL0YN8Y8
523,2017-03-31,금감원삼성바이오로직스특별감리착수논란된분식회계여부등,http://www.mdtoday.co.kr/mdtoday/index.html?no=282472
524,2017-03-31,특징주삼성바이오로직스하락세지속특별감리악재,http://stock.hankyung.com/news/app/newsview.php?aid=2017033135296
525,2017-03-31,삼성바이오로직스특별감리추진소식에사흘연속하락,http://www.sedaily.com/NewsView/1ODL1Y7IHJ
526,2017-03-31,특징주삼성바이오로직스특별감리부담에약세지속,http://www.etoday.co.kr/news/section/newsview.php?idxno=1474860
527,2017-03-31,특징주삼성바이오로직스금융당국특별감리사흘째약세,http://www.newspim.com/news/view/20170331000106
528,2017-03-31,특징주삼성바이오로직스특별감리부담에사흘째하락,http://www.viva100.com/main/view.php?key=20170331010010914
529,2017-03-31,특징주삼성바이오로직스특별감리추진소식에급락,http://www.dailian.co.kr/news/view/622459/?sc=naver
530,2017-03-31,HotLine삼성바이오로직스금감원특별감리소식에약세,http://news.mk.co.kr/newsRead.php?&year=2017&no=218254
531,2017-03-31,삼성바이오로직스특별감리착수에사흘째약세,http://www.newsprime.co.kr/news/article.html?no=369846
532,2017-03-31,특별감리삼성바이오로직스하락세지속,http://news.heraldcorp.com/view.php?ud=20170331000188
533,2017-03-31,특징주삼성바이오로직스금감원특별감리소식사흘째약세,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017033110048020531&outlink=1
534,2017-03-31,특징주삼성바이오로직스특별감리소식에뚝,http://www.seoulfn.com/news/articleView.html?idxno=275857
535,2017-03-31,삼성바이오로직스특별감리‥IPO시장위축우려,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201703300231
536,2017-03-31,삼성바이오로직스금융당국특별감리소식에약세,http://www.sedaily.com/NewsView/1ODL1GY6LB
537,2017-03-31,출발UPDOWNPOSCO삼성바이오로직스,http://www.newstomato.com/ReadNews.aspx?no=742886
538,2017-03-31,삼성바이오로직스상장특별감리커지는중복조사우려,http://www.dailian.co.kr/news/view/622512/?sc=naver
539,2017-03-31,삼성바이오로직스특별감리악재에약세지속,http://www.sisajournal-e.com/biz/article/166906
540,2017-03-31,설상가상삼성바이오로직스이재용구속에특별감리까지,http://www.mhj21.com/sub_read.html?uid=105764§ion=sc243
541,2017-03-31,삼성바이오로직스특별감리후폭풍테슬라요건흔들리나,http://www.etoday.co.kr/news/section/newsview.php?idxno=1475108
542,2017-03-31,외국인투자자순매도삼성전자엔씨소프트삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2017033116134805538
543,2017-03-31,연봉공개김태한삼성바이오로직스대표이사지난해총보수23억1700만원,http://www.etoday.co.kr/news/section/newsview.php?idxno=1475328
544,2017-03-31,삼성바이오로직스김태한대표작년보수23억1700만원,http://www.dailian.co.kr/news/view/622659/?sc=naver
545,2017-04-01,김태한삼성바이오로직스사장지난해연봉23억1700만원,http://www.asiatoday.co.kr/view.php?key=20170401000834589
546,2017-04-01,뒷북경제특별감리받는삼성바이오로직스에무슨일이마법분식회계,http://www.sedaily.com/NewsView/1OEH75WL0G
547,2017-04-01,김태한삼성바이오로직스사장국내제약바이오업계연봉1위,http://www.cstimes.com/news/articleView.html?idxno=242496
548,2017-04-02,김태한삼성바이오로직스사장제약바이오연봉킹약23억원,http://www.ekn.kr/news/article.html?no=278313
549,2017-04-02,특별감리삼성바이오로직스에무슨일이콜옵션가능성반영했을뿐인데분식논란에휘청,http://www.sedaily.com/NewsView/1OEHPCGRKK
550,2017-04-02,2016사업보고서총론삼성바이오로직스6년연속영업손실,http://www.sisajournal-e.com/biz/article/167024
551,2017-04-03,기업분석특별감리받는삼성바이오로직스와자회사삼성바이오에피스지난해실적은적자에서못벗어나,http://www.ekn.kr/news/article.html?no=278377
552,2017-04-03,제약톡톡김태한삼성바이오로직스사장제약업계연봉킹,http://news.heraldcorp.com/view.php?ud=20170403000077
553,2017-04-03,삼성바이오로직스분식특혜논란논란에도주가회복,http://news.heraldcorp.com/view.php?ud=20170403000393
554,2017-04-03,삼성바이오로직스특별감리엇갈린두시선,http://www.kormedi.com/news/news/drug_dist/1222698_2906.html
555,2017-04-03,코스피외국인순매도삼성전자아모레퍼시픽삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2017040316282686384
556,2017-04-03,2016사업보고서직원삼성바이오로직스직원연봉5700만원,http://www.sisajournal-e.com/biz/article/167097
557,2017-04-03,조세금융만평삼성바이오로직스분식회계논란금감원특별감리착수,http://www.tfnews.co.kr/news/article.html?no=32481
558,2017-04-04,교보증권삼성물산2018년삼성바이오로직스실적정상화본격적인합병시너지예상,http://www.g-enews.com/ko-kr/news/article/news_all/201704040810103809c642673384_1/article.html
559,2017-04-04,금감원삼성바이오로직스등올해172곳회계감리,http://biz.chosun.com/site/data/html_dir/2017/04/04/2017040401208.html
560,2017-04-05,기업분석제약사결산④등기이사연봉1위삼성바이오로직스평균16억원,http://www.ekn.kr/news/article.html?no=278985
561,2017-04-05,5분재무제표삼성바이오로직스의창조회계,http://news.einfomax.co.kr/news/articleView.html?idxno=322790
562,2017-04-05,삼성바이오로직스특별감리별문제없는듯노무라,http://www.choicenews.co.kr/news/articleView.html?idxno=32552
563,2017-04-05,BioS삼성바이오로직스2028년까지연3천억원매출확보,http://www.etoday.co.kr/news/section/newsview.php?idxno=1476915
564,2017-04-05,2015년순이익1조9202억원이었던삼성바이오로직스2016년1768억원적자전환,http://www.kukinews.com/news/article.html?no=444981
565,2017-04-05,16년상장제약사매출증가했지만순이익하락은삼성바이오로직스때문,http://www.econotalking.kr/news/articleView.html?idxno=147416
566,2017-04-05,거래소삼성바이오로직스불성실공시법인지정,http://www.newspim.com/news/view/20170405000310
567,2017-04-05,거래소삼성바이오로직스불성실공시법인지정,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170405156900008&did=1195m
568,2017-04-05,거래소삼성바이오로직스불성실공시법인지정제제금800만원,http://www.newsway.co.kr/view.php?tp=1&ud=2017040517261013729
569,2017-04-05,삼성바이오로직스지연공시로불성실공시법인지정,http://www.mt.co.kr/view/mtview.php?type=1&no=2017040517304757207&outlink=1
570,2017-04-05,삼성바이오로직스지연공시로불성실공시법인지정,http://view.asiae.co.kr/news/view.htm?idxno=2017040517320467432
571,2017-04-05,삼성바이오로직스불성실공시법인지정,http://biz.chosun.com/site/data/html_dir/2017/04/05/2017040502641.html
572,2017-04-05,거래소삼성바이오로직스불성실공시법인지정,http://news.sbs.co.kr/news/endPage.do?news_id=N1004131568&plink=ORI&cooper=NAVER
573,2017-04-05,공시거래소삼성바이오로직스불성실공시법인지정,http://www.ajunews.com/view/20170405174246671
574,2017-04-05,삼성바이오로직스6일불성실공시법인으로지정,http://www.sedaily.com/NewsView/1OEJ2SVUQY
575,2017-04-05,거래소삼성바이오로직스불성실공시법인으로지정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017040517362196709
576,2017-04-05,거래소삼성바이오로직스불성실공시법인지정,http://www.viva100.com/main/view.php?key=20170405010001775
577,2017-04-05,삼성바이오로직스지연공시로불성실공시법인지정,http://www.ebn.co.kr/news/view/885584
578,2017-04-05,김태한삼성바이오로직스악재겹쳐흑자전환미뤄질까난감,http://www.businesspost.co.kr/news/articleView.html?idxno=46465
579,2017-04-05,거래소삼성바이오로직스불성실공시법인지정,http://www.etnews.com/20170405000441
580,2017-04-05,거래소삼성바이오로직스불성실공시법인지정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1477081
581,2017-04-05,삼성바이오로직스불성실공시위반제재금800만원부과받아,http://www.kyeongin.com/main/view.php?key=20170405010001706
582,2017-04-06,주요공시삼성바이오로직스신세계건설위메이드등,http://www.intn.co.kr/news/articleView.html?idxno=795958
583,2017-04-06,삼성바이오로직스감사보고서제출지연불성실공시법인지정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017040608553126850
584,2017-04-06,주요공시삼성바이오로직스불성실공시법인지정감사보고서제출지연,http://www.cstimes.com/news/articleView.html?idxno=242858
585,2017-04-06,특징주삼성바이오로직스하락불성실공시법인지정예고,http://stock.hankyung.com/news/app/newsview.php?aid=2017040690076
586,2017-04-06,특징주삼성바이오로직스불성실공시법인지정에하락,http://www.g-enews.com/ko-kr/news/article/news_all/201704060919134036581e5800d6_1/article.html
587,2017-04-06,삼성바이오로직스불성실공시법인지정에약세,http://www.newsprime.co.kr/news/article.html?no=370505
588,2017-04-06,특징주삼성바이오로직스불성실공시법인지정에하락세,http://www.dailian.co.kr/news/view/623899/?sc=naver
589,2017-04-06,특징주삼성바이오로직스불성실공시법인지정에하락,http://www.viva100.com/main/view.php?key=20170406010001877
590,2017-04-06,공시불성실지정삼성바이오로직스주가약세전환,http://www.sedaily.com/NewsView/1OEJICFY04
591,2017-04-06,특징주삼성바이오로직스약세불성실공시법인지정,http://www.inews24.com/php/news_view.php?g_serial=1015868&g_menu=022310&rrf=nv
592,2017-04-06,HotLine삼성바이오로직스불성실공시법인지정소식에약세,http://news.mk.co.kr/newsRead.php?&year=2017&no=233046
593,2017-04-06,특징주불성실공시법인지정삼성바이오로직스약세전환,http://www.mt.co.kr/view/mtview.php?type=1&no=2017040609455784784&outlink=1
594,2017-04-06,특징주삼성바이오로직스약세불성실공시법인지정,http://www.ebn.co.kr/news/view/885667
595,2017-04-06,특징주삼성바이오로직스불성실공시법인지정약세,http://www.seoulfn.com/news/articleView.html?idxno=276307
596,2017-04-06,삼성바이오로직스불성실공시법인지정소식으로약세,http://news.heraldcorp.com/view.php?ud=20170406000388
597,2017-04-06,삼성바이오로직스불성실공시법인지정,http://www.econovill.com/news/articleView.html?idxno=312604
598,2017-04-06,노무라삼성바이오로직스매수권고,http://www.newspim.com/news/view/20170406000149
599,2017-04-06,삼성바이오로직스지연공시로불성실공시법인지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=283061
600,2017-04-10,더벨삼성바이오로직스등작년상장사도안진교체,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201704070100013010000785
601,2017-04-10,ET투자뉴스삼성바이오로직스CMO와항체바이오매수신규바로투자증권,http://www.etnews.com/20170410000222
602,2017-04-10,김태한삼성바이오로직스대표27억원들여자사주1만5000주장내매수,http://biz.chosun.com/site/data/html_dir/2017/04/10/2017041002067.html
603,2017-04-10,삼성바이오로직스김태한사장자사주1만5000주매입,http://news1.kr/articles/?2962618
604,2017-04-10,김태한삼성바이오로직스사장자사주26억장내매수,http://view.asiae.co.kr/news/view.htm?idxno=2017041016323811139
605,2017-04-10,김태한삼성바이오로직스사장자사주1만5천주매입책임경영차원,http://www.dailian.co.kr/news/view/624940/?sc=naver
606,2017-04-10,김태한삼성바이오로직스사장자사주1만5000주매입,http://www.newsis.com/view/?id=NISX20170410_0014821685&cID=10401&pID=10400
607,2017-04-10,김태한삼성바이오로직스사장자사주1만5000주매수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1478623
608,2017-04-10,김태한삼성바이오로직스사장27억원규모자사주매입,http://www.sedaily.com/NewsView/1OELE01XUP
609,2017-04-10,김태한삼성바이오로직스사장자사주26억장내매수,http://www.newspim.com/news/view/20170410000318
610,2017-04-10,김태한삼성바이오로직스사장자사주매입27억원규모,http://www.asiatoday.co.kr/view.php?key=20170410010006201
611,2017-04-10,삼성바이오로직스자사주매입,http://www.kyeongin.com/main/view.php?key=20170410010003225
612,2017-04-11,주요공시LG디스플레이삼성바이오로직스이디등,http://www.intn.co.kr/news/articleView.html?idxno=796040
613,2017-04-11,삼성바이오로직스김태한사장자사주매입책임경영,http://www.sisaweek.com/news/articleView.html?idxno=89726
614,2017-04-11,1g에2억원바이오신약의황금요람송도삼성바이오로직스공장가보니,http://view.asiae.co.kr/news/view.htm?idxno=2017041016573772814
615,2017-04-11,김태한삼성바이오로직스사장27억규모자사주매입책임경영차원,http://www.mdtoday.co.kr/mdtoday/index.html?no=283403
616,2017-04-12,주요공시LG디스플레이삼성바이오로직스코센등,http://www.intn.co.kr/news/articleView.html?idxno=796075
617,2017-04-12,특징주삼성바이오로직스주가팽팽외인힘겨루기,http://www.g-enews.com/ko-kr/news/article/news_all/201704120920316870c642673384_1/article.html
618,2017-04-13,공식석상서인천투자확대밝힌삼성바이오로직스,http://www.kyeongin.com/main/view.php?key=20170413010004530
619,2017-04-13,인천경영포럼김태한삼성바이오로직스사장의약품세계최대생산능력글로벌회사와수주협상중,http://www.kyeongin.com/main/view.php?key=20170413010004727
620,2017-04-14,삼성바이오로직스상장새규정따랐다면불법아냐,http://www.ebn.co.kr/news/view/886916
621,2017-04-14,삼성바이오로직스특혜논란에도집단소송위험낮아,http://www.finomy.com/news/articleView.html?idxno=44168
622,2017-04-17,삼성바이오로직스금감원감리에시끌시끌기업가치뻥튀기”vs국제기준따랐을뿐”,http://news.mk.co.kr/newsRead.php?&year=2017&no=258521
623,2017-04-18,삼성바이오로직스상장규정에따른것이라불법으로보긴어려워,http://www.mdtoday.co.kr/mdtoday/index.html?no=283852
624,2017-04-19,삼성바이오로직스25일1분기실적공시,http://view.asiae.co.kr/news/view.htm?idxno=2017041915412208264
625,2017-04-19,삼성바이오로직스1분기실적25일발표,http://www.edaily.co.kr/news/newspath.asp?newsid=03867126615897760
626,2017-04-19,공시삼성바이오로직스25일1분기결산실적발표,http://www.g-enews.com/ko-kr/news/article/news_all/201704191611502794c642673384_1/article.html
627,2017-04-19,삼성바이오로직스25일1분기실적발표,http://www.cstimes.com/?mod=news&act=articleView&idxno=244021
628,2017-04-19,신약RD⑪삼성바이오로직스세계1위바이오의약품생산기업목표,http://www.seoulfn.com/news/articleView.html?idxno=277345
629,2017-04-20,특징주삼성바이오로직스외인매도에도주가팽팽나흘째상승행진할까,http://www.g-enews.com/ko-kr/news/article/news_all/201704200911081393c642673384_1/article.html
630,2017-04-21,넷마블게임즈삼성바이오로직스등코스피200편입예상”대신증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1482833
631,2017-04-21,특징주삼성바이오로직스코스피200신규편입기대만발주가19만원임박,http://www.g-enews.com/ko-kr/news/article/news_all/201704210918568393c642673384_1/article.html
632,2017-04-21,특징주코스피200편입기대삼성바이오로직스강세,http://stock.hankyung.com/news/app/newsview.php?aid=2017042169486
633,2017-04-21,삼성바이오로직스코스피200편입기대에강세,http://www.newsprime.co.kr/news/article.html?no=372411
634,2017-04-21,특징주삼성바이오로직스외인매수에강세,http://news.mt.co.kr/view/mtview.php?no=2017042109462434893&outlink=1
635,2017-04-21,특징주삼성바이오로직스코스피200편입기대감오름세,http://www.seoulfn.com/news/articleView.html?idxno=277471
636,2017-04-21,삼성바이오로직스창립6주년기념식개최,http://www.dailian.co.kr/news/view/627845/?sc=naver
637,2017-04-21,삼성바이오로직스창립6주년,http://www.medigatenews.com/news/905377995
638,2017-04-21,김태한삼성바이오로직스사장CMO생산비중2배확대게임체인저로거듭날것,http://www.asiatoday.co.kr/view.php?key=20170421010013791
639,2017-04-21,김태한삼성바이오로직스사장CMO생산비중50이상높인다,http://www.ebn.co.kr/news/view/888287
640,2017-04-21,삼성바이오로직스창립6주년기념식개최,http://www.edaily.co.kr/news/newspath.asp?newsid=03102886615898416
641,2017-04-21,삼성바이오로직스창립6주년게임체인저되겠다,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170421120300017&did=1195m
642,2017-04-21,삼성바이오로직스창립6주년바이오의약품의게임체인저될것,http://www.dt.co.kr/contents.html?article_no=2017042102109976029003
643,2017-04-21,김태한삼성바이오로직스사장CMO생산비중2배확대게임체인저로거듭날것”,http://www.ekn.kr/news/article.html?no=282879
644,2017-04-21,김태한삼성바이오로직스사장창립6주년게임체인저비전제시,http://www.seoulfn.com/news/articleView.html?idxno=277515
645,2017-04-21,김태한삼성바이오로직스사장CMO비중50이상끌어올릴것,http://www.newsis.com/view/?id=NISX20170421_0014846709&cID=10402&pID=13000
646,2017-04-21,삼성바이오로직스벌써코스피200효과,http://www.choicenews.co.kr/news/articleView.html?idxno=32902
647,2017-04-21,삼성바이오로직스창립6주년기념식,http://www.g-enews.com/ko-kr/news/article/news_all/20170421164521730e6a49afa8d_1/article.html
648,2017-04-21,삼성바이오로직스창립6주년기념식개최김태한사장CMO시장확대하는게임체인저될것”,http://biz.chosun.com/site/data/html_dir/2017/04/21/2017042102268.html
649,2017-04-21,삼성바이오로직스인천송도본사서창립6주년기념식개최,http://www.m-i.kr/news/articleView.html?idxno=306096
650,2017-04-21,삼성바이오로직스창립6주년기념식개최,http://www.m-i.kr/news/articleView.html?idxno=306086
651,2017-04-21,삼성바이오로직스창립6주년김태한사장CMO생산비중2배확대”,http://www.mdtoday.co.kr/mdtoday/index.html?no=284295
652,2017-04-21,김태한삼성바이오로직스사장CMO비중25서50로높이자,http://daily.hankooki.com/lpage/economy/201704/dh20170421191427138080.htm
653,2017-04-22,여섯돌삼성바이오로직스세계최대바이오시밀러CMO성장,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041541
654,2017-04-22,삼성바이오로직스창립6주년기념식개최,http://www.viva100.com/main/view.php?key=20170422010007666
655,2017-04-23,삼성바이오로직스세계최대규모CMO회사로성장,http://www.newstomato.com/ReadNews.aspx?no=748367
656,2017-04-23,삼성바이오로직스창립6주년기념행사열어,http://www.siminilbo.co.kr/news/articleView.html?idxno=509414
657,2017-04-23,삼성바이오로직스창립6주년기념식개최,http://www.fnnews.com/news/201704231506498717
658,2017-04-23,삼성바이오로직스세계최대CMO회사로성장,http://www.kgnews.co.kr/news/articleView.html?idxno=480507
659,2017-04-23,삼성바이오로직스CMO비중50이상높일것,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=695585
660,2017-04-24,삼성바이오로직스자회사바이오시밀러SB2미국최종판매허가획득,http://view.asiae.co.kr/news/view.htm?idxno=2017042407390367981
661,2017-04-24,삼성바이오로직스SB2미국최종판매허가획득,http://www.newsis.com/view/?id=NISX20170424_0014850197&cID=10401&pID=10400
662,2017-04-24,유진투자증권삼성바이오로직스자회사렌플렉시스미FDA허가하반기미국시장진출본격화”,http://www.g-enews.com/ko-kr/news/article/news_all/201704240812201494c642673384_1/article.html
663,2017-04-24,삼성바이오로직스자회사개발바이오시밀러미국허가,http://www.edaily.co.kr/news/newspath.asp?newsid=01551446615899400
664,2017-04-24,특징주삼성바이오로직스자회사미국FDA서신약판매허가소식에상승세,http://www.dailian.co.kr/news/view/628288/?sc=naver
665,2017-04-24,특징주삼성바이오로직스자회사바이오시밀러렌플렉시스미국FDA허가19만원돌파,http://www.g-enews.com/ko-kr/news/article/news_all/201704240906535695c642673384_1/article.html
666,2017-04-24,삼성바이오로직스창립6주년기념식개최,http://www.ajunews.com/view/20170424091009609
667,2017-04-24,삼성바이오로직스자회사SB2美판매허가소식에강세,http://www.newsprime.co.kr/news/article.html?no=372594
668,2017-04-24,공시삼성바이오로직스바이오시밀러SB2미국최종판매허가획득,http://www.newsway.co.kr/view.php?tp=1&ud=2017042409272614038
669,2017-04-24,삼성바이오로직스美신약판매허가장초반강세,http://news.heraldcorp.com/view.php?ud=20170424000154
670,2017-04-24,삼성바이오로직스자회사개발바이오시밀러SB2美판매허가,http://stock.hankyung.com/news/app/newsview.php?aid=2017042420636
671,2017-04-24,삼성바이오로직스코스피200편입최대수혜시총20위노린다,http://news.heraldcorp.com/view.php?ud=20170424000168
672,2017-04-24,코스피200예약삼성바이오로직스시총20위노린다,http://news.heraldcorp.com/view.php?ud=20170424000484
673,2017-04-24,삼성바이오로직스CMO생산비중50로확대,http://www.kormedi.com/news/news/drug_dist/1223047_2906.html
674,2017-04-24,코스피외국인순매도현대차삼성바이오로직스LG이노텍,http://www.newsway.co.kr/view.php?tp=1&ud=2017042416085600912
675,2017-04-24,​삼성바이오로직스미국판매허가획득날갯짓훨훨,http://www.sisafocus.co.kr/news/articleView.html?idxno=160168
676,2017-04-24,유가증권시장공시동원시스템즈삼성바이오로직스국동등,http://news.mk.co.kr/newsRead.php?&year=2017&no=277691
677,2017-04-25,ET투자뉴스삼성바이오로직스삼성바이오시밀러매수유지유진투자증권,http://www.etnews.com/20170425000042
678,2017-04-25,삼성바이오로직스1분기매출1076억4800만원전년비213↑,http://www.asiatoday.co.kr/view.php?key=20170425010016026
679,2017-04-25,삼성바이오로직스1Q매출1076억전분기比19↑,http://www.seoulfn.com/news/articleView.html?idxno=277743
680,2017-04-25,삼성바이오로직스첫영업흑자1분기영업이익34억1보,http://news1.kr/articles/?2977338
681,2017-04-25,공시삼성바이오로직스1Q영업익34억흑자전환,http://www.viva100.com/main/view.php?key=20170425010009004
682,2017-04-25,삼성바이오로직스1분기영업이익34억원흑자전환,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170425149800008&did=1195m
683,2017-04-25,BioS삼성바이오로직스1분기매출1076억전년비213↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1484377
684,2017-04-25,삼성바이오로직스1Q영업익34억흑자전환,http://www.mt.co.kr/view/mtview.php?type=1&no=2017042515504301178&outlink=1
685,2017-04-25,삼성바이오로직스1분기영업익34억흑자전환성공1보,http://biz.chosun.com/site/data/html_dir/2017/04/25/2017042502216.html
686,2017-04-25,삼성바이오로직스영업익흑자전환성공,http://www.sedaily.com/NewsView/1OES904067
687,2017-04-25,삼성바이오로직스1Q영업익34억원흑자전환,http://view.asiae.co.kr/news/view.htm?idxno=2017042515571875897
688,2017-04-25,삼성바이오로직스1분기개별영업이익34억원흑자전환,http://www.newsis.com/view/?id=NISX20170425_0014853892&cID=10401&pID=10400
689,2017-04-25,삼성바이오로직스1Q매출1076억원영업이익34억원,http://www.ebn.co.kr/news/view/888857
690,2017-04-25,삼성바이오로직스1분기영업익34억원흑자전환,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201704250305
691,2017-04-25,삼성바이오로직스1분기매출1076억원영업익흑자전환,http://ciobiz.etnews.com/20170425120030
692,2017-04-25,삼성바이오로직스흑자전환,http://www.medigatenews.com/news/3029495968
693,2017-04-25,삼성바이오로직스1분기영업익34억원흑자전환성공,http://daily.hankooki.com/lpage/economy/201704/dh20170425160457138080.htm
694,2017-04-25,삼성바이오로직스1Q영업익34억전년比흑자전환,http://biz.chosun.com/site/data/html_dir/2017/04/25/2017042502291.html
695,2017-04-25,삼성바이오로직스1분기영업이익34억흑자전환,https://cnbc.sbs.co.kr/article_hub/10000856749?division=NAVER
696,2017-04-25,삼성바이오로직스1Q영업이익34억원흑자전환,http://www.edaily.co.kr/news/newspath.asp?newsid=03876966615899728
697,2017-04-25,삼성바이오로직스창립6년만에분기흑자,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002791470
698,2017-04-25,삼성바이오로직스올해1분기영업이익34억원흑자전환매출1076억원,http://www.fnnews.com/news/201704251544099538
699,2017-04-25,삼성바이오로직스1분기매출1076억영업이익34억,http://www.fnnews.com/news/201704251548052469
700,2017-04-25,삼성바이오로직스1분기영업이익34억원흑자전환,http://news.heraldcorp.com/view.php?ud=20170425000938
701,2017-04-25,삼성바이오로직스1Q매출1076억영업이익34억흑자전환,http://www.edaily.co.kr/news/newspath.asp?newsid=03922886615899728
702,2017-04-25,종합삼성바이오로직스1분기영업익34억원흑자전환,http://www.viva100.com/main/view.php?key=20170425010009032
703,2017-04-25,삼성바이오로직스흑자전환1분기영업익34억원,http://www.g-enews.com/ko-kr/news/article/news_all/201704251622361105e6a49afa8d_1/article.html
704,2017-04-25,삼성바이오로직스1분기영업익흑자전환당기순익은적자,http://www.cstimes.com/?mod=news&act=articleView&idxno=244501
705,2017-04-25,삼성바이오로직스1분기영업이익34억원흑자전환,http://www.newsis.com/view/?id=NISX20170425_0014853893&cID=10402&pID=13000
706,2017-04-25,1분기실적삼성바이오로직스창사후첫분기흑자,http://www.sedaily.com/NewsView/1OES9G4WQZ
707,2017-04-25,삼성특유의속도전통했다삼성바이오로직스6년만에첫흑자전환종합,http://biz.chosun.com/site/data/html_dir/2017/04/25/2017042502520.html
708,2017-04-25,BioS삼성바이오로직스첫영업이익34억올해흑자전환기대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1484434
709,2017-04-25,삼성바이오로직스1Q영업익34억흑자전환,http://www.dailian.co.kr/news/view/628840/?sc=naver
710,2017-04-25,삼성바이오로직스첫흑자1분기영업이익34억원,http://news.mk.co.kr/newsRead.php?&year=2017&no=280762
711,2017-04-25,삼성바이오로직스1분기영업이익34억흑자전환성공,http://stock.hankyung.com/news/app/newsview.php?aid=2017042568916
712,2017-04-25,삼성바이오로직스창립6년만에첫분기흑자,http://www.mt.co.kr/view/mtview.php?type=1&no=2017042516590185893&outlink=1
713,2017-04-25,삼성바이오로직스첫영업흑자제2공장가동효과상보,http://news1.kr/articles/?2977458
714,2017-04-25,삼성바이오로직스1분기흑자전환성공,http://www.dt.co.kr/contents.html?article_no=2017042602101176029001
715,2017-04-25,삼성바이오로직스1분기영업실적34억원흑자전환,http://www.m-i.kr/news/articleView.html?idxno=306987
716,2017-04-25,삼성바이오로직스사상첫흑자1분기영업익34억,http://www.newspim.com/news/view/20170425000315
717,2017-04-25,삼성바이오로직스1분기영업이익34억흑자전환,http://www.mdtoday.co.kr/mdtoday/index.html?no=284555
718,2017-04-25,삼성바이오로직스1분기영업익34억전분기비흑자전환,http://www.ajunews.com/view/20170425184623035
719,2017-04-25,실적발표삼성바이오로직스티피씨글로벌GS홈쇼핑,http://www.businesspost.co.kr/news/articleView.html?idxno=47968
720,2017-04-25,삼성바이오로직스1분기영업익34억원창립후첫흑자종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170425149851008&did=1195m
721,2017-04-25,삼성바이오로직스첫흑자,http://www.hankyung.com/news/app/newsview.php?aid=2017042572901
722,2017-04-25,삼성바이오로직스창립이래첫분기흑자1분기영업익34억,http://www.etoday.co.kr/news/section/newsview.php?idxno=1484493
723,2017-04-25,삼성바이오로직스올해1Q개별영업이익34억원시현,http://www.newsway.co.kr/view.php?tp=1&ud=2017042520333464536
724,2017-04-25,공시삼성바이오로직스1분기영업익34억원창립후첫흑자,http://www.fnnews.com/news/201704252034305937
725,2017-04-25,삼성바이오로직스1분기영업이익34억원첫흑자달성,http://www.ekn.kr/news/article.html?no=283684
726,2017-04-25,삼성바이오로직스창립6년만에흑자전환에성공,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1344575
727,2017-04-26,삼성바이오로직스흑자전환1분기영업이익34억원기록,http://www.kyeongin.com/main/view.php?key=20170425010008584
728,2017-04-26,삼성바이오로직스첫분기흑자1분기매출1076억영업익34억,http://news.donga.com/3/all/20170425/84070422/1
729,2017-04-26,삼성바이오로직스6년만에첫분기흑자,http://view.asiae.co.kr/news/view.htm?idxno=2017042606561278148
730,2017-04-26,삼성바이오로직스1분기영업익41억흑자전환,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041658
731,2017-04-26,삼성바이오로직스3분기실적턴어라운드본격화NH證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017042607524281046&outlink=1
732,2017-04-26,삼성바이오로직스3분기실적턴어라운드전망NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01666246615900056
733,2017-04-26,삼성바이오로직스2017년1분기매출1076억영업이익34억,http://www.ajunews.com/view/20170426080237388
734,2017-04-26,삼성바이오로직스영업이익흑자전환성공,http://www.asiatoday.co.kr/view.php?key=20170426010016343
735,2017-04-26,장마감공시삼성바이오로직스첫분기흑자1분기영업익34억,http://news1.kr/articles/?2977895
736,2017-04-26,삼성바이오로직스사상첫흑자기록,http://www.joongboo.com/?mod=news&act=articleView&idxno=1161023
737,2017-04-26,삼성바이오로직스1분기영업익34억원창립후첫흑자,https://cnbc.sbs.co.kr/article_hub/10000856809?division=NAVER
738,2017-04-26,NH투자증권삼성바이오로직스하반기파이프라인모멘텀다수3분기본격적인턴어라운드기대”,http://www.g-enews.com/ko-kr/news/article/news_all/201704260822159691c642673384_1/article.html
739,2017-04-26,주요공시효성삼성바이오로직스유진테크등,http://www.intn.co.kr/news/articleView.html?idxno=796365
740,2017-04-26,삼성바이오로직스턴어라운드3분기부터NH투자,http://www.newstomato.com/ReadNews.aspx?no=749241
741,2017-04-26,오늘의종목삼성바이오로직스34분기실적턴어라운드기대NH,http://www.sedaily.com/NewsView/1OESOH92CM
742,2017-04-26,삼성바이오로직스34분기실적턴어라운드예상NH투자,http://www.dailian.co.kr/news/view/628934/?sc=naver
743,2017-04-26,특징주삼성바이오로직스턴어라운드기대만발19만원다시넘나,http://www.g-enews.com/ko-kr/news/article/news_all/201704260907594271c642673384_1/article.html
744,2017-04-26,특징주삼성바이오로직스1Q영업익흑자전환에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02050006615900056
745,2017-04-26,ET투자뉴스삼성바이오로직스1분기역대최대매수삼성증권,http://www.etnews.com/20170426000032
746,2017-04-26,삼성바이오로직스34분기실적턴어라운드전망에오름세,http://www.newsprime.co.kr/news/article.html?no=372984
747,2017-04-26,특징주삼성바이오로직스1분기흑자전환에상승,http://www.viva100.com/main/view.php?key=20170426010009221
748,2017-04-26,삼성바이오로직스턴어라운드날개짓,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201704250324
749,2017-04-26,삼성바이오로직스1분기매출1076억영업이익34억달성,http://www.kukinews.com/news/article.html?no=450162
750,2017-04-26,흑자전환자랑못하는삼성바이오로직스,http://www.hankyung.com/news/app/newsview.php?aid=201704257684A
751,2017-04-26,삼성바이오로직스1분기매출1076억달성,http://www.dailypharm.com/News/224832
752,2017-04-26,​삼성바이오로직스창립이래첫흑자기록,http://www.sisafocus.co.kr/news/articleView.html?idxno=160263
753,2017-04-26,삼성바이오로직스위탁생산증가로올해흑자전환가능,http://www.businesspost.co.kr/news/articleView.html?idxno=48097
754,2017-04-27,오픈토크종목삼성바이오로직스19만원넘길까,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002794140
755,2017-04-28,삼성바이오로직스등42개사2억7169만주의무보호예수해제,http://www.ebn.co.kr/news/view/889596
756,2017-04-28,삼성바이오로직스등42개사5월의무보호예수해제,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170428054300008&did=1195m
757,2017-04-28,5월삼성바이오로직스등42개사의무보호예수해제,http://www.etoday.co.kr/news/section/newsview.php?idxno=1485853
758,2017-04-28,5월삼성바이오로직스등42개사의무보호예수해제,http://www.ajunews.com/view/20170428100103641
759,2017-04-28,삼성바이오로직스등5월중34개사의무보호예수해제,http://www.asiatoday.co.kr/view.php?key=20170428010018359
760,2017-04-28,예탁결제원삼성바이오로직스등42개사의무보호예수해제,http://www.nspna.com/news/?mode=view&newsid=220070
761,2017-04-28,5월삼성바이오로직스등42개사보호예수해제,http://www.mt.co.kr/view/mtview.php?type=1&no=2017042811254434753&outlink=1
762,2017-04-28,삼성바이오로직스등42개사5월중의무보호예수해제,http://www.etnews.com/20170428000165
763,2017-04-28,5월삼성바이오로직스등42개사의무보호예수해제,http://www.fntimes.com/paper/view.aspx?num=179871
764,2017-04-28,삼성물산기업가치삼성바이오로직스활약에달려,http://www.businesspost.co.kr/news/articleView.html?idxno=48274
765,2017-04-29,삼성바이오로직스의무보호예수해제여파는,http://www.choicenews.co.kr/news/articleView.html?idxno=33046
766,2017-04-29,삼성바이오로직스3공장들어서는배후수요인천논현포레오피스텔눈길,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201704290015
767,2017-05-01,삼성바이오로직스올들어22주가껑충의약품업종견인,http://biz.chosun.com/site/data/html_dir/2017/05/01/2017050100153.html
768,2017-05-01,업종대표株상승률1위는삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=01315286615924656
769,2017-05-01,올들어업종대표주주가상승률1위는삼성바이오로직스2185↑,http://www.ekn.kr/news/article.html?no=284638
770,2017-05-01,올해코스피주가상승률1위대표주는삼성바이오로직스,http://www.fnnews.com/news/201705010758352428
771,2017-05-01,삼성바이오로직스3공장품은인천논현포레오피스텔직주근접인기,http://www.ikld.kr/news/articleView.html?idxno=72993
772,2017-05-01,올해코스피업종대표주주가상승률1위삼성바이오로직스,http://www.sporbiz.co.kr/news/articleView.html?idxno=101611
773,2017-05-01,이름값못한업종대표주삼성바이오로직스군계일학,http://www.metroseoul.co.kr/news/newsview?newscd=2017050100025
774,2017-05-01,의약품대표주삼성바이오로직스올들어2185올라최고성적,http://www.fnnews.com/news/201705011704131675
775,2017-05-02,삼성물산삼성전자삼성바이오로직스보통주보호예수기간만료예정,http://www.ebn.co.kr/news/view/890145
776,2017-05-04,날개단삼성바이오로직스작년IPO이어올해성장가속도,http://www.ebn.co.kr/news/view/890365
777,2017-05-04,삼성바이오로직스유럽제약사와471억원계약의향서체결,http://www.mt.co.kr/view/mtview.php?type=1&no=2017050417100284535&outlink=1
778,2017-05-04,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170504147400008&did=1195m
779,2017-05-04,삼성바이오로직스유럽소재제약사와470억위탁생산의향서체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1487674
780,2017-05-04,삼성바이오로직스471억원규모계약의향서체결,http://view.asiae.co.kr/news/view.htm?idxno=2017050417075800341
781,2017-05-04,삼성바이오로직스471억원규모위탁생산의향서체결,http://news1.kr/articles/?2985822
782,2017-05-04,삼성바이오로직스유럽제약사와471억규모위탁생산계약의향서체결,http://www.ekn.kr/news/article.html?no=285245
783,2017-05-04,삼성바이오로직스유럽제약사와471억위탁생산계약,http://www.asiatoday.co.kr/view.php?key=20170504010001444
784,2017-05-04,삼성바이오로직스유럽제약사와471억위탁생산의향서체결,http://www.dt.co.kr/contents.html?article_no=2017050402109976029005
785,2017-05-04,삼성바이오로직스유럽제약사와471억위탁생산계약의향서체결,http://www.newstomato.com/ReadNews.aspx?no=750772
786,2017-05-04,삼성바이오로직스유럽제약사와471억규모계약의향서체결,http://www.fntimes.com/paper/view.aspx?num=180268
787,2017-05-04,삼성바이오로직스471억규모위탁생산계약의향서체결,http://www.cstimes.com/?mod=news&act=articleView&idxno=245109
788,2017-05-04,삼성바이오로직스471억규모의약품생산계약눈앞,http://www.newspim.com/news/view/20170504000300
789,2017-05-04,유가증권시장공시대성산업삼성바이오로직스동원시스템즈등,http://news.mk.co.kr/newsRead.php?&year=2017&no=301734
790,2017-05-04,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://daily.hankooki.com/lpage/economy/201705/dh20170504203202138080.htm
791,2017-05-04,삼성바이오로직스4165만불위탁생산의향서,http://www.kyeongin.com/main/view.php?key=20170504010001488
792,2017-05-08,인베스트조선흑자전환불구채권시장못나서는삼성바이오로직스,http://www.investchosun.com/2017/05/08/3212773
793,2017-05-08,주요공시삼성바이오로직스대성산업제우스등,http://www.intn.co.kr/news/articleView.html?idxno=796537
794,2017-05-08,특징주삼성바이오로직스사흘째상승랠리외인매수주목,http://www.g-enews.com/ko-kr/news/article/news_all/20170508091107221c642673384_1/article.html
795,2017-05-08,특징주삼성바이오로직스471억원위탁생산계약소식에강세,http://www.newstomato.com/ReadNews.aspx?no=751020
796,2017-05-08,삼성바이오로직스470억의약품생산계약,http://www.kormedi.com/news/news/drug_dist/1223218_2906.html
797,2017-05-10,CoverStory삼성바이오로직스글로벌넘버원바이오의약품생산기업목표,http://news.mk.co.kr/newsRead.php?&year=2017&no=310693
798,2017-05-11,ET투자뉴스제약주테마한미약품삼성바이오로직스중심으로강세,http://www.etnews.com/20170511000215
799,2017-05-17,삼성바이오로직스등10종목코스피200신규편입,http://biz.chosun.com/site/data/html_dir/2017/05/17/2017051702088.html
800,2017-05-17,삼성바이오로직스등10종목코스피200신규편입,http://www.edaily.co.kr/news/newspath.asp?newsid=03663766615929904
801,2017-05-17,코스피200삼성바이오로직스등10종목신규편입,http://www.newspim.com/news/view/20170517000241
802,2017-05-17,삼성바이오로직스등10종목코스피200지수신규편입,http://www.fnnews.com/news/201705171611524162
803,2017-05-17,코스피200정기변경삼성바이오로직스등10종목신규편입,http://view.asiae.co.kr/news/view.htm?idxno=2017051716035476802
804,2017-05-17,삼성바이오로직스등10개종목코스피200신규편입,http://www.dailian.co.kr/news/view/633828/?sc=naver
805,2017-05-17,삼성바이오로직스등10종목코스피200신규편입,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170517142100008&did=1195m
806,2017-05-17,삼성바이오로직스등10종목코스피200신규편입,http://www.ajunews.com/view/20170517162814307
807,2017-05-17,삼성바이오로직스등10종목코스피200신규편입,http://news.einfomax.co.kr/news/articleView.html?idxno=334421
808,2017-05-17,코스피200새얼굴삼성바이오로직스팬오션등10종목편입,http://news1.kr/articles/?2996218
809,2017-05-17,코스피200삼성바이오로직스들어가고벽산빠지고,http://www.mt.co.kr/view/mtview.php?type=1&no=2017051714455925137&outlink=1
810,2017-05-17,삼성바이오로직스등10종목코스피200지수신규편입,http://www.sporbiz.co.kr/news/articleView.html?idxno=106365
811,2017-05-17,삼성바이오로직스등10종목코스피200신규편입,http://www.asiatoday.co.kr/view.php?key=20170517010008756
812,2017-05-17,삼성바이오로직스코스피200편입,http://news.mk.co.kr/newsRead.php?&year=2017&no=330241
813,2017-05-17,삼성바이오로직스등10종목코스피200신규편입넷마블은심사후결정,http://www.newsis.com/view/?id=NISX20170517_0014900907&cID=10404&pID=10400
814,2017-05-17,삼성바이오로직스등코스피200확정지금사도될까,http://www.edaily.co.kr/news/newspath.asp?newsid=04047526615929904
815,2017-05-17,삼성바이오로직스등10종목코스피200지수에신규편입,http://www.fnnews.com/news/201705171802049864
816,2017-05-17,삼성바이오로직스등10종목코스피200신규편입,http://www.cstimes.com/?mod=news&act=articleView&idxno=245936
817,2017-05-17,CJCGV삼성바이오로직스내달9일코스피200신규편입,http://www.fntimes.com/paper/view.aspx?num=181065
818,2017-05-17,삼성바이오로직스LIG넥스원등10종목코스피200편입,http://www.ebn.co.kr/news/view/892127
819,2017-05-17,삼성바이오로직스등10개종목코스피200편입,http://www.viva100.com/main/view.php?key=20170517010005750
820,2017-05-17,거래소삼성바이오로직스등10종목코스피200신규편입,http://www.newsway.co.kr/view.php?tp=1&ud=2017051719233458949
821,2017-05-17,삼성바이오로직스GS건설등10종목코스피200신규편입,http://www.ekn.kr/news/article.html?no=287730
822,2017-05-18,특징주삼성바이오로직스코스피200신규편입외인매수주가상승행진이어질까,http://www.g-enews.com/ko-kr/news/article/news_all/201705180909514802c642673384_1/article.html
823,2017-05-18,마감전략A2부7인의관심종목대공개현대모비스삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017051816274134939
824,2017-05-19,특징주삼성바이오로직스코스피200지수편입앞두고강세,http://view.asiae.co.kr/news/view.htm?idxno=2017051915114125166
825,2017-05-20,삼성바이오로직스잇따른外人매수왜,http://www.choicenews.co.kr/news/articleView.html?idxno=33389
826,2017-05-22,송도인근인천새로운블루칩삼성바이오로직스3공장배후수요인천논현포레,http://www.dt.co.kr/contents.html?article_no=2017052202109923811004
827,2017-05-24,특징주삼성바이오로직스주가20만원시대열리나8거래일째상승랠리,http://www.g-enews.com/ko-kr/news/article/news_all/201705240908406427c642673384_1/article.html
828,2017-05-24,삼성바이오로직스셀트리온하반기미국판매주목,http://www.choicenews.co.kr/news/articleView.html?idxno=33454
829,2017-05-24,삼성바이오로직스글로벌CMO시장서게임체인저도전할것,http://www.ntoday.co.kr/news/articleView.html?idxno=53121
830,2017-05-24,코스피외국인순매수SK하이닉스현대로보틱스삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2017052416163495750
831,2017-05-24,이번엔제약바이오삼성바이오로직스중외제약유한양행껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=33464
832,2017-05-25,특징주삼성바이오로직스신고가경신,http://www.ebn.co.kr/news/view/893388
833,2017-05-25,날개단삼성바이오로직스20만원넘었다,http://view.asiae.co.kr/news/view.htm?idxno=2017052510592403823
834,2017-05-25,삼성바이오로직스세계최대CMO회사로우뚝서다,http://www.m-i.kr/news/articleView.html?idxno=313810
835,2017-05-26,삼성바이오로직스열흘째최고가행진21만원찍어,http://www.fntimes.com/paper/view.aspx?num=181698
836,2017-05-26,특징주삼성바이오로직스11거래일연속상승,http://www.mt.co.kr/view/mtview.php?type=1&no=2017052614404886965&outlink=1
837,2017-05-26,삼성바이오로직스삼성SDILG화학신고가,http://www.choicenews.co.kr/news/articleView.html?idxno=33516
838,2017-05-29,터치UpDown삼성바이오로직스10거래일연속최고가행진,http://www.sedaily.com/NewsView/1OG3ZXHBKZ
839,2017-05-29,삼성바이오로직스2017년임원인사전무1명상무1명승진,http://www.asiatoday.co.kr/view.php?key=20170529010015338
840,2017-05-29,인사삼성바이오로직스,http://www.fnnews.com/news/201705290910397433
841,2017-05-29,삼성인사삼성바이오로직스김동중전무이충우상무승진,http://www.ebn.co.kr/news/view/893843
842,2017-05-29,인사삼성바이오로직스,http://www.newsis.com/view/?id=NISX20170529_0014925768&cID=10434&pID=13000
843,2017-05-29,인사삼성바이오로직스2017년임원승진,http://www.ajunews.com/view/20170529091839591
844,2017-05-29,삼성바이오로직스2017년임원승진인사단행전무상무각1명,http://www.dailian.co.kr/news/view/636139/?sc=naver
845,2017-05-29,인사삼성바이오로직스,http://www.viva100.com/main/view.php?key=20170529010009957
846,2017-05-29,인사삼성바이오로직스,http://www.mt.co.kr/view/mtview.php?type=1&no=2017052909251321549&outlink=1
847,2017-05-29,인사삼성바이오로직스,http://news1.kr/articles/?3005943
848,2017-05-29,인사삼성바이오로직스,http://view.asiae.co.kr/news/view.htm?idxno=2017052909264821604
849,2017-05-29,인사삼성바이오로직스,http://www.ajunews.com/view/20170529092742613
850,2017-05-29,인사삼성바이오로직스,http://www.fnnews.com/news/201705290927145080
851,2017-05-29,인사삼성바이오로직스,http://www.fnnews.com/news/201705290934180112
852,2017-05-29,인사삼성바이오로직스,http://www.ekn.kr/news/article.html?no=290060
853,2017-05-29,삼성바이오로직스임원인사전무김동중상무이충우,http://daily.hankooki.com/lpage/economy/201705/dh20170529095057138080.htm
854,2017-05-29,인사삼성바이오로직스,http://www.m-i.kr/news/articleView.html?idxno=314406
855,2017-05-29,인사삼성바이오로직스,http://www.seoulfn.com/news/articleView.html?idxno=279792
856,2017-05-29,특징주삼성바이오로직스또신고가경신,http://www.sporbiz.co.kr/news/articleView.html?idxno=109783
857,2017-05-29,인사삼성바이오로직스,http://www.dt.co.kr/contents.html?article_no=2017052902109976029002
858,2017-05-29,인사삼성바이오로직스,http://www.polinews.co.kr/news/article.html?no=315392
859,2017-05-29,인사삼성바이오로직스,http://www.g-enews.com/ko-kr/news/article/news_all/20170529100449771e6a49afa8d_1/article.html
860,2017-05-29,삼성바이오로직스,http://www.bosa.co.kr/news/articleView.html?idxno=2061737
861,2017-05-29,인사삼성바이오로직스,http://www.etoday.co.kr/news/section/newsview.php?idxno=1496388
862,2017-05-29,인사삼성바이오로직스,http://www.newstomato.com/ReadNews.aspx?no=755664
863,2017-05-29,인사삼성바이오로직스,http://www.kyeongin.com/main/view.php?key=20170529010009682
864,2017-05-29,인사삼성바이오로직스,http://biz.chosun.com/site/data/html_dir/2017/05/29/2017052901009.html
865,2017-05-29,삼성바이오로직스김동중경영자원혁신센터장전무승진,http://www.anewsa.com/detail.php?number=1173761&thread=03r03
866,2017-05-29,인사삼성바이오로직스,http://www.bizwatch.co.kr/pages/view.php?uid=31186
867,2017-05-29,인사삼성바이오로직스,http://www.ggilbo.com/news/articleView.html?idxno=375174
868,2017-05-29,인사삼성바이오로직스,http://www.shinailbo.co.kr/news/articleView.html?idxno=580652
869,2017-05-29,인사삼성바이오로직스,http://www.newspim.com/news/view/20170529000155
870,2017-05-29,인사삼성바이오로직스,http://www.kukinews.com/news/article.html?no=457141
871,2017-05-29,인사삼성바이오로직스삼성바이오에피스제일기획충북도,http://www.businesspost.co.kr/news/articleView.html?idxno=50141
872,2017-05-29,인사삼성바이오로직스,http://ciobiz.etnews.com/20170529120028
873,2017-05-29,인사삼성바이오로직스삼성바이오에피스에스원등,http://news.mk.co.kr/newsRead.php?&year=2017&no=359125
874,2017-05-29,인사삼성바이오로직스,http://www.sporbiz.co.kr/news/articleView.html?idxno=110035
875,2017-05-29,오늘의인사삼성바이오로직스제일기획충북도,http://www.mediapen.com/news/view/271661
876,2017-05-29,인사경기도경기대삼성바이오로직스삼성바이오에피스,http://www.kyeongin.com/main/view.php?key=20170529010010013
877,2017-05-30,삼성바이오로직스승진인사단행,http://www.joongboo.com/?mod=news&act=articleView&idxno=1169129
878,2017-05-30,삼성바이오로직스인사,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=765016
879,2017-05-30,인사종합삼성바이오로직스호텔신라외,http://news1.kr/articles/?3007017
880,2017-05-30,삼성바이오로직스CMO출사표6년만에시장제패,http://www.mt.co.kr/view/mtview.php?type=1&no=2017053015001349747&outlink=1
881,2017-05-30,그것이사고싶다토니모리현대상선삼성바이오로직스外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017053015372154521
882,2017-05-30,코스피외국인순매수LG디스플레이삼성바이오로직스삼성SDI,http://www.newsway.co.kr/view.php?tp=1&ud=2017053016152580871
883,2017-05-31,삼성바이오로직스세계최대규모생산공장으로발돋움,http://www.joongboo.com/?mod=news&act=articleView&idxno=1169399
884,2017-05-31,NH투자코스피200정기변경에삼성바이오로직스주목,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170531045100008&did=1195m
885,2017-05-31,특징주삼성바이오로직스코스피200지수편입기대감강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02276326615934496
886,2017-05-31,특징주삼성바이오로직스코스피200지수편입기대상승,http://www.viva100.com/main/view.php?key=20170531010010979
887,2017-05-31,날개단삼성바이오로직스글로벌CMO챔피언우뚝,http://www.sisaweek.com/news/articleView.html?idxno=91859
888,2017-05-31,삼성바이오로직스코스피200지수신규편입소식에주가↑,http://www.newsprime.co.kr/news/article.html?no=376532
889,2017-05-31,한미약품삼성바이오로직스4껑충왜,http://www.choicenews.co.kr/news/articleView.html?idxno=33600
890,2017-06-01,특징주삼성바이오로직스주가상장이후최고가경신외인은팽팽,http://www.g-enews.com/ko-kr/news/article/news_all/201706010919472842c642673384_1/article.html
891,2017-06-01,특징주삼성바이오로직스신고가경신,http://www.ebn.co.kr/news/view/894509
892,2017-06-01,특징주삼성바이오로직스코스피200지수편입기대감에신고가행진,http://biz.chosun.com/site/data/html_dir/2017/06/01/2017060100809.html
893,2017-06-01,특징주삼성바이오로직스최고가행진22만원대안착,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170601054500008&did=1195m
894,2017-06-01,특징주삼성바이오로직스장중사상최고가경신,http://stock.hankyung.com/news/app/newsview.php?aid=2017060139276
895,2017-06-01,특징주삼성바이오로직스22만8500원사상최고가경신,http://www.seoulfn.com/news/articleView.html?idxno=280121
896,2017-06-01,특징주삼성바이오로직스장중최고가경신22만원대안착,http://www.newsis.com/view/?id=NISX20170601_0000000741&cID=10401&pID=10400
897,2017-06-01,삼성바이오로직스사상최고가경신코스피200편입효과기대,http://news.heraldcorp.com/view.php?ud=20170601000422
898,2017-06-01,종목플러스최고가행진삼성바이오로직스1500억매수세대기,http://stock.hankyung.com/news/app/newsview.php?aid=2017060150366
899,2017-06-01,특징주삼성바이오로직스최고가행진종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170601054551008&did=1195m
900,2017-06-01,코스피외국인순매도POSCO삼성바이오로직스현대제철,http://www.newsway.co.kr/view.php?tp=1&ud=2017060116265887598
901,2017-06-01,삼성바이오로직스주가상장뒤최고가코스피200편입효과,http://www.businesspost.co.kr/news/articleView.html?idxno=50457
902,2017-06-02,특징주삼성바이오로직스또신고가237만원,http://www.mt.co.kr/view/mtview.php?type=1&no=2017060209115877844&outlink=1
903,2017-06-02,특징주삼성바이오로직스사흘째최고가행진,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170602044800008&did=1195m
904,2017-06-02,특징주삼성바이오로직스코스피200지수편입기대에연일신고가,http://biz.chosun.com/site/data/html_dir/2017/06/02/2017060200686.html
905,2017-06-02,특징주삼성바이오로직스또최고가경신,http://www.sporbiz.co.kr/news/articleView.html?idxno=111440
906,2017-06-02,특징주삼성바이오로직스신고가또경신,http://www.ebn.co.kr/news/view/894737
907,2017-06-02,특징주삼성바이오로직스코스피200편입기대에사흘연속신고가갱신,http://www.g-enews.com/ko-kr/news/article/news_all/201706020924033299581e5800d6_1/article.html
908,2017-06-02,특징주삼성바이오로직스연일최고가경신코스피200편입기대,http://www.viva100.com/main/view.php?key=20170602010000657
909,2017-06-02,삼성바이오로직스52주신고가코스피200편입기대↑,http://www.newsprime.co.kr/news/article.html?no=376888
910,2017-06-02,특징주삼성바이오로직스3일연속52주신고가경신,http://www.ekn.kr/news/article.html?no=291097
911,2017-06-02,특징주삼성바이오로직스사흘연속또사상최고가,http://www.seoulfn.com/news/articleView.html?idxno=280223
912,2017-06-02,특징주삼성바이오로직스코스피200편입기대에최고가경신,http://www.fntimes.com/paper/view.aspx?num=182223
913,2017-06-02,코스피외국인사자에2060돌파삼성바이오로직스또사상최고가,http://stock.hankyung.com/news/app/newsview.php?aid=2017060272196
914,2017-06-02,특징주삼성바이오로직스코스피200지수편입임박사흘째최고가경신,http://www.newsis.com/view/?id=NISX20170602_0000001903&cID=10401&pID=10400
915,2017-06-02,삼성바이오로직스겹호재에3일연속사상최고가,http://news.heraldcorp.com/view.php?ud=20170602000364
916,2017-06-02,오픈토크삼성바이오로직스,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002832814
917,2017-06-02,특검↔삼성삼성바이오로직스정부로비의혹공방,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20170602134724
918,2017-06-02,삼성바이오로직스의꽃길청와대개입없었나,http://www.mediatoday.co.kr/?mod=news&act=articleView&idxno=137177
919,2017-06-02,화평법적용배제가특혜삼성바이오로직스이름도몰랐다,http://www.mt.co.kr/view/mtview.php?type=1&no=2017060214534120354&outlink=1
920,2017-06-02,삼성바이오로직스뛰고LG전자날았다,http://www.choicenews.co.kr/news/articleView.html?idxno=33654
921,2017-06-03,터치UpDown삼성바이오로직스지수편입기대감에3거래일연속상승,http://www.sedaily.com/NewsView/1OH1Z3012H
922,2017-06-03,관심주삼성바이오로직스최고가행진코스피200효과,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170602172800008&did=1195m
923,2017-06-05,CEOUpDown365삼성바이오로직스김태한사장CMO1위넘어CDO역량강화,http://www.ebn.co.kr/news/view/894914
924,2017-06-05,삼성바이오로직스고공행진에웃는삼성물산,http://www.mt.co.kr/view/mtview.php?type=1&no=2017060510162122957&outlink=1
925,2017-06-07,특징주삼성바이오로직스외인사자에3↑,http://view.asiae.co.kr/news/view.htm?idxno=2017060714403168751
926,2017-06-07,삼성바이오로직스LG디스플레이연일급등,http://www.choicenews.co.kr/news/articleView.html?idxno=33728
927,2017-06-08,특징주삼성바이오로직스상장이후최고가또뚫었다외인사자,http://www.g-enews.com/ko-kr/news/article/news_all/20170608090750354c642673384_1/article.html
928,2017-06-08,특징주삼성바이오로직스엿새째상승또신고가,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170608043800008&did=1195m
929,2017-06-08,삼성바이오로직스장숭사상최고가경신,http://www.sedaily.com/NewsView/1OH4A6KGVD
930,2017-06-08,삼성바이오로직스연일신고가행진25만원돌파,http://news.heraldcorp.com/view.php?ud=20170608000148
931,2017-06-08,특징주삼성바이오로직스6일째↑내일부터코스피200편입,http://www.mediapen.com/news/view/274991
932,2017-06-08,특징주삼성바이오로직스코스피200편입기대감에상승,http://www.viva100.com/main/view.php?key=20170608010002464
933,2017-06-08,특징주삼성바이오로직스코스피200편입앞두고연일강세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017060809232718634&outlink=1
934,2017-06-08,특징주삼성바이오로직스신고가경신,http://www.cstimes.com/?mod=news&act=articleView&idxno=247505
935,2017-06-08,특징주삼성바이오로직스코스피200지수편입기대감신고가,http://www.dailian.co.kr/news/view/638508/?sc=naver
936,2017-06-08,특징주삼성바이오로직스장중최고가경신내일코스피200편입,http://www.ebn.co.kr/news/view/895462
937,2017-06-08,코스피200편입앞둔삼성바이오로직스52주신고가경신,http://www.newsprime.co.kr/news/article.html?no=377372
938,2017-06-08,사우디제약분야투자설명회삼성바이오로직스등참석,http://daily.hankooki.com/lpage/society/201706/dh20170608114742137830.htm
939,2017-06-08,삼성바이오로직스6일째상승25만원돌파,https://cnbc.sbs.co.kr/article_hub/10000861858?division=NAVER
940,2017-06-08,개장전특징주삼성바이오로직스207940,http://www.newstomato.com/ReadNews.aspx?no=757901
941,2017-06-08,내일코스피200정기변경삼성바이오로직스3대하락,http://www.mt.co.kr/view/mtview.php?type=1&no=2017060815091389276&outlink=1
942,2017-06-08,분식회계논란삼성바이오로직스특별감리감감무소식왜,http://www.hani.co.kr/arti/economy/finance/797990.html
943,2017-06-08,특징주삼성바이오로직스장중최고가후하락,http://www.ekn.kr/news/article.html?no=292096
944,2017-06-08,코스피외국인순매도삼성바이오로직스우리은행넷마블게임즈,http://www.newsway.co.kr/view.php?tp=1&ud=2017060817201735571
945,2017-06-09,ET투자뉴스삼성바이오로직스_외국인의매물이일단그쳐야현재276,http://www.etnews.com/20170609000025
946,2017-06-09,특징주코스피200편입첫날삼성바이오로직스급락,http://view.asiae.co.kr/news/view.htm?idxno=2017060909345474246
947,2017-06-09,1시의증시데이트천장맞추기BGF리테일삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017060914310152346
948,2017-06-09,코스피외국인순매도SK이노베이션삼성바이오로직스넷마블게임즈,http://www.newsway.co.kr/view.php?tp=1&ud=2017060916540008760
949,2017-06-09,숨고르기나선삼성바이오로직스고성장기대는여전,http://www.edaily.co.kr/news/newspath.asp?newsid=03460406615960080
950,2017-06-11,마켓포인트코스피주간외국인순매도1위삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=01712166615960736
951,2017-06-12,에너지공단삼성바이오로직스GGP공동추진MOU체결,http://www.joongboo.com/?mod=news&act=articleView&idxno=1172001
952,2017-06-12,제24회바이오USAK바이오가간다①삼성바이오로직스내년3공장완공땐바이오약생산세계1위,http://www.ajunews.com/view/20170609154810903
953,2017-06-12,특징주삼성바이오로직스이틀연속급락후반등2↑,http://view.asiae.co.kr/news/view.htm?idxno=2017061213380653860
954,2017-06-13,특징주삼성바이오로직스외인매수에5↑,http://view.asiae.co.kr/news/view.htm?idxno=2017061314055475781
955,2017-06-13,美기술주쇼크끝LG디스플레이삼성바이오로직스7급등,http://www.choicenews.co.kr/news/articleView.html?idxno=33849
956,2017-06-13,국고처최승욱종목상담삼성바이오로직스207940,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706100067
957,2017-06-15,한용희트레이더삼성바이오로직스추천2달만에42수익률달성,https://cnbc.sbs.co.kr/article_hub/10000862806?division=NAVER
958,2017-06-15,르포글로벌CMO노린다”삼성바이오로직스RD심장가보니,http://www.sisajournal-e.com/biz/article/170299
959,2017-06-16,마켓인사이트삼성바이오로직스바이오에피스2000억원규모유상증자완료지분율확대,http://stock.hankyung.com/news/app/newsview.php?aid=201706161324u
960,2017-06-18,바이오USA내일개막삼성바이오로직스등K바이오비즈니스장으로,http://daily.hankooki.com/lpage/ittech/201706/dh20170618122541145630.htm
961,2017-06-20,삼성바이오로직스바이오본고장미국서기술력뽐낸다,http://www.ebn.co.kr/news/view/897163
962,2017-06-20,삼성바이오로직스BIO2017참가,http://www.medigatenews.com/news/2768909593
963,2017-06-20,삼성바이오로직스세계최대바이오전시회참가,http://www.dailian.co.kr/news/view/641207/?sc=naver
964,2017-06-20,삼성바이오로직스BIO인터내셔널컨벤션참가,http://www.bosa.co.kr/news/articleView.html?idxno=2063147
965,2017-06-20,삼성바이오로직스바이오USA참석,http://www.newsis.com/view/?id=NISX20170620_0000017389&cID=13001&pID=13000
966,2017-06-20,더벨삼성바이오로직스잠재고객사발굴나선다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201706200100033550002038
967,2017-06-20,삼성바이오로직스세계최대바이오전시회참가,http://www.siminilbo.co.kr/news/articleView.html?idxno=518039
968,2017-06-20,삼성바이오로직스바이오USA참가,http://www.seoulfn.com/news/articleView.html?idxno=281399
969,2017-06-20,세계최대전시회간삼성바이오로직스글로벌제약사앞에서경쟁력눈도장,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=703906
970,2017-06-20,포토삼성바이오로직스美콘퍼런스참가,http://www.kyeongin.com/main/view.php?key=20170620010006465
971,2017-06-20,삼성바이오로직스세계최대바이오전시회참가,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1365540
972,2017-06-21,삼성바이오로직스미국BIO인터내셔널컨벤션참가,http://www.joongboo.com/?mod=news&act=articleView&idxno=1174350
973,2017-06-21,유진투자증권삼성바이오로직스현주가수준에서추가적매수권고어렵다펀더멘털과기대는반영”,http://www.g-enews.com/ko-kr/news/article/news_all/201706210812394966c642673384_1/article.html
974,2017-06-21,더벨삼성바이오로직스론자바이오축제에서도나란히,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201706210100036010002185
975,2017-06-21,유진투자삼성바이오로직스목표가↑투자의견↓,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170621040300008&did=1195m
976,2017-06-21,오늘의종목삼성바이오로직스우호적시장은이미주가에반영,http://www.sedaily.com/NewsView/1OHA93716S
977,2017-06-21,삼성바이오로직스펀더멘탈선반영투자의견하향유진證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017062108521984576&outlink=1
978,2017-06-21,ET투자뉴스삼성바이오로직스펀더멘털과기대는HOLD하향유진투자증권,http://www.etnews.com/20170621000031
979,2017-06-21,특징주삼성바이오로직스이틀째하락펀더멘털과기대감이미반영,http://biz.chosun.com/site/data/html_dir/2017/06/21/2017062100878.html
980,2017-06-21,특징주삼성바이오로직스상승제한적분석에하락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170621054900008&did=1195m
981,2017-06-21,김태한삼성바이오로직스사장2030년헬스케어산업에서1위될것,http://view.asiae.co.kr/news/view.htm?idxno=2017062108441422794
982,2017-06-21,김태한사장삼성바이오로직스수탁개발로사업확장종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170621059851017&did=1195m
983,2017-06-21,특징주삼성바이오로직스추가상승폭제한분석속약세,http://www.newstomato.com/ReadNews.aspx?no=760665
984,2017-06-21,삼성바이오로직스신규사업분야CDO에서조만간계약체결될듯,http://www.fnnews.com/news/201706211007549744
985,2017-06-21,김태한삼성바이오로직스대표2020년에는글로벌CMONO1될것,http://www.fnnews.com/news/201706211052550147
986,2017-06-21,삼성바이오로직스2030년글로벌선두기업도약,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706210135
987,2017-06-21,삼성바이오로직스김태한대표CDO사업진출사업다각화3년내세계1위CMO사우뚝,http://www.fnnews.com/news/201706211729364950
988,2017-06-21,2017바이오삼성바이오로직스싱가포르모델로인력난해소하자,http://www.newspim.com/news/view/20170621000258
989,2017-06-21,김태한삼성바이오로직스사장바이오약위탁생산세계1등머잖아,http://www.ajunews.com/view/20170621070045568
990,2017-06-22,김태한삼성바이오로직스사장바이오의약품위탁생산넘어수탁개발로사업확장”,http://news.donga.com/3/all/20170621/85000545/1
991,2017-06-22,삼성바이오로직스단기과열논란외국인이탈심화,http://biz.chosun.com/site/data/html_dir/2017/06/22/2017062200777.html
992,2017-06-22,김태한삼성바이오로직스사장2020년글로벌CMO챔피언될것,https://cnbc.sbs.co.kr/article_hub/10000863650?division=NAVER
993,2017-06-22,삼성바이오로직스의속도전수탁개발로영역확장,http://daily.hankooki.com/lpage/economy/201706/dh20170622104516138080.htm
994,2017-06-22,삼성바이오로직스의약품위탁개발생산세계1위노려,https://cnbc.sbs.co.kr/article_hub/10000863769?division=NAVER
995,2017-06-23,삼성바이오로직스삼성물산삼성전기삼성그룹株웃었다,http://www.choicenews.co.kr/news/articleView.html?idxno=34093
996,2017-06-23,코스피기관순매수TIGER200BGF리테일삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2017062316170384974
997,2017-06-24,삼성바이오로직스의글로벌전략,http://www.medigatenews.com/news/2351194090
998,2017-06-26,특징주삼성바이오로직스임랄디유럽판매허가임박소식에상승,http://biz.chosun.com/site/data/html_dir/2017/06/26/2017062600626.html
999,2017-06-26,특징주삼성바이오로직스자회사제품유럽판매허가임박에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170626041400008&did=1195m
1000,2017-06-26,특징주삼성바이오로직스임랄디허가임박에상승,http://www.newspim.com/news/view/20170626000056
1001,2017-06-26,특징주삼성바이오로직스임랄디유럽허가임박소식에강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1506739
1002,2017-06-26,특징주삼성바이오로직스신고가임랄디유럽진출기대감,http://www.ebn.co.kr/news/view/898012
1003,2017-06-26,특징주삼성바이오로직스임랄디허가임박소식에신고가,http://www.edaily.co.kr/news/newspath.asp?newsid=01833526615965656
1004,2017-06-26,특징주삼성바이오로직스자회사제품유럽허가임박에상승,http://www.viva100.com/main/view.php?key=20170626010009189
1005,2017-06-26,특징주삼성바이오로직스자회사바이오시밀러임랄리유럽판매허가기대주가사흘째날갯짓,http://www.g-enews.com/ko-kr/news/article/news_all/20170626092518207c642673384_1/article.html
1006,2017-06-26,삼성바이오로직스임랄디유럽판매허가임박사상최고가,http://news.heraldcorp.com/view.php?ud=20170626000139
1007,2017-06-26,삼성바이오로직스임랄디유럽판매기대에신고가,http://www.sedaily.com/NewsView/1OHCKE1XND
1008,2017-06-26,특징주삼성바이오로직스치료제유럽판매허가임박소식에신고가,http://www.dailian.co.kr/news/view/642348/?sc=naver
1009,2017-06-26,특징주삼성바이오로직스신고가임랄디유럽판매허가임박,http://view.asiae.co.kr/news/view.htm?idxno=2017062609445209170
1010,2017-06-26,특징주삼성바이오로직스임랄디유럽판매기대감에30만원터치,http://www.mt.co.kr/view/mtview.php?type=1&no=2017062610092755945&outlink=1
1011,2017-06-26,특징주삼성바이오로직스임랄디유럽허가임박소식에최고가,http://www.newstomato.com/ReadNews.aspx?no=761526
1012,2017-06-26,특징주삼성바이오로직스임랄디유럽판매허가임박소식에급등,http://www.newsway.co.kr/view.php?tp=1&ud=2017062610373861392
1013,2017-06-26,특징주삼성바이오로직스임랄디유럽허가임박소식에급등,http://www.newsis.com/view/?id=NISX20170626_0000022740&cID=10401&pID=10400
1014,2017-06-26,특징주삼성바이오로직스셀트리온시총압도,http://www.sporbiz.co.kr/news/articleView.html?idxno=118601
1015,2017-06-26,1시의증시데이트천장맞히기후성삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017062614173138328
1016,2017-06-26,특징주삼성바이오로직스임랄디유럽판매허가임박에급등종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170626041451008&did=1195m
1017,2017-06-26,오늘장MVP삼성바이오로직스,http://www.newstomato.com/ReadNews.aspx?no=761668
1018,2017-06-26,주목7인의선택파트론지엔씨에너지그리고삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017062616234135546
1019,2017-06-26,코스피외국인순매도삼성전자우선주삼성바이오로직스미래에셋대우,http://www.newsway.co.kr/view.php?tp=1&ud=2017062616412187678
1020,2017-06-26,삼성바이오로직스13급등사상최고가왜,http://www.choicenews.co.kr/news/articleView.html?idxno=34135
1021,2017-06-26,유럽판매허가임박삼성바이오로직스급등,http://www.fnnews.com/news/201706261811442226
1022,2017-06-26,HotStock삼성바이오로직스,http://news.hankyung.com/article/2017062637131
1023,2017-06-26,삼성바이오로직스주가강세바이오시밀러또유럽진출가능,http://www.businesspost.co.kr/news/articleView.html?idxno=52347
1024,2017-06-27,전일특징주삼성바이오로직스,http://daily.hankooki.com/lpage/economy/201706/dh20170627113007138110.htm
1025,2017-06-28,삼성바이오로직스승승장구장세끝났나,http://www.koreaittimes.com/story/71143/%EC%82%BC%EC%84%B1%EB%B0%94%EC%9D%B4%EC%98%A4%EB%A1%9C%EC%A7%81%EC%8A%A4-%E2%80%98%EC%8A%B9%EC%8A%B9%EC%9E%A5%EA%B5%AC-%EC%9E%A5%EC%84%B8%E2%80%99-%EB%81%9D%EB%82%AC%EB%82%98
1026,2017-06-29,삼성바이오로직스2021년까지고성장전망한국,http://news.hankyung.com/article/2017062907966
1027,2017-06-29,한국투자證삼성바이오로직스2021년까지고성장장기적관점에서매수”,http://www.newsway.co.kr/view.php?tp=1&ud=2017062908085269513
1028,2017-06-29,한국투자증권삼성바이오로직스실적의방향성확고장기적관점에서매수권고”,http://www.g-enews.com/ko-kr/news/article/news_all/201706290815506536c642673384_1/article.html
1029,2017-06-29,삼성바이오로직스삼성그룹의미래수년간고성장기대한국,http://biz.chosun.com/site/data/html_dir/2017/06/29/2017062900678.html
1030,2017-06-29,HotLine삼성바이오로직스장기적관점에서매수목표가35만원,http://news.mk.co.kr/newsRead.php?year=2017&no=434955
1031,2017-06-29,삼성바이오로직스삼성그룹차세대성장동력목표가35만원한국투자증권,http://www.dailian.co.kr/news/view/643155/?sc=naver
1032,2017-06-29,삼성바이오로직스삼성그룹미래에투자한국투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017062908280156167
1033,2017-06-29,삼성바이오로직스삼성그룹의차세대성장동력한국투자,http://www.sedaily.com/NewsView/1OHDY3WHIO
1034,2017-06-29,한국투자증권삼성바이오로직스2012년까지고성장할것,http://www.newsprime.co.kr/news/article.html?no=379732
1035,2017-06-29,특징주삼성바이오로직스고성장전망주가하루만에반등vs외인은매도,http://www.g-enews.com/ko-kr/news/article/news_all/201706290905327444c642673384_1/article.html
1036,2017-06-29,특징주삼성바이오로직스고성장전망에상승,http://news.hankyung.com/article/2017062911426
1037,2017-06-29,특징주삼성바이오로직스고성장기대감에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170629050800008&did=1195m
1038,2017-06-29,특징주삼성바이오로직스고성장전망에상승,http://www.viva100.com/main/view.php?key=20170629010010717
1039,2017-06-29,특징주삼성바이오로직스2021년까지고성장전망에강세,http://www.newspim.com/news/view/20170629000079
1040,2017-06-29,특징주삼성바이오로직스고성장전망에강세,http://www.newstomato.com/ReadNews.aspx?no=762411
1041,2017-06-29,특징주삼성바이오로직스증권가고성장분석에오름세,http://www.seoulfn.com/news/articleView.html?idxno=282075
1042,2017-06-29,특징주삼성바이오로직스30만원돌파최고가,http://view.asiae.co.kr/news/view.htm?idxno=2017062910010657077
1043,2017-06-29,특징주삼성바이오로직스고성장기대감에첫30만원돌파,http://www.newsway.co.kr/view.php?tp=1&ud=2017062909590688315
1044,2017-06-29,삼성바이오로직스2021년까지고성장낙관”,http://www.dailymedi.com/detail.php?number=820110&thread=22r05
1045,2017-06-29,코스피장중2400한진중공업삼성바이오로직스5급등,http://www.choicenews.co.kr/news/articleView.html?idxno=34209
1046,2017-06-29,코스피외국인순매도삼성바이오로직스삼성전기삼성전자,http://www.newsway.co.kr/view.php?tp=1&ud=2017062916471157512
1047,2017-06-30,삼성바이오로직스상장7개월만에주가2배껑충,http://www.dailypharm.com/News/228163
1048,2017-06-30,삼성바이오로직스빛나는시장대응력확고한실적방향성,http://www.newspim.com/news/view/20170630000031
1049,2017-06-30,오늘의종목삼성바이오로직스2021년까지고성장전망,http://www.sedaily.com/NewsView/1OHEEPK6VR
1050,2017-06-30,특징주삼성바이오로직스강세30만원돌파,http://news.hankyung.com/article/2017063042126
1051,2017-06-30,특징주삼성바이오로직스주가30만원시대다시열었다상장이후최고치경신,http://www.g-enews.com/ko-kr/news/article/news_all/201706300920356237c642673384_1/article.html
1052,2017-06-30,특징주삼성바이오로직스실적개선기대감에상승,http://www.viva100.com/main/view.php?key=20170630010011181
1053,2017-06-30,삼성바이오로직스사상최고가또경신30만원안착,http://news.heraldcorp.com/view.php?ud=20170630000149
1054,2017-06-30,삼성바이오로직스연일상승주가30만원안착,http://www.newsprime.co.kr/news/article.html?no=379909
1055,2017-06-30,코스피기관순매도삼성전자삼성바이오로직스현대모비스,http://www.newsway.co.kr/view.php?tp=1&ud=2017063016082430986
1056,2017-06-30,코스피외국인순매도삼성바이오로직스SK하이닉스삼성전자우,http://www.newsway.co.kr/view.php?tp=1&ud=2017063016074710067
1057,2017-07-01,주간관심주삼성바이오로직스성장기대감에고공비행,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170630151400008&did=1195m
1058,2017-07-02,지난주증시코스피2400돌파에증권주랠리삼성바이오로직스신고가,http://www.ebn.co.kr/news/view/898949
1059,2017-07-03,특징주삼성바이오로직스단기급등후이틀째약세,http://biz.chosun.com/site/data/html_dir/2017/07/03/2017070300684.html
1060,2017-07-03,삼성바이오로직스매수가181500원비중100,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201707030007
1061,2017-07-04,삼성바이오로직스636억원규모의약품위탁생산계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170704100500008&did=1195m
1062,2017-07-04,삼성바이오로직스선파마글로벌과636억위약품위탁생산계약,http://www.mt.co.kr/view/mtview.php?type=1&no=2017070412000286535&outlink=1
1063,2017-07-04,삼성바이오로직스636억규모의약품위탁생산계약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=02961846615991240
1064,2017-07-04,특징주삼성바이오로직스의약품위탁생산계약에강세,http://www.newstomato.com/ReadNews.aspx?no=763390
1065,2017-07-04,삼성바이오로직스인도제약사선파마와5500만달러규모바이오의약품위탁생산계약,http://biz.chosun.com/site/data/html_dir/2017/07/04/2017070401381.html
1066,2017-07-04,삼성바이오로직스인도선파마社와635억원규모CMO계약,http://www.ebn.co.kr/news/view/899347
1067,2017-07-04,삼성바이오로직스636억규모의약품위탁생산계약,http://www.newsis.com/view/?id=NISX20170704_0000031246&cID=10401&pID=10400
1068,2017-07-04,삼성바이오로직스635억의약품위탁생산계약,http://www.asiae.co.kr/news/view.htm?idxno=2017070413170768857
1069,2017-07-04,삼성바이오로직스印최대제약사와636억원생산계약,http://news1.kr/articles/?3038783
1070,2017-07-04,삼성바이오로직스635억원규모의약품위탁생산계약체결,http://www.newspim.com/news/view/20170704000166
1071,2017-07-04,삼성바이오로직스636억규모의약품위탁생산계약,http://www.cstimes.com/?mod=news&act=articleView&idxno=249801
1072,2017-07-04,삼성바이오로직스인도제약사와630억원규모계약,http://www.seoulfn.com/news/articleView.html?idxno=282465
1073,2017-07-04,삼성바이오로직스인도선파마와636억규모의약품위탁생산계약,http://daily.hankooki.com/lpage/economy/201707/dh20170704134403138080.htm
1074,2017-07-04,특징주삼성바이오로직스의약품위탁생산계약소식에강세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017070413463211977&outlink=1
1075,2017-07-04,삼성바이오로직스636억원규모의약품위탁생산계약종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170704100551008&did=1195m
1076,2017-07-04,삼성바이오로직스인도제약사선파마와635억위탁생산계약,http://news.hankyung.com/article/2017070432536
1077,2017-07-04,삼성바이오로직스6356억규모의약품위탁생산계약,http://news.heraldcorp.com/view.php?ud=20170704000628
1078,2017-07-04,삼성바이오로직스635억규모의생산계약체결,http://www.newstomato.com/ReadNews.aspx?no=763398
1079,2017-07-04,삼성바이오로직스인도선파마와위탁생산계약체결,http://www.mt.co.kr/view/mtview.php?type=1&no=2017070413560190759&outlink=1
1080,2017-07-04,삼성바이오로직스인도최대제약사선파마와장기계약체결,http://news.heraldcorp.com/view.php?ud=20170704000634
1081,2017-07-04,삼성바이오로직스인도선파마사와630억원규모CMO계약체결,http://www.fnnews.com/news/201707041400169222
1082,2017-07-04,삼성바이오로직스인도최대제약사선파마와계약체결,http://www.fnnews.com/news/201707041403575761
1083,2017-07-04,삼성바이오로직스인도최대제약사선파마와계약체결,http://www.dailian.co.kr/news/view/644409/?sc=naver
1084,2017-07-04,삼성바이오로직스인도최대제약사와손잡는다,http://www.sisajournal-e.com/biz/article/171036
1085,2017-07-04,삼성바이오로직스636억원규모의약품위탁생산계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1510446
1086,2017-07-04,공시삼성바이오로직스636억규모의약품위탁생산계약,http://www.viva100.com/main/view.php?key=20170704010001145
1087,2017-07-04,삼성바이오로직스印선파마와5500만달러규모생산계약,http://www.newsis.com/view/?id=NISX20170704_0000031217&cID=13001&pID=13000
1088,2017-07-04,삼성바이오로직스인도선파마와635억계약,http://www.dt.co.kr/contents.html?article_no=2017070402109976029006&ref=naver
1089,2017-07-04,삼성바이오로직스인도최대제약사와5500만달러규모계약,http://biz.newdaily.co.kr/news/article.html?no=10135842
1090,2017-07-04,삼성바이오로직스인도제약사와위탁생산계약체결,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1044006
1091,2017-07-04,630억원잭팟삼성바이오로직스인도최대제약사와생산계약체결,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201707040199
1092,2017-07-04,삼성바이오로직스636억원규모건선치료제장기위탁생산계약,http://www.ekn.kr/news/article.html?no=297774
1093,2017-07-04,공시삼성바이오로직스636억규모의약품위택생산계약,http://www.newsway.co.kr/view.php?tp=1&ud=2017070414375754380
1094,2017-07-04,삼성바이오로직스636억원규모계약소식에오름세,http://www.sedaily.com/NewsView/1OICG1ER77
1095,2017-07-04,삼성바이오로직스인도최대제약사와630억원규모계약체결,http://ciobiz.etnews.com/20170704120013
1096,2017-07-04,삼성바이오로직스선파마건선치료제장기위탁생산,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170704215000017&did=1196m
1097,2017-07-04,삼성바이오로직스인도최대제약사와장기계약,http://news.mk.co.kr/newsRead.php?year=2017&no=447737
1098,2017-07-04,삼성바이오로직스인도최대제약사건선약생산,http://www.edaily.co.kr/news/newspath.asp?newsid=03424326615991240
1099,2017-07-04,삼성바이오로직스인도최대제약사와635억계약,http://www.asiae.co.kr/news/view.htm?idxno=2017070415123213954
1100,2017-07-04,삼성바이오로직스인도선파마와5500만달러규모계약체결,http://www.m-i.kr/news/articleView.html?idxno=323677
1101,2017-07-04,삼성바이오로직스인도최대제약사선파마와계약체결,http://www.metroseoul.co.kr/news/newsview?newscd=2017070400069
1102,2017-07-04,삼성바이오로직스인도선파마와630억위탁생산계약,http://www.newspim.com/news/view/20170704000246
1103,2017-07-04,삼성바이오로직스인도제약사SunPharma社와계약체결,http://www.siminilbo.co.kr/news/articleView.html?idxno=520451
1104,2017-07-04,삼성바이오로직스인도최대제약사선파마와계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=289870
1105,2017-07-04,삼성바이오로직스인도선파마와5500만불규모의약품위탁생산계약,http://www.kukinews.com/news/article.html?no=466328
1106,2017-07-04,삼성바이오로직스인도제약사와632억원규모위탁생산계약,http://www.newstomato.com/ReadNews.aspx?no=763508
1107,2017-07-04,삼성바이오로직스인도서636억수주,http://news.mk.co.kr/newsRead.php?year=2017&no=448438
1108,2017-07-04,삼성바이오로직스인도최대제약사선파마와위탁생산맞손,http://www.etoday.co.kr/news/section/newsview.php?idxno=1510598
1109,2017-07-04,삼성바이오로직스인도제약사와630억원규모위탁생산계약,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017070417292530106
1110,2017-07-04,74제약한줄뉴스삼성바이오로직스바이로메드보령바이오파마,http://www.koreahealthlog.com/news/articleView.html?idxno=21760
1111,2017-07-04,삼성바이오로직스글로벌CMO정상보인다,http://www.sedaily.com/NewsView/1OICFUV4SR
1112,2017-07-04,삼성바이오로직스인도제약기업과636억CMO계약,https://cnbc.sbs.co.kr/article_hub/10000865295?division=NAVER
1113,2017-07-04,삼성바이오로직스630억의약품위탁생산계약,http://www.fnnews.com/news/201707041948580337
1114,2017-07-04,삼성바이오로직스인도최대제약사SunPharma와위탁생산계약,http://www.kgnews.co.kr/news/articleView.html?idxno=487153
1115,2017-07-04,삼성바이오로직스印선파마631억원의약품의탁생산체결,http://www.ajunews.com/view/20170704115548788
1116,2017-07-04,삼성바이오로직스亞진출교두보마련,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=705917
1117,2017-07-04,주요공시삼성바이오로직스CJEMDMS外,http://www.tfnews.co.kr/news/article.html?no=35467
1118,2017-07-04,5500만달러의약품위탁생산삼성바이오로직스빅딜성사,http://www.kyeongin.com/main/view.php?key=20170704010001188
1119,2017-07-04,삼성바이오로직스인도최대제약사선파마SunPharma사와최소구매물량636억원5천500만달러장기계약체결,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1370466
1120,2017-07-05,삼성바이오로직스인도선파마와의약품위탁생산계약,http://www.joongboo.com/?mod=news&act=articleView&idxno=1177575
1121,2017-07-05,삼성바이오로직스선파마의약품위탁생산,http://news.donga.com/3/all/20170704/85202801/1
1122,2017-07-05,유가증권기업공시4일삼성바이오로직스등,http://news.hankyung.com/article/2017070551081
1123,2017-07-05,교보증권삼성물산삼성바이오로직스등성장성높은지분가치증가본질가치레벨업구간”,http://www.g-enews.com/ko-kr/news/article/news_all/201707050816214881c642673384_1/article.html
1124,2017-07-05,주요공시SK가스삼성바이오로직스카카오등,http://www.intn.co.kr/news/articleView.html?idxno=797543
1125,2017-07-05,삼성바이오로직스인도선파마사의약품위탁생산,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=207487
1126,2017-07-05,삼성바이오로직스론자에특허무효소송,http://www.sedaily.com/NewsView/1OICWV78IW
1127,2017-07-05,삼성바이오로직스스위스론자에국내특허무효소송CDO진입장벽제거”,http://biz.chosun.com/site/data/html_dir/2017/07/05/2017070502735.html
1128,2017-07-05,삼성바이오로직스론자에세포주관련특허무효소송제기,http://ciobiz.etnews.com/20170705120032
1129,2017-07-05,삼성바이오로직스다국적제약사론자에특허무효소송제기,http://www.fnnews.com/news/201707052027361967
1130,2017-07-05,삼성바이오로직스스위스론자상대로세포주특허무효소송제기,http://www.asiatoday.co.kr/view.php?key=20170705010002541
1131,2017-07-05,삼성바이오로직스스위스론자상대로국내특허무효소송,http://news1.kr/articles/?3040492
1132,2017-07-05,삼성바이오로직스론자에세포주기술특허무효소송제기,http://www.etoday.co.kr/news/section/newsview.php?idxno=1511217
1133,2017-07-05,삼성바이오로직스스위스제약업체대상으로특허무효소송,http://www.businesspost.co.kr/news/articleView.html?idxno=53225
1134,2017-07-06,삼성바이오로직스스위스론자상대로국내특허무효소송,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017070608143118036
1135,2017-07-06,특징주삼성바이오로직스주가29만원회복외인팔고사고,http://www.g-enews.com/ko-kr/news/article/news_all/201707060917245858c642673384_1/article.html
1136,2017-07-06,삼성바이오로직스론자상대세포주관련특허무효소송,https://cnbc.sbs.co.kr/article_hub/10000865528?division=NAVER
1137,2017-07-06,특징주삼성바이오로직스론자상대특허무효소송에29만원선회복,http://www.asiae.co.kr/news/view.htm?idxno=2017070610135347109
1138,2017-07-06,삼성바이오로직스인도제약사와의약품위탁생산계약,http://www.kormedi.com/news/news/drug_dist/1223909_2906.html
1139,2017-07-06,관심받는삼성바이오로직스수주잭팟기대감상승,http://www.ebn.co.kr/news/view/899762
1140,2017-07-07,삼성바이오로직스CDO세계1위론자에특허무효소송,http://www.mdtoday.co.kr/mdtoday/index.html?no=290088
1141,2017-07-07,이재용재판인사이드삼성바이오로직스미래이끌신성장동력으로상장,http://www.g-enews.com/ko-kr/news/article/news_all/20170707143602128700af48a60a_1/article.html
1142,2017-07-09,단독삼성바이오로직스내년하반기삼성바이오에피스위탁생산돌입,http://www.sedaily.com/NewsView/1OIEQSNMC8
1143,2017-07-12,특징주삼성바이오로직스외인팔자에3↓,http://www.asiae.co.kr/news/view.htm?idxno=2017071214420972301
1144,2017-07-12,코스피외국인순매도삼성생명삼성전자우삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2017071217261825609
1145,2017-07-13,1시의증시데이트천장맞히기POSCO삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017071314222197672
1146,2017-07-13,코스피외국인순매도삼성바이오로직스삼성생명삼성전자우,http://www.newsway.co.kr/view.php?tp=1&ud=2017071316184870651
1147,2017-07-14,삼성바이오로직스3공장건설현장600만무재해인시달성,http://www.ebn.co.kr/news/view/900858
1148,2017-07-14,특징주삼성바이오로직스외인팔자에5↓,http://www.asiae.co.kr/news/view.htm?idxno=2017071414453317338
1149,2017-07-14,코스피외국인순매도SK하이닉스삼성바이오로직스삼성전자,http://www.newsway.co.kr/view.php?tp=1&ud=2017071416084332069
1150,2017-07-16,마켓포인트코스피주간개인순매수1위삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=01669526615995176
1151,2017-07-17,화제의보고서삼성그룹의미래에투자하라CMO업계의금수저삼성바이오로직스,http://news.mk.co.kr/v2/economy/view.php?year=2017&no=479326
1152,2017-07-17,혁신형제약바이오기업을가다④삼성바이오로직스도전은계속된다,http://www.metroseoul.co.kr/news/newsview?newscd=2017071700075
1153,2017-07-19,코스피기관순매수엔씨소프트삼성바이오로직스삼성전자,http://www.newsway.co.kr/view.php?tp=1&ud=2017071916022364187
1154,2017-07-19,삼성바이오로직스2분기적자에도긍정적,http://www.fnnews.com/news/201707191813214192
1155,2017-07-20,삼성바이오로직스주아동폭력예방교육후원,http://www.anewsa.com/detail.php?number=1197046&thread=09r02
1156,2017-07-21,특징주삼성바이오로직스외인매수주가사흘째기지개,http://www.g-enews.com/ko-kr/news/article/news_all/201707210916146945c642673384_1/article.html
1157,2017-07-21,이재용재판특검의삼성바이오로직스상장특혜논리증인통해무너지다,http://www.g-enews.com/ko-kr/news/article/news_all/20170721120946466600af48a60a_1/article.html
1158,2017-07-21,이재용재판삼성바이오로직스상장한국거래소가먼저요청,http://www.dailian.co.kr/news/view/648489/?sc=naver
1159,2017-07-21,삼성바이오로직스상장거래소가먼저권유특혜없었다,http://www.newspim.com/news/view/20170721000160
1160,2017-07-21,진웅섭원장삼성바이오로직스감리절차대로진행할것,http://biz.chosun.com/site/data/html_dir/2017/07/21/2017072101825.html
1161,2017-07-21,ET투자뉴스삼성바이오로직스207940수주공급계약유럽소재제약사,http://www.etnews.com/20170721000301
1162,2017-07-21,삼성바이오로직스157억원규모공급계약체결,http://www.mt.co.kr/view/mtview.php?type=1&no=2017072115425442515&outlink=1
1163,2017-07-21,삼성바이오로직스유럽제약사와157억규모의약품공급계약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=03204566615996816
1164,2017-07-21,삼성바이오로직스유럽제약사와157억규모공급계약체결,http://www.asiae.co.kr/news/view.htm?idxno=2017072115494303315
1165,2017-07-21,삼성바이오로직스유럽제약사에157억원규모의약품공급,http://biz.chosun.com/site/data/html_dir/2017/07/21/2017072101904.html
1166,2017-07-21,삼성바이오로직스157억원규모공급계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1517910
1167,2017-07-21,공시삼성바이오로직스유럽제약사와의약품위탁생산계약,http://www.newsprime.co.kr/news/article.html?no=382342
1168,2017-07-21,삼성바이오로직스유럽제약사와의약품157억규모생산계약,http://news1.kr/articles/?3054867
1169,2017-07-21,공시삼성바이오로직스157억규모의약품위탁생산계약,http://www.viva100.com/main/view.php?key=20170721010008040
1170,2017-07-21,삼성바이오로직스유럽제약사와1573억규모의약품공급계약체결,http://news.heraldcorp.com/view.php?ud=20170721000735
1171,2017-07-21,삼성바이오로직스유럽제약사와157억규모공급계약체결,http://www.ebn.co.kr/news/view/901992
1172,2017-07-21,진웅섭삼성바이오로직스감리주가상승관계없이절차대로진행,http://news.hankyung.com/article/2017072118396
1173,2017-07-21,진웅섭삼성바이오로직스감리따질것다따져봐야”,http://www.sedaily.com/NewsView/1OIK8390DC
1174,2017-07-21,삼성바이오로직스157억규모의약품생산계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170721132700008&did=1195m
1175,2017-07-21,삼성바이오로직스유럽제약사와CMO계약체결,http://www.dailypharm.com/News/229074
1176,2017-07-21,삼성바이오로직스유럽제약사157억원의약품생산계약체결,http://www.sedaily.com/NewsView/1OIK9HHKB0
1177,2017-07-21,삼성바이오로직스상장특혜없었다김병률前유가증권시장본부상무,http://www.fnnews.com/news/201707211546567996
1178,2017-07-21,삼성바이오로직스유럽제약사와157억규모의약품위탁생산계약,http://www.newstomato.com/ReadNews.aspx?no=767145
1179,2017-07-21,삼성바이오로직스157억규모공급계약,http://www.newsis.com/view/?id=NISX20170721_0000047705&cID=10401&pID=10400
1180,2017-07-21,삼성바이오로직스157억규모의약품위탁생산계약체결,http://www.viva100.com/main/view.php?key=20170721010008054
1181,2017-07-21,삼성바이오로직스유럽제약사와157억규모의약품생산계약,http://www.asiatoday.co.kr/view.php?key=20170721010011060
1182,2017-07-21,삼성바이오로직스157억규모공급계약,http://www.getnews.co.kr/view.php?ud=20170721165453689254b3c2d373_16
1183,2017-07-21,삼성바이오로직스유럽제약사와157억규모의약품생산계약,http://ciobiz.etnews.com/20170721120029
1184,2017-07-21,삼성바이오로직스157억규모의약품생산계약,http://www.cstimes.com/?mod=news&act=articleView&idxno=251388
1185,2017-07-21,삼성바이오로직스코스피상장문제없었다,http://biz.newdaily.co.kr/news/article.html?no=10137210
1186,2017-07-21,삼성바이오로직스유럽제약사와157억계약,http://www.dailymedi.com/detail.php?number=820833&thread=22r05
1187,2017-07-21,삼성바이오로직스157억규모의약품생산계약,http://www.dt.co.kr/contents.html?article_no=2017072102109976029003&ref=naver
1188,2017-07-21,삼성바이오로직스상장특혜없었다”,http://www.fnnews.com/news/201707211729561573
1189,2017-07-21,삼성바이오로직스유럽제약사와157억원의약품생산계약,http://www.newspim.com/news/view/20170721000209
1190,2017-07-21,삼성바이오로직스유럽제약사와157억원의약품생산계약,http://www.ebn.co.kr/news/view/902028
1191,2017-07-21,삼성바이오로직스상장은거래소가먼저권유,http://www.businesspost.co.kr/news/articleView.html?idxno=54563
1192,2017-07-23,진웅섭주가상승관계없이삼성바이오로직스감리절차대로진행”,http://www.fntimes.com/paper/view.aspx?num=185280
1193,2017-07-24,분식회계의혹삼성바이오로직스감리절차대로진행,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=772794
1194,2017-07-24,주요공시삼성바이오로직스코오롱글로벌비아트론등,http://www.intn.co.kr/news/articleView.html?idxno=797813
1195,2017-07-24,특징주삼성바이오로직스157억의약품생산에상승,http://www.viva100.com/main/view.php?key=20170724010008533
1196,2017-07-24,삼성바이오로직스2분기영업이익–85억원전분기대비119억원감소1보,http://biz.chosun.com/site/data/html_dir/2017/07/24/2017072402066.html
1197,2017-07-24,삼성바이오로직스2Q매출632억원전년比33증가1보,http://news1.kr/articles/?3056631
1198,2017-07-24,삼성바이오로직스2Q영업손실84억전기비적자전환,http://www.mt.co.kr/view/mtview.php?type=1&no=2017072415591580480&outlink=1
1199,2017-07-24,삼성바이오로직스2Q매출감소설비유지보수때문,http://www.edaily.co.kr/news/newspath.asp?newsid=03457126615997800
1200,2017-07-24,삼성바이오로직스2Q영업손85억원전년比166증가,http://www.asiae.co.kr/news/view.htm?idxno=2017072416075669001
1201,2017-07-24,삼성바이오로직스2분기매출632억,http://www.medigatenews.com/news/2720109257
1202,2017-07-24,삼성바이오로직스2Q영업손실85억적자폭확대,http://www.edaily.co.kr/news/newspath.asp?newsid=03466966615997800
1203,2017-07-24,삼성바이오로직스2분기영업손실85억원166↓,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170724129300008&did=1195m
1204,2017-07-24,삼성바이오로직스2분기영업손848억적자폭확대,http://news.heraldcorp.com/view.php?ud=20170724000782
1205,2017-07-24,공시삼성바이오로직스2분기영업손실85억적자확대,http://www.viva100.com/main/view.php?key=20170724010008853
1206,2017-07-24,삼성바이오로직스2분기영업적자설비유지보수때문,http://news.hankyung.com/article/2017072491626
1207,2017-07-24,삼성바이오로직스24분기영업손실85억적자폭확대,http://www.sedaily.com/NewsView/1OILMH59S8
1208,2017-07-24,삼성바이오로직스2분기매출액632억원영업손실85억원,http://ciobiz.etnews.com/20170724120029
1209,2017-07-24,삼성바이오로직스2Q영업적자85억원연내손익분기점달성”,http://news.heraldcorp.com/view.php?ud=20170724000786
1210,2017-07-24,삼성바이오로직스2분기적자전환영업손실85억원,http://www.ebn.co.kr/news/view/902273
1211,2017-07-24,삼성바이오로직스2Q영업손실85억원적자폭늘어,http://www.asiatoday.co.kr/view.php?key=20170724010012020
1212,2017-07-24,삼성바이오로직스2분기영업손실85억전기비적자전환,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017072416245680838
1213,2017-07-24,삼성바이오로직스2분기85억적자12공장설비유지보수영향”종합,http://biz.chosun.com/site/data/html_dir/2017/07/24/2017072402172.html
1214,2017-07-24,삼성바이오로직스2분기영업손실85억원적자폭전년比166확대,http://www.newsis.com/view/?id=NISX20170724_0000049389&cID=10401&pID=10400
1215,2017-07-24,삼성바이오로직스2분기매출632억영업이익85억,http://www.siminilbo.co.kr/news/articleView.html?idxno=523744
1216,2017-07-24,삼성바이오로직스2분기영업익85억원166↓,http://www.dailypharm.com/News/229147
1217,2017-07-24,삼성바이오로직스2분기84억8300만원영업손실적자폭확대,http://www.newstomato.com/ReadNews.aspx?no=767597
1218,2017-07-24,삼성바이오로직스2분기적자전환영업손실85억,http://www.ceoscoredaily.com/news/article.html?no=30972
1219,2017-07-24,삼성바이오로직스2분기영업손실85억원설비유지보수탓종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170724129351008&did=1195m
1220,2017-07-24,삼성바이오로직스2Q영업적자85억원적자전환,http://daily.hankooki.com/lpage/economy/201707/dh20170724164832138080.htm
1221,2017-07-24,삼성바이오로직스2분기영업손85억원적자폭166확대,http://www.sisajournal-e.com/biz/article/171763
1222,2017-07-24,삼성바이오로직스2017년2분기매출632억기록,http://www.m-i.kr/news/articleView.html?idxno=328967
1223,2017-07-24,삼성바이오로직스올해첫영업흑자낸다,http://news.hankyung.com/article/2017072494681
1224,2017-07-24,전화연결삼성바이오로직스2분기공장보수로적자,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201707240237
1225,2017-07-24,삼성바이오로직스2분기영업손실85억원적자더커졌다,http://www.getnews.co.kr/view.php?ud=20170724171615119854b3c2d373_16
1226,2017-07-24,삼성바이오로직스2분기적자85억공장설비보수영향,http://biz.newdaily.co.kr/news/article.html?no=10137341
1227,2017-07-24,삼성바이오로직스올해2분기85억영업손실,https://cnbc.sbs.co.kr/article_hub/10000867892?division=NAVER
1228,2017-07-24,인베스트조선삼성바이오로직스1분기만에영업익적자전환,http://www.investchosun.com/2017/07/24/3215885
1229,2017-07-24,삼성바이오로직스2분기영업손실85억설비유지보수때문,http://www.metroseoul.co.kr/news/newsview?newscd=2017072400094
1230,2017-07-24,BioS삼성바이오로직스1분기만에적자전환공장유지보수영향,http://www.etoday.co.kr/news/section/newsview.php?idxno=1518731
1231,2017-07-24,삼성바이오로직스2분기매출632억원세계최대3공장준공앞둬,http://www.kukinews.com/news/article.html?no=471479
1232,2017-07-24,삼성바이오로직스2분기영업손실85억,http://www.newspim.com/news/view/20170724000219
1233,2017-07-24,생산량감소에삼성바이오로직스적자전환,http://news.mk.co.kr/newsRead.php?year=2017&no=496840
1234,2017-07-24,삼성바이오로직스2Q영업손실85억원,http://www.seoulfn.com/news/articleView.html?idxno=284018
1235,2017-07-24,삼성바이오로직스2Q영업손실85억적자전환,http://www.newspim.com/news/view/20170724000216
1236,2017-07-24,삼성바이오로직스2분기매출전기비418감소영업익적전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208131
1237,2017-07-24,종합2분기삼성바이오로직스영업손실85억원전년比1658↑,http://www.newsis.com/view/?id=NISX20170724_0000049514&cID=13001&pID=13000
1238,2017-07-24,삼성바이오로직스연내손익분기점달성,http://www.fnnews.com/news/201707241824112706
1239,2017-07-24,삼성바이오로직스2분기영업손실85억공장유지보수영향,http://www.dailian.co.kr/news/view/649084/?sc=naver
1240,2017-07-24,삼성바이오로직스2분기영업손실84억8300만원전년比적자지속,http://www.nspna.com/news/?mode=view&newsid=233228
1241,2017-07-24,삼성바이오로직스올해2분기매출632억영업이익85억,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1044733
1242,2017-07-24,삼성바이오로직스2분기적자김태한올해흑자목표,http://www.businesspost.co.kr/news/articleView.html?idxno=54704
1243,2017-07-24,삼성바이오로직스유럽제약사와157억원규모CMO계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=291421
1244,2017-07-24,삼성바이오로직스2Q영업손실85억설비유지보수영향,http://www.dailian.co.kr/news/view/649092/?sc=naver
1245,2017-07-24,삼성바이오로직스2분기영업손실85억원,http://www.dt.co.kr/contents.html?article_no=2017072402109976029007&ref=naver
1246,2017-07-24,삼성바이오로직스2분기영업손실85억원공장설비보수영향,http://www.mdtoday.co.kr/mdtoday/index.html?no=291435
1247,2017-07-24,삼성바이오로직스2분기매출영업이익감소,http://www.kyeongin.com/main/view.php?key=20170724010007914
1248,2017-07-24,삼성바이오로직스2분기영업손실85억원1분기만에다시적자전환,http://www.etoday.co.kr/news/section/newsview.php?idxno=1518760
1249,2017-07-24,삼성바이오로직스2분기영업익85억,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=708640
1250,2017-07-24,삼성바이오로직스2분기영업손실85억원166↓,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1377179
1251,2017-07-25,삼성바이오로직스바이오사업예정대로순항삼성,http://www.edaily.co.kr/news/newspath.asp?newsid=01413686615998128
1252,2017-07-25,클릭e종목삼성바이오로직스2Q적자는예상된결과,http://www.asiae.co.kr/news/view.htm?idxno=2017072508042023869
1253,2017-07-25,NH투자증권삼성바이오로직스하반기다수의파이프라인모멘텀기대자회사바이오에피스손익개선긍정적”,http://www.g-enews.com/ko-kr/news/article/news_all/201707250815326613c642673384_1/article.html
1254,2017-07-25,삼성바이오로직스2Q실적부진예상된결과NH투자증권,http://www.ebn.co.kr/news/view/902342
1255,2017-07-25,클릭e종목삼성바이오로직스2Q적자는예상된실적,http://www.asiae.co.kr/news/view.htm?idxno=2017072508494092825
1256,2017-07-25,오늘의종목삼성바이오로직스자회사바이오에피스가치부각전망,http://www.sedaily.com/NewsView/1OIM1SPUUW
1257,2017-07-25,삼성바이오로직스하반기최대분기실적경신기대목표가↑삼성,http://www.edaily.co.kr/news/newspath.asp?newsid=01617046615998128
1258,2017-07-25,삼성바이오로직스하반기실적개선삼성證,http://www.seoulfn.com/news/articleView.html?idxno=284053
1259,2017-07-25,NH證삼성바이오로직스2분기실적부진예상된결과,http://www.viva100.com/main/view.php?key=20170725010009019
1260,2017-07-25,ET투자뉴스삼성바이오로직스삼성바이오사업매수삼성증권,http://www.etnews.com/20170725000037
1261,2017-07-25,삼성바이오로직스하반기최대실적기대감상승,http://www.newsprime.co.kr/news/article.html?no=382609
1262,2017-07-25,특징주삼성바이오로직스실적긍정적평가에상승,http://biz.chosun.com/site/data/html_dir/2017/07/25/2017072500757.html
1263,2017-07-25,특징주삼성바이오로직스하반기파이프라인모멘텀기대주가시동,http://www.g-enews.com/ko-kr/news/article/news_all/201707250915242948c642673384_1/article.html
1264,2017-07-25,특징주삼성바이오로직스향후실적기대감업고5대강세,http://www.newspim.com/news/view/20170725000060
1265,2017-07-25,특징주삼성바이오로직스하반기실적기대에급등,http://www.ebn.co.kr/news/view/902359
1266,2017-07-25,증권가적자기업삼성바이오로직스에사업순항중호평,http://news.einfomax.co.kr/news/articleView.html?idxno=3404030
1267,2017-07-25,특징주삼성바이오로직스실적개선전망에강세자회사美시장공략본격화,http://news.hankyung.com/article/2017072512216
1268,2017-07-25,삼성바이오로직스2분기적자불구하반기실적기대감에5대강세,http://news.heraldcorp.com/view.php?ud=20170725000175
1269,2017-07-25,특징주삼성바이오로직스강세하반기실적개선기대,http://www.asiae.co.kr/news/view.htm?idxno=2017072509421166820
1270,2017-07-25,특징주삼성바이오로직스하반기긍정평가에강세,http://www.newstomato.com/ReadNews.aspx?no=767716
1271,2017-07-25,특징주삼성바이오로직스美바이오시밀러제품출시소식에강세,http://www.dailian.co.kr/news/view/649192/?sc=naver
1272,2017-07-25,특징주2분기적자에도삼성바이오로직스5대상승세,http://www.newsis.com/view/?id=NISX20170725_0000050099&cID=10401&pID=10400
1273,2017-07-25,코스피숨고르기삼성바이오로직스껑충vsSK하이닉스급락,http://www.choicenews.co.kr/news/articleView.html?idxno=34715
1274,2017-07-25,이재용빠진삼성바이오로직스2분기적자전환은예정된수순,http://ilyo.co.kr/?ac=article_view&entry_id=260337
1275,2017-07-25,더벨공장보수삼성바이오로직스영업익적자전환,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201707240100045810002739
1276,2017-07-25,삼성바이오로직스주가급등3분기흑자전환유력,http://www.businesspost.co.kr/news/articleView.html?idxno=54821
1277,2017-07-26,삼성바이오로직스성장날개달다,http://www.ajunews.com/view/20170725090852958
1278,2017-07-26,삼성바이오로직스자회사유럽판매성장지분가치높아질것한국,http://news.hankyung.com/article/2017072650976
1279,2017-07-26,한국투자증권삼성바이오로직스장기적관점에서매수권고”,http://www.newsway.co.kr/view.php?tp=1&ud=2017072608113986434
1280,2017-07-26,삼성바이오로직스유럽서잘팔리는베네팔리한국투자證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017072608545824034&outlink=1
1281,2017-07-26,ET투자뉴스삼성바이오로직스베네팔리도램시마매수유지한국투자증권,http://www.etnews.com/20170726000149
1282,2017-07-26,영인프런티어삼성바이오로직스공급영업익629증가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1519601
1283,2017-07-26,삼성바이오로직스vs셀트리온바이오대장주어느것을살까,http://news.heraldcorp.com/view.php?ud=20170726000376
1284,2017-07-26,공모가두배삼성바이오로직스주가부담vs더오른다,http://www.mt.co.kr/view/mtview.php?type=1&no=2017072513484796692&outlink=1
1285,2017-07-27,영인프런티어6조세포바이오시장삼성바이오로직스등유세포분석기공급확대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1520243
1286,2017-07-28,두배오른삼성바이오로직스더오를수있을까,http://www.mdtoday.co.kr/mdtoday/index.html?no=291801
1287,2017-07-28,상승전환한헬스케어ETF삼성바이오로직스효과,http://www.newsway.co.kr/view.php?tp=1&ud=2017072818274608003
1288,2017-07-31,삼성바이오로직스현금성자산비중5년새23뚝왜,http://news1.kr/articles/?3062627
1289,2017-08-01,DataScore삼성바이오로직스차입금의존도89,http://www.ceoscoredaily.com/news/article.html?no=30911
1290,2017-08-03,삼성바이오로직스주가고공행진가격적정성글쎄,http://www.kukinews.com/news/article.html?no=473982
1291,2017-08-07,더벨삼성바이오로직스상장특혜냐유치냐,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201708040100009420000561
1292,2017-08-09,단독이재용부회장경영공백삼성바이오로직스45공장건설에도불똥,http://www.viva100.com/main/view.php?key=20170809010003366
1293,2017-08-10,코스닥탈출이대안인가②삼성바이오로직스와비교받는셀트리온,http://www.mdtoday.co.kr/mdtoday/index.html?no=292808
1294,2017-08-10,WhoIs김태한삼성바이오로직스사장,http://www.businesspost.co.kr/news/articleView.html?idxno=56153
1295,2017-08-14,삼성바이오로직스2019년CMO세계1위기업도약목표가31만원NH,http://news.hankyung.com/article/2017081432836
1296,2017-08-14,브랜드평판제약상장기업브랜드8월빅데이터분석1위셀트리온2위삼성바이오로직스3위셀트리온헬스케어,http://www.futurekorea.co.kr/news/articleView.html?idxno=42470
1297,2017-08-14,제약상장기업브랜드평판8월빅데이터1위셀트리온2위삼성바이오로직스3위셀트리온헬스케어로분,http://www.betanews.net:8080/article/726144.html
1298,2017-08-14,삼성바이오로직스뛰어난패스트팔로워목표주가31만원NH,http://www.ebn.co.kr/news/view/905238
1299,2017-08-14,ET투자뉴스삼성바이오로직스fastfollo매수신규NH투자증권,http://www.etnews.com/20170814000358
1300,2017-08-14,셀트리온8월제약상장사브랜드평판1위삼성바이오로직스뒤이어,http://www.mdtoday.co.kr/mdtoday/index.html?no=293092
1301,2017-08-17,유한양행녹십자삼성바이오로직스상반기수출1000억돌파,http://www.mdtoday.co.kr/mdtoday/index.html?no=293289
1302,2017-08-17,식약처삼성바이오로직스서의약품안전지킴이현장견학,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=208820
1303,2017-08-17,식약처의약품안전지킴이삼성바이오로직스현장견학실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=293319
1304,2017-08-18,클릭e종목삼성바이오로직스목표주가30만원제시,http://www.asiae.co.kr/news/view.htm?idxno=2017081807120829168
1305,2017-08-18,삼성바이오로직스성장만남았다대신,http://biz.chosun.com/site/data/html_dir/2017/08/18/2017081800467.html
1306,2017-08-18,삼성바이오로직스커버리지개시목표가30만원대신證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017081807545474472&outlink=1
1307,2017-08-18,대신증권삼성바이오로직스성장만남았다”,http://www.newsway.co.kr/view.php?tp=1&ud=2017081808085146867
1308,2017-08-18,삼성바이오로직스1위바이오CMO업체로부상전망,http://www.newspim.com/news/view/20170818000020
1309,2017-08-18,대신증권삼성바이오로직스2공장가동률상승으로실적성장기대”,http://www.g-enews.com/ko-kr/news/article/news_all/201708180817487246c642673384_1/article.html
1310,2017-08-18,삼성바이오로직스증설수혜기대목표가30만원대신,http://www.edaily.co.kr/news/newspath.asp?newsid=01492406616028632
1311,2017-08-18,HotLine삼성바이오로직스공장증설추가수주기대,http://news.mk.co.kr/newsRead.php?year=2017&no=553403
1312,2017-08-18,ET투자뉴스삼성바이오로직스성장만남았다시장수익률신규대신증권,http://www.etnews.com/20170818000009
1313,2017-08-18,대신증권삼성바이오로직스바이오의약품위탁생산증가목표가30만원,http://www.viva100.com/main/view.php?key=20170818010006347
1314,2017-08-18,삼성바이오로직스성장성충분대신증권,http://www.ebn.co.kr/news/view/905810
1315,2017-08-18,특징주삼성바이오로직스실적성장기대주가는힘겨루기,http://www.g-enews.com/ko-kr/news/article/news_all/20170818091001852c642673384_1/article.html
1316,2017-08-18,아주종목분석삼성바이오로직스공장증설추가공급계약기대,http://www.ajunews.com/view/20170818091856932
1317,2017-08-18,2017반기보고서총론⑮삼성바이오로직스다시빠진적자경영,http://www.sisajournal-e.com/biz/article/172901
1318,2017-08-18,특징주삼성바이오로직스2019년까지고성장´전망´,http://www.sisaon.co.kr/news/articleView.html?idxno=61526
1319,2017-08-18,삼성바이오로직스올해흑자전환남은일은실적증가,http://www.businesspost.co.kr/news/articleView.html?idxno=56801
1320,2017-08-21,삼성바이오로직스신약개발자회사덕본다,http://www.viva100.com/main/view.php?key=20170821010007442
1321,2017-08-22,삼성바이오로직스신약개발청사진도제시한국,http://news.hankyung.com/article/2017082269256
1322,2017-08-22,삼성바이오로직스日다케다제약과손잡고신약개발청사진한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1529630
1323,2017-08-22,클릭e종목삼성바이오로직스글로벌신약개발업체로변모,http://www.asiae.co.kr/news/view.htm?idxno=2017082207460465321
1324,2017-08-22,한국투자증권삼성바이오로직스3분기부터흑자기조전망및신약개발청사진제시”,http://www.g-enews.com/ko-kr/news/article/news_all/201708220810122241c642673384_1/article.html
1325,2017-08-22,한국투자증권삼성바이오로직스긴호흡에서매수권고”,http://www.newsway.co.kr/view.php?tp=1&ud=2017082208194122823
1326,2017-08-22,한국투자삼성바이오로직스신약개발청사진제시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170822027900008&did=1195m
1327,2017-08-22,한투삼성바이오로직스신약개발청사진긍정적,http://www.fnnews.com/news/201708220823343131
1328,2017-08-22,ET투자뉴스삼성바이오로직스장차크게될회사매수유지한국투자증권,http://www.etnews.com/20170822000003
1329,2017-08-22,삼성증권삼성바이오로직스신약개발로성장동력장착,http://www.fnnews.com/news/201708220841069741
1330,2017-08-22,한국투자증권삼성바이오로직스장기관점으로매수,http://www.viva100.com/main/view.php?key=20170822010007587
1331,2017-08-22,HotLine삼성바이오로직스신약개발청사진제시긴호흡에서매수,http://news.mk.co.kr/newsRead.php?year=2017&no=561004
1332,2017-08-22,STOCK삼성바이오로직스장기적청사진제시”,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017082208498061628&outlink=1
1333,2017-08-22,특징주삼성바이오로직스日다케다제약바이오신약개발협력에강세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017082209022832174&outlink=1
1334,2017-08-22,삼성바이오로직스장기성장에주목하반기흑자기대한국,http://www.cstimes.com/?mod=news&act=articleView&idxno=254038
1335,2017-08-22,삼성바이오로직스신약개발장기청사진긍정적한국투자증권,http://www.ebn.co.kr/news/view/906199
1336,2017-08-22,특징주삼성바이오로직스신약개발기대감에강세,http://www.newspim.com/news/view/20170822000052
1337,2017-08-22,특징주삼성바이오로직스다케다제약과신약개발소식에상승,http://www.viva100.com/main/view.php?key=20170822010007615
1338,2017-08-22,특징주삼성바이오로직스신약개발에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01758086616029944
1339,2017-08-22,특징주삼성바이오로직스다케다제약과개별협력에강세,http://www.newstomato.com/ReadNews.aspx?no=773023
1340,2017-08-22,삼성바이오로직스자회사신약개발기대감으로강세,http://www.sedaily.com/NewsView/1OJUMLGUOV
1341,2017-08-22,ET투자뉴스삼성바이오로직스_수급영향력은기관이외인보다커현재437,http://www.etnews.com/20170822000018
1342,2017-08-22,특징주삼성바이오로직스다케다제약과협력계약소식에4↑,http://www.asiae.co.kr/news/view.htm?idxno=2017082209103056749
1343,2017-08-22,특징주삼성바이오로직스자회사신약개발기대에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170822041700008&did=1195m
1344,2017-08-22,특징주삼성바이오로직스강세日다케다제약과신약개발,http://news.hankyung.com/article/2017082272986
1345,2017-08-22,특징주삼성바이오로직스강세日기업과바이오신약개발,http://www.ebn.co.kr/news/view/906204
1346,2017-08-22,특징주삼성바이오로직스다케다제약협력기대감에상승,http://biz.chosun.com/site/data/html_dir/2017/08/22/2017082200718.html
1347,2017-08-22,삼성바이오로직스日제약사와신약개발계약4급등세,http://news.heraldcorp.com/view.php?ud=20170822000119
1348,2017-08-22,특징주삼성바이오로직스日다케다제약과협력소식에급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1529699
1349,2017-08-22,특징주삼성바이오로직스일본제약사와신약공동개발소식에강세,http://www.dailian.co.kr/news/view/655415/?sc=naver
1350,2017-08-22,삼성바이오로직스신약개발기대감에주가↑,http://www.newsprime.co.kr/news/article.html?no=385467
1351,2017-08-22,특징주삼성바이오로직스日제약사와바이오신약개발소식에강세,http://www.newsis.com/view/?id=NISX20170822_0000073720&cID=10401&pID=10400
1352,2017-08-22,특징주삼성바이오로직스바이오신약개발기대감에강세,http://www.seoulfn.com/news/articleView.html?idxno=286062
1353,2017-08-22,코스피기관외인동반매수에장초반강보합삼성바이오로직스3강세,http://www.newstomato.com/ReadNews.aspx?no=773029
1354,2017-08-22,특징주삼성바이오로직스자회사신약개발기대감에상승세,http://www.fnnews.com/news/201708220958208984
1355,2017-08-22,열린시장이슈IN삼성바이오로직스신약개발청사진,http://www.newstomato.com/ReadNews.aspx?no=773057
1356,2017-08-22,ET투자뉴스삼성바이오로직스바이오신약개발추매수삼성증권,http://www.etnews.com/20170822000073
1357,2017-08-22,아주종목분석신약개발삼성바이오로직스강세증권사도호평,http://www.ajunews.com/view/20170822112020339
1358,2017-08-22,이종목은왜시장이주목하는이종목삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017082213554153241
1359,2017-08-22,눈치보기장세삼성바이오로직스삼성SDI껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=35342
1360,2017-08-22,삼성바이오로직스셀트리온제약바이오대장주위력,http://www.econovill.com/news/articleView.html?idxno=321217
1361,2017-08-22,이종목은왜오늘의특징주집중분석삼성바이오로직스깨끗한나라파라텍,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017082216123120039
1362,2017-08-22,HotStock삼성바이오로직스,http://news.hankyung.com/article/2017082296471
1363,2017-08-23,개장전특징주삼성바이오로직스207940,http://www.newstomato.com/ReadNews.aspx?no=773311
1364,2017-08-25,공시삼성바이오로직스바이오시밀러임랄디유럽판매허가획득,http://www.newsway.co.kr/view.php?tp=1&ud=2017082508064882532
1365,2017-08-25,특징주삼성바이오로직스SB5유럽판매허가에강세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017082509031802958&outlink=1
1366,2017-08-25,특징주삼성바이오로직스자회사제품유럽판매허가에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170825041100008&did=1195m
1367,2017-08-25,특징주삼성바이오로직스상승임랄디유럽판매허가,http://news.hankyung.com/article/2017082592386
1368,2017-08-25,삼성바이오로직스자회사의약품유럽판매허가획득에강세,http://www.asiae.co.kr/news/view.htm?idxno=2017082509100221047
1369,2017-08-25,특징주삼성바이오로직스SB5유럽판매허가소식에강세,http://www.dailian.co.kr/news/view/656169/?sc=naver
1370,2017-08-25,삼성바이오로직스자회사제품유럽판매허가획득에주가↑,http://www.newsprime.co.kr/news/article.html?no=385830
1371,2017-08-25,특징주삼성바이오로직스자회사바이오시밀러유럽판매허가에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=01876166616030928
1372,2017-08-25,특징주삼성바이오로직스상승자회사바이오시밀러,http://www.viva100.com/main/view.php?key=20170825010009137
1373,2017-08-25,삼성바이오로직스SB5유럽최종판매허가획득소식에강세,http://www.sedaily.com/NewsView/1OJVZNAZC8
1374,2017-08-25,특징주삼성바이오로직스임랄디유럽판매허가에↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1531209
1375,2017-08-25,특징주삼성바이오로직스임랄디판매허가소식에오름세,http://biz.chosun.com/site/data/html_dir/2017/08/25/2017082500873.html
1376,2017-08-25,특징주삼성바이오로직스자회사제품유럽판매허가에강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=139059
1377,2017-08-25,특징주삼성바이오로직스상승SB5유럽판매허가획득,http://www.ebn.co.kr/news/view/906706
1378,2017-08-25,특징주삼성바이오로직스바이오시밀러유럽판매허가에오름세,http://www.seoulfn.com/news/articleView.html?idxno=286335
1379,2017-08-25,특징주삼성바이오로직스임랄디유럽판매허가소식에강세,http://www.newstomato.com/ReadNews.aspx?no=773814
1380,2017-08-25,삼성바이오로직스임랄디유럽판매허가에강세,http://news.heraldcorp.com/view.php?ud=20170825000231
1381,2017-08-25,삼성바이오로직스휴미라바이오시밀러유럽판매허가획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209103
1382,2017-08-25,특징주삼성바이오로직스자회사바이오시밀러유럽판매허가강세,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017082510508095980&outlink=1
1383,2017-08-29,北리스크코스피5p하락삼성물산삼성바이오로직스반등,http://www.choicenews.co.kr/news/articleView.html?idxno=35509
1384,2017-08-31,삼성바이오로직스이재용부재에도바이오에피스로흑자기대,http://www.ceoscoredaily.com/news/article.html?no=31851
1385,2017-08-31,삼성바이오로직스위탁생산수주꾸준히발생유안타,http://biz.chosun.com/site/data/html_dir/2017/08/31/2017083100548.html
1386,2017-08-31,삼성바이오로직스위탁생산수주↑매출기대감↑유안타證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017083108004799605&outlink=1
1387,2017-08-31,HotLIne삼성바이오로직스CMO바이오시밀러개발시너지긍정적,http://news.mk.co.kr/newsRead.php?year=2017&no=583294
1388,2017-08-31,ET투자뉴스삼성바이오로직스삼성과바이오바매수신규유안타증권,http://www.etnews.com/20170831000075
1389,2017-08-31,삼성바이오로직스위탁생산의뢰늘어성장지속,http://www.businesspost.co.kr/news/articleView.html?idxno=57822
1390,2017-09-05,삼성바이오로직스RD설비증설로성장가도달린다,http://www.ebn.co.kr/news/view/908209
1391,2017-09-06,삼성바이오로직스105억원규모위탁생산의향서체결,http://www.mt.co.kr/view/mtview.php?type=1&no=2017090617301489015&outlink=1
1392,2017-09-06,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170906158100008&did=1195m
1393,2017-09-06,삼성바이오로직스유럽제약사105억원의약품생산계약체결,http://www.sedaily.com/NewsView/1OKX87Q15G
1394,2017-09-06,삼성바이오로직스105억규모바이오의약품위탁생산의향서체결,http://www.newspim.com/news/view/20170906000203
1395,2017-09-06,삼성바이오로직스105억원규모위탁생산의향서체결,http://www.cstimes.com/?mod=news&act=articleView&idxno=255344
1396,2017-09-06,유가증권시장공시에이블씨엔씨삼성바이오로직스대한전선등,http://news.mk.co.kr/newsRead.php?year=2017&no=599318
1397,2017-09-06,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://www.sedaily.com/NewsView/1OKX96O5F4
1398,2017-09-06,삼성바이오로직스바이오의약품위탁생산계약의향서체결,http://news1.kr/articles/?3094355
1399,2017-09-06,삼성바이오로직스유럽제약사와105억원위탁생산계약의향서체결,http://www.asiatoday.co.kr/view.php?key=20170906010002981
1400,2017-09-06,공시삼성바이오로직스105억규모위탁생산계약의향서체결,http://www.viva100.com/main/view.php?key=20170906010002252
1401,2017-09-06,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://www.ebn.co.kr/news/view/908463
1402,2017-09-06,삼성바이오로직스바이오의약품유럽제약사에위탁생산,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209531
1403,2017-09-06,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://www.newsis.com/view/?id=NISX20170906_0000088507&cID=10401&pID=10400
1404,2017-09-06,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://www.ciobiz.co.kr/news/article.html?id=20170906120033
1405,2017-09-06,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://www.etnews.com/20170906000350
1406,2017-09-06,삼성바이오로직스유럽제약사와위탁생산계약체결,http://www.newsworks.co.kr/news/articleView.html?idxno=137337
1407,2017-09-06,공시삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://www.newsway.co.kr/view.php?tp=1&ud=2017090618193039623
1408,2017-09-06,삼성바이오로직스유럽제약사와105억원의약품위탁생산계약체결,http://daily.hankooki.com/lpage/economy/201709/dh20170906193136138080.htm
1409,2017-09-06,삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1391812
1410,2017-09-07,주요공시삼성바이오로직스유럽제약사와위탁생산계약의향서체결,http://www.cstimes.com/?mod=news&act=articleView&idxno=255354
1411,2017-09-07,주요공시삼성바이오로직스대한전선유지인트등,http://www.intn.co.kr/news/articleView.html?idxno=864883
1412,2017-09-07,특징주삼성바이오로직스유럽제약사계약소식에상승세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017090708561074493&outlink=1
1413,2017-09-07,특징주삼성바이오로직스위탁생산계약의향서체결에상승,http://www.viva100.com/main/view.php?key=20170907010002405
1414,2017-09-07,삼성바이오로직스유럽제약사와105억원생산계약의향서체결,http://www.dt.co.kr/contents.html?article_no=2017090602109976029004&ref=naver
1415,2017-09-08,반도체의바이오버전삼성바이오로직스에피스,http://www.edaily.co.kr/news/newspath.asp?newsid=01289046616058152
1416,2017-09-12,특징주삼성바이오로직스바이오업종기대감에이틀째상승세,http://biz.chosun.com/site/data/html_dir/2017/09/12/2017091200906.html
1417,2017-09-12,특징주삼성바이오로직스강세이유는,http://www.sporbiz.co.kr/news/articleView.html?idxno=144321
1418,2017-09-12,특징주삼성바이오로직스5안팎강세종가30만원첫돌파하나,http://www.newsis.com/view/?id=NISX20170912_0000093007&cID=10401&pID=10400
1419,2017-09-12,특징주삼성바이오로직스자회사항암바이오시밀러유럽허가선점기대감에4↑,http://www.asiae.co.kr/news/view.htm?idxno=2017091211010778317
1420,2017-09-12,특징주삼성바이오로직스외국인기관매수세에30만원터치,http://www.mt.co.kr/view/mtview.php?type=1&no=2017091211084154754&outlink=1
1421,2017-09-12,삼성바이오로직스외국인기관매수에종가30만원돌파,http://www.mt.co.kr/view/mtview.php?type=1&no=2017091214110228009&outlink=1
1422,2017-09-12,삼성바이오로직스사상최초30만원돌파마감,http://www.newstomato.com/ReadNews.aspx?no=777067
1423,2017-09-12,삼성바이오로직스첫30만원돌파신약개발기대감반영,http://www.sedaily.com/NewsView/1OKZZBXHX7
1424,2017-09-12,실적기대감SK하이닉스또신고가삼성바이오로직스6급등,http://www.choicenews.co.kr/news/articleView.html?idxno=35813
1425,2017-09-12,종합삼성바이오로직스6대상승마감종가첫30만원돌파,http://www.newsis.com/view/?id=NISX20170912_0000093447&cID=10401&pID=10400
1426,2017-09-12,삼성바이오로직스종가도30만원뚫었다최고가,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170912154200008&did=1195m
1427,2017-09-12,코스피기관순매수삼성전자삼성바이오로직스SK하이닉스,http://www.newsway.co.kr/view.php?tp=1&ud=2017091216424417255
1428,2017-09-12,코스피외국인순매수SK하이닉스삼성바이오로직스현대모비스,http://www.newsway.co.kr/view.php?tp=1&ud=2017091216413259161
1429,2017-09-12,HotStock삼성바이오로직스,http://news.hankyung.com/article/2017091203051
1430,2017-09-12,삼성바이오로직스종가30만원돌파,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=715637
1431,2017-09-12,삼성바이오로직스종가도30만원뚫었다최고가,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1393743
1432,2017-09-13,브랜드평판제약상장기업브랜드9월빅데이터분석1위한미약품2위삼성바이오로직스3위셀트리온,http://www.futurekorea.co.kr/news/articleView.html?idxno=43162
1433,2017-09-13,제약상장기업브랜드평판9월빅데이터1위한미약품2위삼성바이오로직스3위셀트리온,http://www.betanews.net:8080/article/740029.html
1434,2017-09-13,특징주삼성바이오로직스또최고가경신,http://www.sporbiz.co.kr/news/articleView.html?idxno=144679
1435,2017-09-13,올해흑자기대삼성바이오로직스신고가경신,http://news.heraldcorp.com/view.php?ud=20170913000185
1436,2017-09-13,특징주삼성바이오로직스첫흑자전환예상에52주신고가,http://www.asiae.co.kr/news/view.htm?idxno=2017091309422931235
1437,2017-09-13,삼성바이오로직스주가30만원돌파시총SK텔레콤제쳐,http://www.ebn.co.kr/news/view/909387
1438,2017-09-13,제약상장기업9월브랜드평판한미약품삼성바이오로직스셀트리온순,http://www.mdtoday.co.kr/mdtoday/index.html?no=295543
1439,2017-09-13,EBN오늘이슈종합아이폰X안면인식기능페이스ID삼성바이오로직스주가30만원돌파사드후폭풍현대차그룹계열사와르르,http://www.ebn.co.kr/news/view/909524
1440,2017-09-14,대세는바이오시밀러②삼성바이오로직스셀트리온바이오시밀러유럽맹활약중,http://www.mdtoday.co.kr/mdtoday/index.html?no=295644
1441,2017-09-14,대세는바이오시밀러③셀트리온삼성바이오로직스이제는미국이다,http://www.mdtoday.co.kr/mdtoday/index.html?no=295645
1442,2017-09-14,대세는바이오시밀러④연일고공행진삼성바이오로직스코스피이전상장예측되는셀트리온,http://www.mdtoday.co.kr/mdtoday/index.html?no=295646
1443,2017-09-14,LG화학삼성바이오로직스시총점프포스코LG전자도선전,http://www.viva100.com/main/view.php?key=20170914010005288
1444,2017-09-14,특징주삼성바이오로직스52주신고가다시뚫을까성장성부각,http://www.g-enews.com/ko-kr/news/article/news_all/201709140920246250c642673384_1/article.html
1445,2017-09-14,특징주삼성바이오로직스6껑충최고가,http://www.asiae.co.kr/news/view.htm?idxno=2017091414485994323
1446,2017-09-14,코스피이달첫2370선기록의약품강세삼성바이오로직스69상승,https://cnbc.sbs.co.kr/article_hub/10000874726?division=NAVER
1447,2017-09-15,오늘의종목삼성바이오로직스올해영업익흑자전환예상,http://www.sedaily.com/NewsView/1OL1BWU955
1448,2017-09-15,연결고리2삼성바이오로직스셀트리온신고가의미는,http://www.newstomato.com/ReadNews.aspx?no=777716
1449,2017-09-15,삼성바이오로직스성장성전망에사상최고가경신행진,http://news.heraldcorp.com/view.php?ud=20170915000314
1450,2017-09-15,삼성바이오로직스3공장준공하면매출1조가뿐,http://www.businesspost.co.kr/BP?command=article_view&num=58993
1451,2017-09-15,이시각공시리포트삼성바이오로직스글로벌1위바이오CMO성장예상,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201709150245
1452,2017-09-15,셀트리온과삼성바이오로직스주가나란히최고가신기록,http://www.businesspost.co.kr/BP?command=article_view&num=59008
1453,2017-09-16,삼성바이오로직스셀트리온연일랠리배경은,http://www.choicenews.co.kr/news/articleView.html?idxno=35921
1454,2017-09-17,목표가눈앞삼성바이오로직스더갈까,http://news.mk.co.kr/newsRead.php?year=2017&no=624391
1455,2017-09-18,클릭e종목삼성바이오로직스3분기부터흑자전망목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2017091807171810253
1456,2017-09-18,삼성바이오로직스바이오시밀러유럽출시유력목표주가↑한투證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017091807492560934&outlink=1
1457,2017-09-18,삼성바이오로직스온트루잔트유럽출시기대감목표주가상향한국,http://biz.chosun.com/site/data/html_dir/2017/09/18/2017091800544.html
1458,2017-09-18,삼성바이오로직스바이오시밀러시장확산기대감목표가↑한국투자증권,http://www.dailian.co.kr/news/view/661702/?sc=naver
1459,2017-09-18,한국투자증권삼성바이오로직스두번째firstmover장착목표가↑,http://www.newsis.com/view/?id=NISX20170918_0000097989&cID=10401&pID=10400
1460,2017-09-18,삼성바이오로직스온트루잔트내년초유럽출시유력목표주가↑–한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1540340
1461,2017-09-18,한국투자증권삼성바이오로직스3분기부터흑자기조지속할듯긴호흡에서매수권고”,http://www.g-enews.com/ko-kr/news/article/news_all/201709180825221363c642673384_1/article.html
1462,2017-09-18,ET투자뉴스삼성바이오로직스또하나의퍼스트매수삼성증권,http://www.etnews.com/20170918000013
1463,2017-09-18,삼성바이오로직스내년실적기대고조목표가↑한국투자증권,http://www.ebn.co.kr/news/view/909930
1464,2017-09-18,한투삼성바이오로직스자회사유럽출시기대감,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170918028200008&did=1195m
1465,2017-09-18,ET투자뉴스삼성바이오로직스바이오시밀러두번째매수유지한국투자증권,http://www.etnews.com/20170918000023
1466,2017-09-18,한국證삼성바이오로직스바이오시밀러기대”목표가↑,http://www.viva100.com/main/view.php?key=20170918010006587
1467,2017-09-18,HotLine삼성바이오로직스세계최대바이오시밀러허가권자등극,http://news.mk.co.kr/newsRead.php?year=2017&no=624746
1468,2017-09-18,삼성바이오로직스유럽시장금년내진출목표가↑,http://www.asiatoday.co.kr/view.php?key=20170918010008104
1469,2017-09-18,삼성바이오로직스또하나의퍼스트바이오시밀러유럽승인권고삼성證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017091808424830984&outlink=1
1470,2017-09-18,한국투자증권삼성바이오로직스긴호흡에서매수권고”,http://www.newsway.co.kr/view.php?tp=1&ud=2017091808532006424
1471,2017-09-18,삼성증권삼성바이오로직스바이오시밀러유럽출시기대,http://www.fnnews.com/news/201709180855373328
1472,2017-09-18,STOCK삼성바이오로직스두번째퍼스트무버장착”목표가↑,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017091808578073704&outlink=1
1473,2017-09-18,특징주삼성바이오로직스상승자회사유방암치료제유럽허가임박,http://news.hankyung.com/article/2017091862496
1474,2017-09-18,삼성바이오로직스신규바이오시밀러유럽진출에신고가,http://www.sedaily.com/NewsView/1OL2QE1SJ1
1475,2017-09-18,특징주삼성바이오로직스잉여현금흐름개선전망신고가,http://www.ebn.co.kr/news/view/909951
1476,2017-09-18,특징주삼성바이오로직스바이오시밀러유럽허가취득에신고가,http://www.newsis.com/view/?id=NISX20170918_0000098111&cID=10401&pID=10400
1477,2017-09-18,삼성바이오로직스바이오시밀러내년유럽출시가능성주가↑,http://www.newsprime.co.kr/news/article.html?no=388612
1478,2017-09-18,특징주삼성바이오로직스바이오시밀러허가취득에강세,http://www.viva100.com/main/view.php?key=20170918010006617
1479,2017-09-18,특징주삼성바이오로직스새바이오시밀러유럽판매허가기대↑,http://www.edaily.co.kr/news/newspath.asp?newsid=01725286616061432
1480,2017-09-18,이종목은왜새복제약유럽을뚫다특징주삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017091813200170356
1481,2017-09-18,삼성물산주가급등삼성전자와삼성바이오로직스의지분덕분,http://www.businesspost.co.kr/BP?command=article_view&num=59159
1482,2017-09-18,코스피외국인순매도LG화학삼성바이오로직스삼성전기,http://www.newsway.co.kr/view.php?tp=1&ud=2017091816455982096
1483,2017-09-18,삼성바이오로직스셀트리온바이오주투톱나란히사상최고가,http://news.hankyung.com/article/2017091892571
1484,2017-09-19,삼성바이오로직스자회사에피스호재로주가고공행진,http://www.mdtoday.co.kr/mdtoday/index.html?no=295960
1485,2017-09-20,삼성바이오로직스시총CMO세계1위론자제쳤다,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170919156100008&did=1195m
1486,2017-09-20,삼성바이오로직스시총CMO세계1위론자제쳤다,http://news.heraldcorp.com/view.php?ud=20170920000091
1487,2017-09-20,특징주삼성바이오로직스5거래일연속상승34만원도넘어,http://www.asiae.co.kr/news/view.htm?idxno=2017092009180205495
1488,2017-09-20,삼성바이오로직스닷새째상승3분기흑자기조전망,http://news.heraldcorp.com/view.php?ud=20170920000220
1489,2017-09-20,특징주삼성바이오로직스3Q흑자전환기대감에52주신고가,http://www.edaily.co.kr/news/newspath.asp?newsid=02246806616062088
1490,2017-09-20,특징주삼성바이오로직스셀트리온바이오시밀러투톱또신고가,http://www.newsis.com/view/?id=NISX20170920_0000100665&cID=10401&pID=10400
1491,2017-09-20,삼성바이오로직스시총22조4000억원CMO세계1위론자22조1000억원제쳤다,http://news.heraldcorp.com/view.php?ud=20170920000462
1492,2017-09-20,삼성바이오로직스시총CMO세계1위론자뛰어넘어,http://www.shinailbo.co.kr/news/articleView.html?idxno=1001250
1493,2017-09-20,삼성바이오로직스휴미라바이오시밀러SB5국내판매허가획득,http://www.edaily.co.kr/news/newspath.asp?newsid=03837606616062088
1494,2017-09-20,삼성바이오로직스SB5한국최종판매허가획득,http://www.sedaily.com/NewsView/1OL3OULS2K
1495,2017-09-20,삼성바이오로직스휴미라바이오시밀러SB5국내판매허가획득,http://www.newspim.com/news/view/20170920000235
1496,2017-09-20,삼성바이오로직스휴미라바이오시밀러한국판매허가획득,http://www.asiae.co.kr/news/view.htm?idxno=2017092018285398864
1497,2017-09-20,삼성바이오로직스삼성바이오에피스SB5한국판매허가획득,http://www.ebn.co.kr/news/view/910364
1498,2017-09-20,삼성바이오로직스휴미라바이오시밀러SB5국내판매허가취득,http://www.newstomato.com/ReadNews.aspx?no=778783
1499,2017-09-20,공시삼성바이오로직스삼성바이오에피스SB5한국판매허가획득”,http://www.newsway.co.kr/view.php?tp=1&ud=2017092018455885346
1500,2017-09-20,삼성바이오로직스시총CMO세계1위론자제쳤다,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1396721
1501,2017-09-20,삼성바이오로직스시총CMO세계1위로,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=716785
1502,2017-09-20,유가증권기업공시20일삼성바이오로직스등,http://news.hankyung.com/article/2017092085451
1503,2017-09-21,삼성바이오로직스시총CMO1위론자제쳤다,http://www.seoul.co.kr/news/newsView.php?id=20170921021009&wlog_tag3=naver
1504,2017-09-21,삼성바이오로직스상장후주가155↑바이오대장주자리굳혔다,http://www.newsway.co.kr/view.php?tp=1&ud=2017092015334647745
1505,2017-09-21,주요공시삼성바이오로직스기업은행우원개발등,http://www.intn.co.kr/news/articleView.html?idxno=865203
1506,2017-09-22,특징주삼성바이오로직스새바이오시밀러허가에도하락,http://www.newspim.com/news/view/20170922000049
1507,2017-09-25,국고처최승욱종목상담삼성바이오로직스207940,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201709230063
1508,2017-09-25,동국대삼성바이오로직스인프라투어,http://www.kbmaeil.com/news/articleView.html?idxno=425937
1509,2017-09-26,삼성바이오로직스삼성자본력기술력매수SK證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017092607513598902&outlink=1
1510,2017-09-26,삼성바이오로직스고평가논란영업적자에도주가만고공행진,http://www.ekn.kr/news/article.html?no=314715
1511,2017-09-26,SK증권삼성바이오로직스매출성장지속2017년영업이익흑자전환할것”,http://www.g-enews.com/ko-kr/news/article/news_all/20170926083252300c642673384_1/article.html
1512,2017-09-26,SK증권삼성바이오로직스세계최대CMO”목표가39만,http://www.viva100.com/main/view.php?key=20170926010009991
1513,2017-09-26,ET투자뉴스삼성바이오로직스삼성의새로운도전매수신규편입SK증권,http://www.etnews.com/20170926000014
1514,2017-09-26,삼성바이오로직스올해영업익흑자전환기대SK,http://www.cstimes.com/?mod=news&act=articleView&idxno=256981
1515,2017-09-26,특징주삼성바이오로직스매출성장영업이익흑자전환기대주가꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201709260923174103c642673384_1/article.html
1516,2017-09-26,르포CMO챔피언눈앞삼성바이오로직스3공장건설현장가보니,http://daily.hankooki.com/lpage/economy/201709/dh20170926093327138080.htm
1517,2017-09-27,옆걸음장세삼성바이오로직스LG이노텍두산중공업훈풍,http://www.choicenews.co.kr/news/articleView.html?idxno=36213
1518,2017-09-28,머니S톡삼성바이오로직스끝은어디,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017092108218086118&outlink=1
1519,2017-09-28,바이오시밀러가격하락삼성바이오로직스셀트리온괜찮을까,http://www.mdtoday.co.kr/mdtoday/index.html?no=296854
1520,2017-09-29,셀트리온코스피행삼성바이오로직스거품걷힐까,http://www.mt.co.kr/view/mtview.php?type=1&no=2017092909461291144&outlink=1
1521,2017-09-29,삼성전자삼성물산삼성바이오로직스기업지배구조보고서공개,http://www.businesspost.co.kr/BP?command=article_view&num=60299
1522,2017-10-10,특징주삼성바이오로직스개장직후급등신고가,http://www.fnnews.com/news/201710100920072686
1523,2017-10-10,삼성바이오로직스장초반높은상승세,http://www.sedaily.com/NewsView/1OM8YP2A9Y
1524,2017-10-10,삼성바이오로직스장초반신고가경신,http://www.newsprime.co.kr/news/article.html?no=390556
1525,2017-10-10,삼성바이오로직스신고가기록장초반상승세,http://www.newsis.com/view/?id=NISX20171010_0000112934&cID=10401&pID=10400
1526,2017-10-10,삼성바이오로직스자회사덕분에신고가경신,http://www.choicenews.co.kr/news/articleView.html?idxno=36548
1527,2017-10-11,KB증권삼성전기삼성바이오로직스유니퀘스트외,http://www.seoulfn.com/news/articleView.html?idxno=289708
1528,2017-10-11,특징주삼성바이오로직스장중52주신고가,http://www.fnnews.com/news/201710111041207880
1529,2017-10-11,삼성바이오로직스KB금융턱밑까지추격시총톱10노린다,http://www.edaily.co.kr/news/newspath.asp?newsid=03565366616091936
1530,2017-10-11,이종목은왜오늘의특징주삼성의힘삼성바이오로직스실적호조내년까지하이트진로,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101118045157986
1531,2017-10-12,삼성바이오로직스미FDA2공장생산제품제조승인획득,http://www.fnnews.com/news/201710120841165149
1532,2017-10-12,김태한삼성바이오로직스사장2공장FDA인증제조경쟁력입증,http://www.ebn.co.kr/news/view/912588
1533,2017-10-12,삼성바이오로직스2공장생산품첫FDA승인획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01672806616092264
1534,2017-10-12,KB증권삼성전기삼성바이오로직스유니퀘스트외,http://www.seoulfn.com/news/articleView.html?idxno=289823
1535,2017-10-12,삼성바이오로직스美FDA로부터2공장인증획득,http://news.hankyung.com/article/2017101238456
1536,2017-10-12,삼성바이오로직스2공장첫FDA인증획득,http://www.siminilbo.co.kr/news/articleView.html?idxno=534604
1537,2017-10-12,삼성바이오로직스2공장미FDA제조승인획득,http://www.dailypharm.com/News/231749
1538,2017-10-12,삼성바이오로직스2공장첫FDA인증획득1공장보다6개월빠른19개월만에승인,http://biz.chosun.com/site/data/html_dir/2017/10/12/2017101200750.html
1539,2017-10-12,삼성바이오로직스2공장미FDA의약품제조승인획득,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171012047500017&did=1195m
1540,2017-10-12,삼성바이오로직스2공장첫FDA인증획득,http://www.newsis.com/view/?id=NISX20171012_0000115208&cID=13001&pID=13000
1541,2017-10-12,삼성바이오로직스2공장美FDA서첫제조승인획득,http://news.einfomax.co.kr/news/articleView.html?idxno=3415791
1542,2017-10-12,삼성바이오로직스미FDA로부터2공장제조인증획득,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710120059
1543,2017-10-12,삼성바이오로직스2공장美FDA제조승인획득,http://daily.hankooki.com/lpage/economy/201710/dh20171012093742138080.htm
1544,2017-10-12,삼성바이오로직스FDA서2공장생산제품판매허가받아,http://news.mk.co.kr/newsRead.php?year=2017&no=672881
1545,2017-10-12,삼성바이오로직스2공장첫FDA인증획득,http://news.heraldcorp.com/view.php?ud=20171012000262
1546,2017-10-12,삼성바이오로직스2공장美FDA인증따냈다,http://www.sedaily.com/NewsView/1OM9W86TZX
1547,2017-10-12,삼성바이오로직스제2공장미FDA인증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=56059
1548,2017-10-12,삼성바이오로직스2공장美FDA제조승인획득글로벌품질경쟁력인정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1548085
1549,2017-10-12,삼성바이오로직스2공장FDA제조승인,http://www.dt.co.kr/contents.html?article_no=2017101202109976029001&ref=naver
1550,2017-10-12,삼성바이오로직스2공장첫FDA인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=297712
1551,2017-10-12,삼성바이오로직스2공장생산제품美FDA첫인증,http://news1.kr/articles/?3121267
1552,2017-10-12,삼성바이오로직스2공장미국FDA제조승인획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101208544154986
1553,2017-10-12,삼성바이오로직스2공장FDA인증획득,http://www.newstomato.com/ReadNews.aspx?no=781407
1554,2017-10-12,삼성바이오로직스2공장생산품첫FDA승인획득,http://www.asiae.co.kr/news/view.htm?idxno=2017101210061639946
1555,2017-10-12,삼성바이오로직스2공장미FDA의약품제조승인,https://cnbc.sbs.co.kr/article_hub/10000877474?division=NAVER
1556,2017-10-12,삼성바이오로직스2공장19개월만에첫美FDA승인,http://www.sisajournal-e.com/biz/article/174714
1557,2017-10-12,삼성바이오로직스이번엔2공장제품승인이호재,http://www.choicenews.co.kr/news/articleView.html?idxno=36611
1558,2017-10-12,삼성바이오로직스2공장생산품FDA첫승인,http://www.newspim.com/news/view/20171012000043
1559,2017-10-12,서울경제TV삼성바이오로직스2공장FDA인증얻어,http://www.sedaily.com/NewsView/1OM9X7N31G
1560,2017-10-12,삼성바이오로직스미국FDA로부터2공장제조승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=60805
1561,2017-10-12,삼성바이오로직스2공장미FDA제조승인획득,http://www.dailian.co.kr/news/view/666274/?sc=naver
1562,2017-10-12,삼성바이오로직스2공장첫FDA제조승인획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1047493
1563,2017-10-12,삼성바이오로직스2공장FDA인증획득,http://www.ciobiz.co.kr/news/article.html?id=20171012120001
1564,2017-10-12,삼성바이오로직스2공장생산제품첫FDA제조승인획득,http://www.sisaon.co.kr/news/articleView.html?idxno=63703
1565,2017-10-12,삼성바이오로직스높아지는미국무역장벽뚫고시장확대성공,http://www.news2day.co.kr/93410
1566,2017-10-12,특징주삼성바이오로직스2공장생산품FDA승인에신고가,http://www.ebn.co.kr/news/view/912700
1567,2017-10-12,삼성바이오로직스미FDA서첫의약품제조승인획득,http://www.metroseoul.co.kr/news/newsview?newscd=2017101200044
1568,2017-10-12,특징주삼성바이오로직스시총10위진입,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171012130500008&did=1195m
1569,2017-10-12,특징주삼성바이오로직스2공장美FDA의약품제조승인획득에신고가,http://www.newsis.com/view/?id=NISX20171012_0000115851&cID=10401&pID=10400
1570,2017-10-12,특징주삼성바이오로직스시총8위점프,http://www.viva100.com/main/view.php?key=20171012010002511
1571,2017-10-12,삼성바이오로직스2공장첫FDA인증세계최초단일공장배양기10개설치,http://www.kukinews.com/news/article.html?no=490923
1572,2017-10-12,삼성바이오로직스하루새8급등시가총액톱10올랐다,http://www.edaily.co.kr/news/newspath.asp?newsid=03470246616092264
1573,2017-10-12,삼성바이오로직스미국FDA로부터2공장인증획득시총9위등극,http://www.sporbiz.co.kr/news/articleView.html?idxno=153259
1574,2017-10-12,삼성바이오로직스2공장FDA제조승인,http://www.seoulfn.com/news/articleView.html?idxno=289899
1575,2017-10-12,삼성바이오로직스2공장美FDA제조승인획득품질경쟁력인정,http://biz.newdaily.co.kr/news/article.html?no=10143116
1576,2017-10-12,코스피또사상최고삼성바이오로직스급등시총9위로,http://www.choicenews.co.kr/news/articleView.html?idxno=36616
1577,2017-10-12,제약한줄뉴스신라젠삼성바이오로직스녹십자엠에스,http://www.koreahealthlog.com/news/articleView.html?idxno=22077
1578,2017-10-12,김태한이건희속도경영으로삼성바이오로직스빠르게키워,http://www.businesspost.co.kr/BP?command=article_view&num=60841
1579,2017-10-12,특징주삼성바이오로직스시가총액8위도약종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171012130551008&did=1195m
1580,2017-10-12,시황코스피2470선도넘었다삼성바이오로직스863급등시총8위로,http://daily.hankooki.com/lpage/economy/201710/dh20171012171350138110.htm
1581,2017-10-12,삼성바이오로직스시총9위로껑충,http://www.sedaily.com/NewsView/1OM9X68XCN
1582,2017-10-12,삼성바이오로직스2공장생산제품美FDA제조승인획득,http://www.sisafocus.co.kr/news/articleView.html?idxno=167916
1583,2017-10-12,삼성바이오로직스2공장美FDA의약품제조승인획득,https://cnbc.sbs.co.kr/article_hub/10000877565?division=NAVER
1584,2017-10-12,삼성바이오로직스2공장의약품美FDA제조승인최강경쟁력,http://www.fnnews.com/news/201710121922394798
1585,2017-10-12,삼성바이오로직스2공장생산품미국FDA인증,http://news.hankyung.com/article/2017101267411
1586,2017-10-12,삼성바이오로직스2공장제품도美FDA승인,http://news.kmib.co.kr/article/view.asp?arcid=0923829799&code=11151400&cp=nv
1587,2017-10-12,삼성바이오로직스2공장첫FDA인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1116925
1588,2017-10-12,삼성바이오로직스미국FDA로부터2공장생산제품첫번째제조승인을획득,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1402517
1589,2017-10-12,삼성바이오로직스2공장美제조승인획득,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=719183
1590,2017-10-12,삼성바이오로직스2공장제품美FDA제조승인CMO순풍,http://www.kyeongin.com/main/view.php?key=20171012010002328
1591,2017-10-13,삼성바이오로직스시총9위로껑충,http://www.sedaily.com/NewsView/1OMACL2GYH
1592,2017-10-13,삼성바이오로직스생산설비우수성입증한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01426806616092592
1593,2017-10-13,삼성바이오로직스美FDA승인에가동률↑한국투자,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101307432888261&outlink=1
1594,2017-10-13,삼성바이오로직스생산설비우수성입증목표가44만원↑한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1548588
1595,2017-10-13,삼성바이오로직스생산설비우수목표가↑한국투자증권,http://www.dailian.co.kr/news/view/666495/?sc=naver
1596,2017-10-13,한국투자증권삼성바이오로직스3공장풀가동달성시기단축될듯목표주가상향”,http://www.g-enews.com/ko-kr/news/article/news_all/201710130814209934c642673384_1/article.html
1597,2017-10-13,삼성바이오로직스2공장FDA제조승인획득,http://www.ajunews.com/view/20171012090033036
1598,2017-10-13,삼성바이오로직스목표주가올라미국FDA제조승인반영,http://www.businesspost.co.kr/BP?command=article_view&num=60923
1599,2017-10-13,HotLine삼성바이오로직스잉여현금흐름개선기대목표가↑,http://news.mk.co.kr/newsRead.php?year=2017&no=675672
1600,2017-10-13,한국투자증권삼성바이오로직스3공장가동예정목표가44만원↑,http://www.viva100.com/main/view.php?key=20171013010002723
1601,2017-10-13,삼성바이오로직스생산설비우수성입증목표주가상향한국,http://biz.chosun.com/site/data/html_dir/2017/10/13/2017101300657.html
1602,2017-10-13,삼성바이오로직스잉여현금흐름개선한투證,http://www.seoulfn.com/news/articleView.html?idxno=289949
1603,2017-10-13,삼성바이오로직스잉여현금흐름개선기대목표가상향한국투자,http://www.sedaily.com/NewsView/1OMACUQ55C
1604,2017-10-13,KB증권삼성전기삼성바이오로직스유니퀘스트외,http://www.seoulfn.com/news/articleView.html?idxno=289952
1605,2017-10-13,한국투자증권삼성물산삼성전자삼성바이오로직스대안주”,http://www.newsway.co.kr/view.php?tp=1&ud=2017101308464576782
1606,2017-10-13,특징주삼성바이오로직스美FDA2공장제조승인에이틀째강세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101309085274091&outlink=1
1607,2017-10-13,특징주삼성바이오로직스2공장허가소식에이틀연속강세,http://www.viva100.com/main/view.php?key=20171013010002756
1608,2017-10-13,ET투자뉴스삼성바이오로직스바이오시밀러의생산매수유지한국투자증권,http://www.etnews.com/20171013000006
1609,2017-10-13,특징주삼성바이오로직스이틀째급등시총7위,http://www.newstomato.com/ReadNews.aspx?no=781712
1610,2017-10-13,특징주삼성바이오로직스2공장생산제품美승인에강세,http://www.newspim.com/news/view/20171013000066
1611,2017-10-13,특징주삼성바이오로직스2공장美FDA인증신고가행진,http://news.hankyung.com/article/2017101384966
1612,2017-10-13,삼성바이오로직스2공장美FDA제조승인소식에40만원바짝,http://www.sedaily.com/NewsView/1OMADGTUPW
1613,2017-10-13,특징주삼성바이오로직스또신고가시총7위,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171013055400008&did=1195m
1614,2017-10-13,시총7위자리꿰찬삼성바이오로직스주가40만원초읽기,http://news.heraldcorp.com/view.php?ud=20171013000167
1615,2017-10-13,삼성바이오로직스美FDA제조승인에주가↑,http://www.newsprime.co.kr/news/article.html?no=391080
1616,2017-10-13,특징주삼성바이오로직스시가총액8위로점프,http://www.newsway.co.kr/view.php?tp=1&ud=2017101309394552453
1617,2017-10-13,특징주삼성바이오로직스美FDA2공장제조승인소식에신고가,http://www.dailian.co.kr/news/view/666530/?sc=naver
1618,2017-10-13,특징주삼성바이오로직스이틀째강세시총8위로껑충,http://www.sporbiz.co.kr/news/articleView.html?idxno=153452
1619,2017-10-13,특징주삼성바이오로직스40만원돌파시총6위,http://www.asiae.co.kr/news/view.htm?idxno=2017101309572371284
1620,2017-10-13,특징주삼성바이오로직스40만원대돌파시총7위,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101310044505970&outlink=1
1621,2017-10-13,특징주삼성바이오로직스40만원대돌파시총7위,http://www.edaily.co.kr/news/newspath.asp?newsid=02128726616092592
1622,2017-10-13,특징주삼성바이오로직스40만원첫돌파시총8위로껑충,http://www.newsis.com/view/?id=NISX20171013_0000116618&cID=10401&pID=10400
1623,2017-10-13,버핏이라면공모가3배가된삼성바이오로직스제2의삼성전자될까,http://www.news2day.co.kr/93469
1624,2017-10-13,삼성바이오로직스주가폭등바이오주관심,http://www.ftoday.co.kr/news/articleView.html?idxno=80820
1625,2017-10-13,개장전특징주삼성바이오로직스207940,http://www.newstomato.com/ReadNews.aspx?no=781724
1626,2017-10-13,특징주삼성바이오로직스또신고가시총7위종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171013055451008&did=1195m
1627,2017-10-13,삼성바이오로직스41만원터치시총7위등극,http://www.sedaily.com/NewsView/1OMADV60E3
1628,2017-10-13,코스피외국인순매도삼성바이오로직스삼성전자아모레퍼시픽,http://www.newsway.co.kr/view.php?tp=1&ud=2017101315465046289
1629,2017-10-13,아주종목분석삼성바이오로직스美판매승인힘입어신고가,http://www.ajunews.com/view/20171013170733886
1630,2017-10-13,삼성바이오로직스주가상승세시가총액에서LG화학제칠기세,http://www.businesspost.co.kr/BP?command=article_view&num=60985
1631,2017-10-14,주간관심주새내기주삼성바이오로직스시총7위등극,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171013166100008&did=1195m
1632,2017-10-14,삼성바이오로직스상장11개월만에코스피시총10위권진입,http://www.mediapen.com/news/view/306701
1633,2017-10-15,바이오투톱삼성바이오로직스셀트리온주가상승세신고가행진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101515240255952
1634,2017-10-15,HotStock삼성바이오로직스,http://news.hankyung.com/article/2017101547591
1635,2017-10-16,삼성바이오로직스글로벌CMO공룡으로성장하나,http://www.dailypharm.com/News/231915
1636,2017-10-16,삼성바이오로직스2공장FDA제조승인에주가강세시총7위LG화학추격,http://www.mdtoday.co.kr/mdtoday/index.html?no=297995
1637,2017-10-16,KB증권삼성전기삼성바이오로직스파라다이스外,http://www.seoulfn.com/news/articleView.html?idxno=290103
1638,2017-10-16,SK바이오텍세종공장삼성바이오로직스넘겠다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1117753
1639,2017-10-16,삼성전자삼성바이오로직스랠리수혜주는삼성물산‥내년엔더좋아,http://www.fnnews.com/news/201710131636220903
1640,2017-10-16,그것이사고싶다물량급증기대감삼성바이오로직스外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101616133174053
1641,2017-10-16,삼성전자삼성바이오로직스잘난아들덕에웃는삼성물산,http://www.fnnews.com/news/201710161800298135
1642,2017-10-17,오늘의추천종목KB증권삼성바이오로직스룽투코리아등,http://www.asiatoday.co.kr/view.php?key=20171017010005032
1643,2017-10-17,KB증권삼성전기삼성바이오로직스룽투코리아외,http://www.seoulfn.com/news/articleView.html?idxno=290224
1644,2017-10-17,김태한삼성바이오로직스사장셀라인개발부터양산까지원스톱해결,http://www.ebn.co.kr/news/view/913189
1645,2017-10-17,흑자시동건삼성바이오로직스김태한사장의속도경영통했다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1550091
1646,2017-10-17,최흥식삼성바이오로직스감리신속하고확실하게하겠다,http://news1.kr/articles/?3126599
1647,2017-10-18,외국인투자유치빌미로1조덕보는삼성바이오로직스,http://www.dailypharm.com/News/232092
1648,2017-10-18,KB증권삼성전기삼성바이오로직스룽투코리아外,http://www.seoulfn.com/news/articleView.html?idxno=290337
1649,2017-10-18,SK바이오텍2020년삼성바이오로직스추월,http://www.kormedi.com/news/news/industry/1224888_2908.html
1650,2017-10-18,삼성바이오로직스25일3분기결산실적공시,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101815354828503&outlink=1
1651,2017-10-18,공시삼성바이오로직스3분기실적25일발표,http://www.viva100.com/main/view.php?key=20171018010004998
1652,2017-10-19,KB증권삼성전기삼성바이오로직스룽투코리아外,http://www.seoulfn.com/news/articleView.html?idxno=290446
1653,2017-10-19,특징주삼성바이오로직스외인팔자에이틀째하락,http://www.asiae.co.kr/news/view.htm?idxno=2017101909240892764
1654,2017-10-19,특징주삼성바이오로직스시총TOP10서밀리나,http://www.newsway.co.kr/view.php?tp=1&ud=2017101915112079243
1655,2017-10-19,코스피기관순매도삼성전자삼성바이오로직스엔씨소프트,http://www.newsway.co.kr/view.php?tp=1&ud=2017101916173586622
1656,2017-10-19,코스피외국인순매수LG전자삼성바이오로직스POSCO,http://www.newsway.co.kr/view.php?tp=1&ud=2017101916164697812
1657,2017-10-20,숨고르기들어간삼성바이오로직스셀트리온셀트리온헬스케어여전히추천주,http://www.mdtoday.co.kr/mdtoday/index.html?no=298738
1658,2017-10-20,KB증권삼성전기삼성바이오로직스룽투코리아외,http://www.seoulfn.com/news/articleView.html?idxno=290571
1659,2017-10-23,유치에매몰됐던삼성바이오로직스무상토지임대,http://www.dailypharm.com/News/232233
1660,2017-10-23,오늘의추천종목KB증권삼성바이오로직스웹젠등,http://www.asiatoday.co.kr/view.php?key=20171023010008132
1661,2017-10-23,KB증권삼성전기삼성바이오로직스웹젠외,http://www.seoulfn.com/news/articleView.html?idxno=290706
1662,2017-10-24,시총10조클럽35개사상최다삼성바이오로직스카뱅합류,http://www.sportsseoul.com/news/read/562746
1663,2017-10-24,KB증권삼성전기삼성바이오로직스웹젠외,http://www.seoulfn.com/news/articleView.html?idxno=290842
1664,2017-10-24,새내기주대분석삼성바이오로직스삼성차세대먹거리공모가3배뛰며바이오대장株우뚝,http://www.etoday.co.kr/news/section/newsview.php?idxno=1553062
1665,2017-10-24,IR센터삼성물산삼성바이오로직스시장예상실적,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710240150
1666,2017-10-24,삼성바이오로직스vs셀트리온바이오대장주전쟁,http://www.viva100.com/main/view.php?key=20171024010007013
1667,2017-10-25,삼성바이오로직스바이오제약시장게임체인저될것”,http://news.donga.com/3/all/20171024/86935339/1
1668,2017-10-25,삼성바이오로직스토지무상혜택조례개정움직임,http://www.dailypharm.com/News/232460
1669,2017-10-25,오늘의추천종목KB증권삼성바이오로직스웹젠등,http://www.asiatoday.co.kr/view.php?key=20171025010009551
1670,2017-10-25,KB증권삼성전기삼성바이오로직스웹젠외,http://www.seoulfn.com/news/articleView.html?idxno=290956
1671,2017-10-25,삼성바이오로직스3Q영업익204억전년比흑전,http://www.mt.co.kr/view/mtview.php?type=1&no=2017102515413768316&outlink=1
1672,2017-10-25,삼성바이오로직스3Q영업익204억원흑자전환,http://www.etoday.co.kr/news/section/newsview.php?idxno=1553860
1673,2017-10-25,삼성바이오로직스3분기영업익205억원흑자전환,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171025134300008&did=1195m
1674,2017-10-25,삼성바이오로직스3분기영업익204억흑자전환,http://www.sedaily.com/NewsView/1OMFVQ7ZHT
1675,2017-10-25,삼성바이오로직스3Q영업익205억전년比흑자전환,http://www.asiatoday.co.kr/view.php?key=20171025010010036
1676,2017-10-25,삼성바이오로직스3Q매출액1275억전년比1415증가1보,http://news1.kr/articles/?3134068
1677,2017-10-25,삼성바이오로직스3분기전기비매출1274억영업익흑전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211183
1678,2017-10-25,삼성바이오로직스3Q매출1275억영업이익205억,http://www.ebn.co.kr/news/view/914531
1679,2017-10-25,삼성바이오로직스3분기영업익205억흑자전환,http://www.asiae.co.kr/news/view.htm?idxno=2017102515475774188
1680,2017-10-25,삼성바이오로직스3Q영업익205억원연간흑자전환전망,http://news.heraldcorp.com/view.php?ud=20171025000851
1681,2017-10-25,삼성바이오로직스3분기영업익205억원전년비흑자전환,http://www.newstomato.com/ReadNews.aspx?no=784134
1682,2017-10-25,삼성바이오로직스3분기영업이익204억원흑자전환,http://news.hankyung.com/article/2017102515496
1683,2017-10-25,삼성바이오로직스3분기영업이익전년비흑자전환,http://news.hankyung.com/article/2017102515616
1684,2017-10-25,삼성바이오로직스3분기영업익205억흑자전환성공,http://www.dailian.co.kr/news/view/669280/?sc=naver
1685,2017-10-25,삼성바이오로직스3분기영업익205억원흑자전환,http://www.sporbiz.co.kr/news/articleView.html?idxno=157244
1686,2017-10-25,삼성바이오로직스3분기영업익205억흑자전환,http://www.newsis.com/view/?id=NISX20171025_0000128293&cID=10401&pID=10400
1687,2017-10-25,삼성바이오로직스3Q영업익205억원공장가동률상승,http://news.einfomax.co.kr/news/articleView.html?idxno=3418023
1688,2017-10-25,삼성바이오로직스3분기영업익205억원전년比흑자전환,http://daily.hankooki.com/lpage/economy/201710/dh20171025155707138080.htm
1689,2017-10-25,삼성바이오로직스3분기영업익204억원흑자전환달성,http://www.edaily.co.kr/news/newspath.asp?newsid=03591606616096528
1690,2017-10-25,공시삼성바이오로직스3분기영업익205억흑자전환,http://www.viva100.com/main/view.php?key=20171025010007766
1691,2017-10-25,공시삼성바이오로직스3Q영업익205억원흑자전환,http://www.newsway.co.kr/view.php?tp=1&ud=2017102516034504811
1692,2017-10-25,삼성바이오로직스3분기영업익2046억흑자전환,http://news.heraldcorp.com/view.php?ud=20171025000875
1693,2017-10-25,공시삼성바이오로직스3분기영업이익204억원전년대비흑자전환,http://www.g-enews.com/ko-kr/news/article/news_all/201710251608172109c642673384_1/article.html
1694,2017-10-25,삼성바이오로직스3분기에영업이익흑자로전환,http://www.kpinews.co.kr/news/articleView.html?idxno=57491
1695,2017-10-25,삼성바이오로직스3분기영업익205억흑자전환성공,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017102516051485379
1696,2017-10-25,삼성바이오로직스3Q매출1275억영업익205억,http://www.medigatenews.com/news/2608542189
1697,2017-10-25,삼성바이오로직스3분기영업익205억원흑자전환,http://www.sisajournal-e.com/biz/article/175303
1698,2017-10-25,삼성바이오로직스3분기영업익205억원흑자전환성공,http://biz.chosun.com/site/data/html_dir/2017/10/25/2017102501906.html
1699,2017-10-25,삼성바이오로직스3Q영업익205억흑자전환성공상보,http://news1.kr/articles/?3134120
1700,2017-10-25,종합삼성바이오로직스3분기영업익205억흑자전환,http://www.newsis.com/view/?id=NISX20171025_0000128357&cID=13001&pID=13000
1701,2017-10-25,삼성바이오로직스3분기영업이익흑자전환성공,http://www.news2day.co.kr/94071
1702,2017-10-25,삼성바이오로직스3분기실적개선흑자전환성공,http://www.dt.co.kr/contents.html?article_no=2017102502109976029008&ref=naver
1703,2017-10-25,삼성바이오로직스3분기매출액1275억원기록,http://www.fnnews.com/news/201710251623109574
1704,2017-10-25,삼성바이오로직스3분기영업익205억원흑자전환종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171025134351008&did=1195m
1705,2017-10-25,삼성바이오로직스공장가동률올라3분기흑자전환,http://www.businesspost.co.kr/BP?command=article_view&num=62062
1706,2017-10-25,삼성바이오로직스3분기매출1275억영업이익205억,http://www.sisafocus.co.kr/news/articleView.html?idxno=168572
1707,2017-10-25,삼성바이오로직스3분기영업익205억흑자전환달성,http://www.dailian.co.kr/news/view/669308/?sc=naver
1708,2017-10-25,삼성바이오로직스본격성장가도달린다,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710250186
1709,2017-10-25,삼성바이오로직스3분기영업익205억전년비흑자전환,http://www.ajunews.com/view/20171025171805105
1710,2017-10-25,삼성바이오로직스3분기영업이익205억원흑자전환,http://www.ekn.kr/news/article.html?no=319926
1711,2017-10-25,삼성바이오로직스3Q영업익205억흑자전환연간흑자기조굳혔다종합,http://www.edaily.co.kr/news/newspath.asp?newsid=04198406616096528
1712,2017-10-25,삼성바이오로직스3분기매출1275억원100성장,http://www.ciobiz.co.kr/news/article.html?id=20171025120026
1713,2017-10-25,삼성바이오로직스3분기영업익205억흑자전환,http://www.newspim.com/news/view/20171025000245
1714,2017-10-25,삼성바이오로직스연간영업익첫흑자기대,http://www.sedaily.com/NewsView/1OMFW0CY8Q
1715,2017-10-25,코스피외국인순매도삼성전자우삼성바이오로직스LG생활건강,http://www.newsway.co.kr/view.php?tp=1&ud=2017102518022346682
1716,2017-10-25,삼성바이오로직스3Q영업이익205억원,https://cnbc.sbs.co.kr/article_hub/10000879263?division=NAVER
1717,2017-10-25,삼성바이오로직스흑자전환3분기영업익205억원,http://www.kyeongin.com/main/view.php?key=20171025010006798
1718,2017-10-25,삼성바이오로직스흑자전환공장가동률보면턴어라운드보인다,http://www.g-enews.com/ko-kr/news/article/news_all/201710251929184057c642673384_1/article.html
1719,2017-10-25,삼성바이오로직스3Q영업익205억원흑자전환,http://www.seoulfn.com/news/articleView.html?idxno=291047
1720,2017-10-25,그룹기대주삼성바이오로직스LG이노텍3분기포텐폭발,http://www.viva100.com/main/view.php?key=20171025010007928
1721,2017-10-25,삼성바이오로직스3분기매출1275억영업이익205억,http://www.kyeongin.com/main/view.php?key=20171025010006719
1722,2017-10-26,기자의눈삼성바이오로직스와시대정신,http://www.dailypharm.com/News/232575
1723,2017-10-26,클릭e종목삼성바이오로직스목표주가41만원으로상향장기적접근,http://www.asiae.co.kr/news/view.htm?idxno=2017102606474488853
1724,2017-10-26,삼성바이오로직스깜짝실적기록내년영업익1000억전망한국,http://news.hankyung.com/article/2017102634676
1725,2017-10-26,삼성바이오로직스성장진행중유안타,http://biz.chosun.com/site/data/html_dir/2017/10/26/2017102600620.html
1726,2017-10-26,삼성바이오로직스실적좋다목표가41만원,http://www.newspim.com/news/view/20171026000022
1727,2017-10-26,IBK투자증권삼성바이오로직스수주기대감높다3분기영업이익턴어라운드”,http://www.g-enews.com/ko-kr/news/article/news_all/201710260810151180c642673384_1/article.html
1728,2017-10-26,삼성바이오로직스공장가동률계속높아져목표주가도올라,http://www.businesspost.co.kr/BP?command=article_view&num=62105
1729,2017-10-26,오늘의종목삼성바이오로직스어닝서프라이즈계속된다,http://www.sedaily.com/NewsView/1OMGBDDEON
1730,2017-10-26,IBK투자삼성바이오로직스중장기실적기대상승,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171026035400008&did=1195m
1731,2017-10-26,삼성바이오로직스3Q예정된흑자전환목표가41만으로↑대신증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1554107
1732,2017-10-26,삼성바이오로직스중장기실적기대목표가↑IBK투자,http://www.seoulfn.com/news/articleView.html?idxno=291064
1733,2017-10-26,삼성바이오로직스3분기턴어라운드달성목표가상향대신증권,http://www.newstomato.com/ReadNews.aspx?no=784254
1734,2017-10-26,삼성바이오로직스3분기호실적삼성,http://www.edaily.co.kr/news/newspath.asp?newsid=01685926616096856
1735,2017-10-26,HotLine삼성바이오로직스2공장BEP달성목표가↑,http://news.mk.co.kr/newsRead.php?year=2017&no=707408
1736,2017-10-26,유안타증권삼성바이오로직스흑자전환성공성장진행中,http://www.newsprime.co.kr/news/article.html?no=392826
1737,2017-10-26,특징주삼성바이오로직스3분기깜짝실적에강세,http://news.hankyung.com/article/2017102637866
1738,2017-10-26,특징주삼성바이오로직스3분기영업익흑자전환에강세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017102609030085263&outlink=1
1739,2017-10-26,IBK투자증권삼성바이오로직스3분기영업이익흑자목표가42만원↑,http://www.viva100.com/main/view.php?key=20171026010007996
1740,2017-10-26,특징주삼성바이오로직스3분기깜찍실적에상승,http://www.asiae.co.kr/news/view.htm?idxno=2017102609054486101
1741,2017-10-26,특징주삼성바이오로직스어닝서프라이즈에강세,http://www.newspim.com/news/view/20171026000056
1742,2017-10-26,KB증권삼성전기삼성바이오로직스웹젠외,http://www.seoulfn.com/news/articleView.html?idxno=291080
1743,2017-10-26,삼성바이오로직스3분기호실적에주가맑음,http://www.newsprime.co.kr/news/article.html?no=392832
1744,2017-10-26,특징주삼성바이오로직스흑자전환소식에강세,http://www.viva100.com/main/view.php?key=20171026010007999
1745,2017-10-26,ET투자뉴스삼성바이오로직스3분기매출증가매수유지유안타증권,http://www.etnews.com/20171026000023
1746,2017-10-26,특징주삼성바이오로직스중장기실적기대감에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171026048100008&did=1195m
1747,2017-10-26,유안타증권삼성바이오로직스성장은진행형”,http://www.newsway.co.kr/view.php?tp=1&ud=2017102609170109978
1748,2017-10-26,특징주삼성바이오로직스흑자전환소식에강세,http://www.seoulfn.com/news/articleView.html?idxno=291086
1749,2017-10-26,왕좌의게임③왕좌노리는삼성바이오로직스,http://www.mdtoday.co.kr/mdtoday/index.html?no=299398
1750,2017-10-26,CLSA가보는삼성바이오로직스의향방은,http://www.choicenews.co.kr/news/articleView.html?idxno=36950
1751,2017-10-26,한국투자증권삼성바이오로직스좋아질일만남았다”,http://www.newsway.co.kr/view.php?tp=1&ud=2017102609012545005
1752,2017-10-26,특징주삼성바이오로직스3분기흑자전환에강세,http://www.newstomato.com/ReadNews.aspx?no=784292
1753,2017-10-26,삼성바이오로직스어닝서프라이즈강세중장기기대감,http://news.heraldcorp.com/view.php?ud=20171026000281
1754,2017-10-26,특징주삼성바이오로직스3분기깜짝호실적에주가강세,http://www.sisaon.co.kr/news/articleView.html?idxno=64449
1755,2017-10-26,아주종목분석삼성바이오로직스중장기실적전망상향,http://www.ajunews.com/view/20171026101005474
1756,2017-10-26,ET투자뉴스삼성바이오로직스예상보다빠른바이매수삼성증권,http://www.etnews.com/20171026000089
1757,2017-10-26,턴어라운드삼성바이오로직스삼성물산곁불,http://www.asiae.co.kr/news/view.htm?idxno=2017102608313206994
1758,2017-10-26,삼성증권삼성바이오로직스바이오예탁생산손익분기점돌파목표가↑”,http://www.newsway.co.kr/view.php?tp=1&ud=2017102608394657395
1759,2017-10-26,삼성바이오로직스3분기흑자전환성공,https://cnbc.sbs.co.kr/article_hub/10000879332?division=NAVER
1760,2017-10-26,특징주삼성바이오로직스3분기영업익흑자전환에강세,http://www.fnnews.com/news/201710261059135147
1761,2017-10-26,ET투자뉴스삼성바이오로직스향후실적에대한매수유지한국투자증권,http://www.etnews.com/20171026000137
1762,2017-10-26,ET투자뉴스삼성바이오로직스예정된턴어라운드시장수익률유지대신증권,http://www.etnews.com/20171026000149
1763,2017-10-26,특징주삼성바이오로직스3Q깜짝실적에상승,http://www.newsway.co.kr/view.php?tp=1&ud=2017102613092150701
1764,2017-10-26,ET투자뉴스삼성바이오로직스2공장BEP달성매수HMC투자증권,http://www.etnews.com/20171026000228
1765,2017-10-26,ET투자뉴스삼성바이오로직스3Q17영업이익매수유지IBK투자증권,http://www.etnews.com/20171026000262
1766,2017-10-26,유안타삼성바이오로직스성장이어질것”,http://www.econovill.com/news/articleView.html?idxno=325229
1767,2017-10-26,삼성바이오로직스3분기매출1275억영업이익205억,http://www.kukinews.com/news/article.html?no=495284
1768,2017-10-26,삼성바이오로직스영업흑자에도늘어난손실왜,http://news.hankyung.com/article/201710265850f
1769,2017-10-26,스톡인사이드삼성바이오로직스잇단호재에실적쑥전자안부럽네,http://www.sedaily.com/NewsView/1OMGCMUZ6J
1770,2017-10-26,고평가논란부터깜짝실적까지”삼성바이오로직스파란만장했던1년,http://www.newsway.co.kr/view.php?tp=1&ud=2017102616082874706
1771,2017-10-26,삼성바이오로직스성장궤도에본격진입증권가한목소리,http://www.businesspost.co.kr/BP?command=article_view&num=62209
1772,2017-10-27,삼성바이오로직스잇단호재에실적쑥전자안부럽네,http://www.sedaily.com/NewsView/1OMGR4EIGT
1773,2017-10-27,만평으로본삼성바이오로직스무상토지임대료,http://www.dailypharm.com/News/232648
1774,2017-10-27,공장가동률상승한삼성바이오로직스4분기실적도↑,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048106
1775,2017-10-27,KB증권삼성전기삼성바이오로직스웹젠외,http://www.seoulfn.com/news/articleView.html?idxno=291181
1776,2017-10-27,바이오시밀러전성시대삼성바이오로직스셀트리온훨훨,http://www.ebn.co.kr/news/view/914965
1777,2017-10-30,KB증권삼성전기삼성바이오로직스웹젠외,http://www.seoulfn.com/news/articleView.html?idxno=291324
1778,2017-10-30,3분기깜짝실적삼성바이오로직스흑자궤도,http://www.kormedi.com/news/news/drug_dist/1225004_2906.html
1779,2017-10-30,머크삼성바이오로직스전략적제휴연장,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75231
1780,2017-10-30,머크삼성바이오로직스바이오의약전략적제휴MOU,http://www.ebn.co.kr/news/view/915235
1781,2017-10-30,머크삼성바이오로직스바이오의약품제조공정개발분야제휴,http://www.newsis.com/view/?id=NISX20171030_0000132748&cID=13001&pID=13000
1782,2017-10-30,독일머크삼성바이오로직스바이오의약품공정개발위해전략적제휴확대,http://www.sedaily.com/NewsView/1OMI6LL74F
1783,2017-10-30,머크삼성바이오로직스전략적제휴확대연장,http://www.medigatenews.com/news/667396692
1784,2017-10-30,머크삼성바이오로직스와양해각서공정개발역량강화,http://www.asiatime.co.kr/news/articleView.html?idxno=157792
1785,2017-10-30,머크삼성바이오로직스제휴확대연장,http://www.newstomato.com/ReadNews.aspx?no=785066
1786,2017-10-30,머크삼성바이오로직스바이오의약품공정개발제휴확대,http://www.dt.co.kr/contents.html?article_no=2017103002109976029009&ref=naver
1787,2017-10-30,머크삼성바이오로직스전략적제휴확대연장,http://www.m-i.kr/news/articleView.html?idxno=354629
1788,2017-10-30,머크와삼성바이오로직스바이오의약품공정개발분야전략적제휴MOU체결,http://www.fnnews.com/news/201710301634381183
1789,2017-10-30,머크삼성바이오로직스바이오의약품공정개발전략적제휴확대,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710300333
1790,2017-10-30,독일머크삼성바이오로직스바이오의약품제휴연장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171030158100017&did=1195m
1791,2017-10-30,삼성바이오로직스독일머크와바이오의약품제휴연장,http://daily.hankooki.com/lpage/ittech/201710/dh20171030180826145630.htm
1792,2017-10-30,머크삼성바이오로직스제휴확대연장,http://www.kpanews.co.kr/article/show.asp?idx=188533&table=article&category=D
1793,2017-10-30,머크삼성바이오로직스바이오의약품제조공정개발제휴,http://www.viva100.com/main/view.php?key=20171030020021279
1794,2017-10-31,독일머크삼성바이오로직스바이오의약품제휴한번더,http://www.bosa.co.kr/news/articleView.html?idxno=2071351
1795,2017-10-31,머크삼성바이오로직스바이오의약품공정개발전략적제휴확대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017103111310189606
1796,2017-10-31,삼성바이오로직스상장그후1년,http://premium.mk.co.kr/view.php?no=20452
1797,2017-11-01,ET투자뉴스제약주테마한미약품삼성바이오로직스중심으로강세,http://www.etnews.com/20171101000088
1798,2017-11-01,머크삼성바이오로직스와전략적제휴확대연장,http://www.kukinews.com/news/article.html?no=496964
1799,2017-11-01,특징주삼성바이오로직스40만원재돌파,http://www.asiae.co.kr/news/view.htm?idxno=2017110115273440263
1800,2017-11-01,특징주삼성바이오로직스주당40만원돌파,http://www.newsway.co.kr/view.php?tp=1&ud=2017110115483486410
1801,2017-11-01,삼성바이오로직스주당40만원대돌파시가총액26조8630억,http://www.mdtoday.co.kr/mdtoday/index.html?no=300134
1802,2017-11-01,코스피시장의약품업종강세삼성바이오로직스주당40만원대돌파,http://www.mdtoday.co.kr/mdtoday/index.html?no=300148
1803,2017-11-02,머크삼성바이오로직스바이오의약품제조전략적협력,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211524
1804,2017-11-02,독일머크와삼성바이오로직스전략적협력체결,http://medipana.com/news/news_viewer.asp?NewsNum=209019&MainKind=A&NewsKind=5&vCount=12&vKind=1
1805,2017-11-02,KB증권삼성전기삼성바이오로직스신신제약외,http://www.seoulfn.com/news/articleView.html?idxno=291700
1806,2017-11-02,PRNewswire머크와삼성바이오로직스전략적협력체결,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171102058600009&did=1195m
1807,2017-11-02,머크삼성바이오로직스전략적협약체결,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048376
1808,2017-11-02,삼성바이오로직스머크전략적협력체결,http://www.kormedi.com/news/news/drug_dist/1225047_2906.html
1809,2017-11-02,제약바이오업종에떠오른대장주삼성바이오로직스신라젠,http://www.mdtoday.co.kr/mdtoday/index.html?no=300283
1810,2017-11-02,코스피외국인순매도엔씨소프트LG디스플레이삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2017110216080675368
1811,2017-11-02,삼성바이오로직스머크바이오의약품공정개발분야전략적MOU체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=300296
1812,2017-11-02,삼성바이오로직스독일머크사와바이오약품제조및바이오로직스공정개발분야에대한협력양해각서체결,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1409826
1813,2017-11-03,삼성바이오로직스독일머크공정개발협약,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=785832
1814,2017-11-03,KB증권삼성전기삼성바이오로직스신신제약외,http://www.seoulfn.com/news/articleView.html?idxno=291795
1815,2017-11-03,IT주쉬고삼성바이오로직스신고가한미약품훨훨,http://www.choicenews.co.kr/news/articleView.html?idxno=37171
1816,2017-11-07,현장세계1위CMO눈앞삼성바이오로직스송도공장가다,http://www.dailian.co.kr/news/view/672092/?sc=naver
1817,2017-11-07,KB증권삼성전기삼성바이오로직스더블유게임즈외,http://www.seoulfn.com/news/articleView.html?idxno=292008
1818,2017-11-07,국고처오재원종목상담삼성바이오로직스207940,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711040061
1819,2017-11-07,삼성바이오로직스보통주2047만주보호예수기간10일해제,http://www.mt.co.kr/view/mtview.php?type=1&no=2017110715491778174&outlink=1
1820,2017-11-07,공시삼성바이오로직스보통주205만여주보호예수만료,http://www.newsway.co.kr/view.php?tp=1&ud=2017110715512014876
1821,2017-11-07,삼성바이오로직스보통주보호예수기간10일해제,http://www.sedaily.com/NewsView/1ONHKOWZLJ
1822,2017-11-07,삼성바이오로직스보통주204만주10일보호예수해제,http://www.asiae.co.kr/news/view.htm?idxno=2017110716460531582
1823,2017-11-07,공시삼성바이오로직스오는10일205만주보호예수해제,http://www.viva100.com/main/view.php?key=20171107010002676
1824,2017-11-07,삼성바이오로직스보통주204만주10일보호예수해제,http://www.ebn.co.kr/news/view/916569
1825,2017-11-07,삼성바이오로직스오는10일보통주205만주보호예수기간만료,http://www.newsis.com/view/?id=NISX20171107_0000141155&cID=10401&pID=10400
1826,2017-11-08,주요공시삼성바이오로직스보통주보호예수기간10일해제,http://www.cstimes.com/?mod=news&act=articleView&idxno=259826
1827,2017-11-08,삼성바이오로직스보통주보호예수204만주10일보호예수해제,http://www.mdtoday.co.kr/mdtoday/index.html?no=300837
1828,2017-11-08,KB증권삼성전기삼성바이오로직스더블유게임즈외,http://www.seoulfn.com/news/articleView.html?idxno=292114
1829,2017-11-08,삼성바이오로직스美제약사와80억규모의약품위탁생산계약,http://www.asiae.co.kr/news/view.htm?idxno=2017110815395080204
1830,2017-11-08,삼성바이오로직스美제약사와80억원규모위탁생산계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171108146200008&did=1195m
1831,2017-11-08,삼성바이오로직스80억규모의약품위탁생산계약,http://news.hankyung.com/article/2017110803326
1832,2017-11-08,삼성바이오로직스美소재제약사와80억규모위탁생산계약,http://www.sedaily.com/NewsView/1ONI0AJV1D
1833,2017-11-08,공시삼성바이오로직스미국제약사와80억원의의약품위탁생산계약체결,http://www.newsway.co.kr/view.php?tp=1&ud=2017110815462963881
1834,2017-11-08,삼성바이오로직스미국제약사와80억원규모의약품위탁생산계약체결,http://biz.chosun.com/site/data/html_dir/2017/11/08/2017110802281.html
1835,2017-11-08,삼성바이오로직스美제약사와80억규모의약품위탁생산계약,http://www.edaily.co.kr/news/newspath.asp?newsid=03968806616123752
1836,2017-11-08,ET투자뉴스삼성바이오로직스207940수주공급계약미국소재제약사,http://www.etnews.com/20171108000407
1837,2017-11-08,삼성바이오로직스美제약사와80억규모위탁생산계약,http://news.einfomax.co.kr/news/articleView.html?idxno=3420351
1838,2017-11-08,삼성바이오로직스80억규모바이오의약품위탁생산수주,http://news1.kr/articles/?3147204
1839,2017-11-08,삼성바이오로직스美소재제약사와80억규모위탁생산계약,http://www.newsis.com/view/?id=NISX20171108_0000142237&cID=10401&pID=10400
1840,2017-11-08,e2BOT삼성바이오로직스80억원규모의기타판매공급계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1560180
1841,2017-11-08,삼성바이오로직스미국소재제약사와80억원규모위탁생산계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1560230
1842,2017-11-08,삼성바이오로직스미국제약회사와위탁생산계약체결80억,http://www.sisafocus.co.kr/news/articleView.html?idxno=169331
1843,2017-11-08,삼성바이오로직스美제약사와의약품위탁생산계약,http://www.newspim.com/news/view/20171108000260
1844,2017-11-08,삼성바이오로직스美제약사80억원규모의약품위탁생산계약,http://www.ebn.co.kr/news/view/916745
1845,2017-11-08,삼성바이오로직스美제약사와80억대위탁생산계약,http://www.seoulfn.com/news/articleView.html?idxno=292198
1846,2017-11-08,삼성바이오로직스美제약사와80억규모위탁생산계약,http://www.dailian.co.kr/news/view/672694/?sc=naver
1847,2017-11-09,공시삼성바이오로직스삼성바이오에피스SB3최종시판허가획득”,http://www.viva100.com/main/view.php?key=20171109010003323
1848,2017-11-09,삼성바이오로직스SB3국내시판허가,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017110908164453730
1849,2017-11-09,공시삼성바이오로직스삼성바이오에피스바이오시밀러SB3국내판매허가획득,http://www.ajunews.com/view/20171109082343542
1850,2017-11-09,삼성바이오로직스80억원규모의약품위탁생산계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=300970
1851,2017-11-09,KB증권삼성전기삼성바이오로직스더블유게임즈외,http://www.seoulfn.com/news/articleView.html?idxno=292215
1852,2017-11-09,삼성바이오로직스첫바이오시밀러삼페넷국내판매허가에상승세,http://www.sedaily.com/NewsView/1ONIGU52VV
1853,2017-11-09,특징주삼성바이오로직스나흘만에상승SB3국내시판허가,http://news.hankyung.com/article/2017110925736
1854,2017-11-09,특징주삼성바이오로직스SB3시판허가소식에강세,http://www.viva100.com/main/view.php?key=20171109010003375
1855,2017-11-09,삼성바이오로직스SB3시판허가로상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=300983
1856,2017-11-09,특징주삼성바이오로직스SB3시판허가소식에나흘만에상승세,http://www.fnnews.com/news/201711090939170830
1857,2017-11-09,특징주삼성바이오로직스SB3시판허가소식에나흘만에상승세,http://www.fnnews.com/news/201711090939170830
1858,2017-11-09,삼성바이오로직스항암바이오로직스국내판매허가받아,http://www.businesspost.co.kr/BP?command=article_view&num=63570
1859,2017-11-09,삼성바이오로직스삼성바이오에피스바이오시밀러SB3국내판매허가획득”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1560666
1860,2017-11-10,바이오판키우는삼성삼성바이오로직스상장1년성과는,http://www.asiatoday.co.kr/view.php?key=20171109010005055
1861,2017-11-10,KB증권삼성전기삼성바이오로직스더블유게임즈외,http://www.seoulfn.com/news/articleView.html?idxno=292310
1862,2017-11-10,삼성바이오로직스美제약사와80억규모위탁생산계약,http://www.kormedi.com/news/news/drug_dist/1225129_2906.html
1863,2017-11-13,KB증권삼성전기삼성바이오로직스CJEM외,http://www.seoulfn.com/news/articleView.html?idxno=292454
1864,2017-11-13,임원매수삼성바이오로직스더오를까,http://www.asiae.co.kr/news/view.htm?idxno=2017111310535708282
1865,2017-11-13,삼성바이오로직스임원들자사주최고가매수호재작용할까,http://www.mdtoday.co.kr/mdtoday/index.html?no=301324
1866,2017-11-14,삼성바이오로직스올들어시총142증가30대기업중톱,http://www.ceoscoredaily.com/news/article.html?no=33974
1867,2017-11-14,KB증권삼성전기삼성바이오로직스CJEM외,http://www.seoulfn.com/news/articleView.html?idxno=292539
1868,2017-11-14,국고처류태형종목상담삼성바이오로직스207940,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711110046
1869,2017-11-15,삼성바이오로직스장기위탁생산계약건선치료제유럽출시6개월이상지연,http://www.mdtoday.co.kr/mdtoday/index.html?no=301568
1870,2017-11-15,KB증권삼성전기삼성바이오로직스CJEM외,http://www.seoulfn.com/news/articleView.html?idxno=292664
1871,2017-11-15,코스피기관순매수삼성전자삼성바이오로직스한미약품,http://www.newsway.co.kr/view.php?tp=1&ud=2017111516102902592
1872,2017-11-16,KB증권삼성전기삼성바이오로직스CJEM외,http://www.seoulfn.com/news/articleView.html?idxno=292772
1873,2017-11-16,셀트리온급등삼성바이오로직스시총도추월,http://www.ebn.co.kr/news/view/918011
1874,2017-11-17,KB증권삼성전기삼성바이오로직스CJEM외,http://www.seoulfn.com/news/articleView.html?idxno=292876
1875,2017-11-19,베스트파트너3인의와우밴드종목진단삼성바이오로직스유럽서삼페넷허가가능성,http://news.hankyung.com/article/2017111955791
1876,2017-11-20,삼성바이오로직스자회사바이오시밀러온트루잔트유럽판매허가획득,http://www.mt.co.kr/view/mtview.php?type=1&no=2017112007472199269&outlink=1
1877,2017-11-20,삼성바이오로직스자회사항암바이오시밀러온트루잔트유럽판매허가,http://www.asiae.co.kr/news/view.htm?idxno=2017112008020194810
1878,2017-11-20,삼성바이오로직스자회사바이오시밀러온트루잔트유럽판매허가획득,http://news.hankyung.com/article/2017112073616
1879,2017-11-20,삼성바이오로직스삼성바이오에피스SB3유럽최종판매허가획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01518646616127688
1880,2017-11-20,삼성바이오로직스SB3유럽최종판매허가획득,http://www.newsis.com/view/?id=NISX20171120_0000152600&cID=10401&pID=10400
1881,2017-11-20,특징주삼성바이오로직스자회사복제약유럽허가소식에강세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017112009012736580&outlink=1
1882,2017-11-20,특징주삼성바이오로직스자회사바이오시밀러유럽판매허가획득소식에상승,http://www.g-enews.com/ko-kr/news/article/news_all/201711200902248531581e5800d6_1/article.html
1883,2017-11-20,특징주삼성바이오로직스자회사SB3유럽최종판매허가획득3↑,http://www.asiae.co.kr/news/view.htm?idxno=2017112009050457446
1884,2017-11-20,특징주삼성바이오로직스SB3유럽판매허가에강세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017112009070039236
1885,2017-11-20,특징주삼성바이오로직스자회사항암바이오시밀러유럽판매허가에강세,http://www.newstomato.com/ReadNews.aspx?no=789329
1886,2017-11-20,ET투자뉴스삼성바이오로직스_주가강세속에6일연속상승현재278,http://www.etnews.com/20171120000023
1887,2017-11-20,특징주삼성바이오로직스자회사복제약유럽허가소식에강세,http://news.hankyung.com/article/2017112076376
1888,2017-11-20,삼성바이오로직스온트루잔트유럽최종판매허가획득,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003016581
1889,2017-11-20,특징주삼성바이오로직스강세자회사항암복제약유럽판매허가,http://www.ebn.co.kr/news/view/918324
1890,2017-11-20,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293042
1891,2017-11-20,삼성바이오로직스자회사바이오시밀러유럽판매허가오름세,http://www.newsprime.co.kr/news/article.html?no=395659
1892,2017-11-20,특징주삼성바이오로직스신고가바이오시밀러유럽판매허가,http://www.mediapen.com/news/view/314590
1893,2017-11-20,삼성바이오로직스삼성바이오에피스SB3유럽판매허가에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=302123
1894,2017-11-20,특징주삼성바이오로직스온트루잔트유럽허가에상승,http://www.viva100.com/main/view.php?key=20171120010007242
1895,2017-11-20,특징주삼성바이오로직스자회사복제약유럽허가에신고가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1564502
1896,2017-11-20,특징주삼성바이오로직스자회사바이오시밀러유럽판매허가에강세,http://www.newspim.com/news/view/20171120000048
1897,2017-11-20,특징주삼성바이오로직스SB3유럽최종판매허가획득↑,http://www.seoulfn.com/news/articleView.html?idxno=293043
1898,2017-11-20,특징주삼성바이오로직스자회사복제약유럽판매허가에신고가,http://news20.busan.com/controller/newsController.jsp?newsId=20171120000045
1899,2017-11-20,특징주삼성바이오로직스자회사복제약유럽판매허가소식에강세,http://www.asiatoday.co.kr/view.php?key=20171120010010218
1900,2017-11-20,특징주삼성바이오로직스연일상승시총순위NAVER와초박빙,http://www.fnnews.com/news/201711201008040229
1901,2017-11-20,증시이끄는제약바이오신라젠삼성바이오로직스한미약품상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=302162
1902,2017-11-20,매일장보는남녀삼성바이오로직스207940,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003017365
1903,2017-11-20,삼성바이오로직스허셉틴바이오시밀러유럽판매허가획득,http://www.kpanews.co.kr/article/show.asp?idx=189178&table=article&category=D
1904,2017-11-21,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293141
1905,2017-11-22,투자자사이비교되는셀트리온삼성바이오로직스뭐가다를까,http://www.mdtoday.co.kr/mdtoday/index.html?no=302411
1906,2017-11-22,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293244
1907,2017-11-23,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293341
1908,2017-11-24,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293441
1909,2017-11-27,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293580
1910,2017-11-28,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293652
1911,2017-11-29,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293754
1912,2017-11-30,KB증권삼성전기삼성바이오로직스셀트리온헬스케어외,http://www.seoulfn.com/news/articleView.html?idxno=293862
1913,2017-11-30,특징주삼성바이오로직스9일연속외국인매도에하락세,http://biz.chosun.com/site/data/html_dir/2017/11/30/2017113001233.html
1914,2017-11-30,삼성바이오로직스9거래일연속하락,http://www.mdtoday.co.kr/mdtoday/index.html?no=303394
1915,2017-11-30,삼성바이오로직스9거래일연속하락코스피2500선붕괴,http://www.mdtoday.co.kr/mdtoday/index.html?no=303398
1916,2017-11-30,특징주삼성바이오로직스외국인매도에연일하락세,http://www.newsway.co.kr/view.php?tp=1&ud=2017113014035918148
1917,2017-11-30,KoreaReport삼성바이오로직스삼성그룹의차세대성장동력”,https://cnbc.sbs.co.kr/article_hub/10000883535?division=NAVER
1918,2017-11-30,KoreaReport김태한삼성바이오로직스사장사업플랫폼해외로확대할것”,https://cnbc.sbs.co.kr/article_hub/10000883536?division=NAVER
1919,2017-11-30,KoreaReport김태한삼성바이오로직스사장CMO비중50이상늘릴것”,https://cnbc.sbs.co.kr/article_hub/10000883537?division=NAVER
1920,2017-11-30,삼성바이오로직스3공장준공2020년본격생산시작,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171130139400017&did=1195m
1921,2017-11-30,삼성바이오로직스짐싸는외국인때문에휘청증권가전망은여전히밝아”,http://www.newsway.co.kr/view.php?tp=1&ud=2017113015343943155
1922,2017-11-30,삼성바이오로직스세계최대제3공장준공,http://www.dt.co.kr/contents.html?article_no=2017113002109976029006&ref=naver
1923,2017-11-30,삼성바이오로직스제3공장준공세계1위CMO기업도약,http://www.sedaily.com/NewsView/1ONS4HD0M3
1924,2017-11-30,삼성바이오로직스세계최대규모3공장준공,http://www.ebn.co.kr/news/view/919866
1925,2017-11-30,삼성바이오로직스세계최대바이오의약품생산공장준공,http://www.edaily.co.kr/news/newspath.asp?newsid=03808086616130968
1926,2017-11-30,기업삼성바이오로직스3공장준공2020년본격생산,http://www.ytn.co.kr/_ln/0102_201711301648238332
1927,2017-11-30,삼성바이오로직스서울월드컵경기장2배규모제3공장준공,http://www.businesspost.co.kr/BP?command=article_view&num=65646
1928,2017-11-30,삼성바이오로직스세계최대규모제3공장준공,http://daily.hankooki.com/lpage/economy/201711/dh20171130173414138080.htm
1929,2017-11-30,삼성바이오로직스3공장준공2020년본격생산시작,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711300346
1930,2017-11-30,삼성바이오로직스제3공장준공세계1위CMO기업우뚝,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017113016420768762
1931,2017-11-30,삼성바이오로직스3공장준공2020년본격생산,https://cnbc.sbs.co.kr/article_hub/10000883572?division=NAVER
1932,2017-12-01,브랜드평판제약상장기업브랜드12월빅데이터분석1위한미약품2위셀트리온3위삼성바이오로직스,http://www.futurekorea.co.kr/news/articleView.html?idxno=44848
1933,2017-12-01,제약상장기업브랜드평판12월빅데이터1위한미약품2위셀트리온3위삼성바이오로직스,http://www.betanews.net:8080/article/774495.html
1934,2017-12-01,삼성바이오로직스10거래일만에상승세2대↑,http://www.newsprime.co.kr/news/article.html?no=397335
1935,2017-12-01,ET투자뉴스삼성바이오로직스_지속된약세흐름속에서오늘은반등현재321,http://www.etnews.com/20171201000039
1936,2017-12-01,특징주삼성바이오로직스제3공장준공5↑,http://www.asiae.co.kr/news/view.htm?idxno=2017120109241458755
1937,2017-12-01,삼성바이오로직스10거래일만에5상승,http://www.sedaily.com/NewsView/1OOOPY3NK8
1938,2017-12-01,특징주삼성바이오로직스제3공장준공소식에4대상승세,http://biz.chosun.com/site/data/html_dir/2017/12/01/2017120100867.html
1939,2017-12-01,특징주삼성바이오로직스세계최대생산공장준공소식에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=02092646616154256
1940,2017-12-01,특징주삼성바이오로직스제3공장준공소식에4대상승,http://www.cstimes.com/?mod=news&act=articleView&idxno=261882
1941,2017-12-01,특징주삼성바이오로직스제3공장준공소식에상승세,http://www.dailian.co.kr/news/view/677650/?sc=naver
1942,2017-12-01,삼성바이오로직스송도제3공장준공에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=303523
1943,2017-12-01,ET투자뉴스제약주테마삼성바이오로직스녹십자중심으로강세,http://www.etnews.com/20171201000121
1944,2017-12-01,삼성전자SK하이닉스찔끔삼성바이오로직스종근당껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=37773
1945,2017-12-02,제약상장기업브랜드평판12월빅데이터분석1위한미약품2위셀트리온3위삼성바이오로직스,http://www.ggilbo.com/news/articleView.html?idxno=425616
1946,2017-12-03,삼성바이오로직스제3공장준공年36만L생산체제로,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=726761
1947,2017-12-04,삼성바이오로직스세계최대규모바이오의약품제3공장준공,http://news.heraldcorp.com/view.php?ud=20171204000276
1948,2017-12-05,삼성손영권효과삼성바이오로직스주목,http://news.heraldcorp.com/view.php?ud=20171205000197
1949,2017-12-05,국고처김종철종목상담삼성바이오로직스207940,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201712020029
1950,2017-12-05,제3공장준공삼성바이오로직스매출2조가능,http://www.kormedi.com/news/news/drug_dist/1225375_2906.html
1951,2017-12-05,특징주우울한삼성바이오로직스주가하락세뚜렷,http://www.kukinews.com/news/article.html?no=506688
1952,2017-12-05,삼성바이오로직스손영권효과,http://news.heraldcorp.com/view.php?ud=20171205000514
1953,2017-12-07,ET투자뉴스제약주테마한미약품삼성바이오로직스중심으로약세,http://www.etnews.com/20171207000084
1954,2017-12-08,특징주삼성바이오로직스5일만에강세,http://www.asiae.co.kr/news/view.htm?idxno=2017120813553503557
1955,2017-12-08,삼성바이오로직스5거래일만에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=304440
1956,2017-12-08,ET투자뉴스전기전자업종의약품업종강세_SK하이닉스삼성바이오로직스두드러져,http://www.etnews.com/20171208000172
1957,2017-12-11,삼성바이오로직스세계최대규모바이오의약품생산공장준공삼성증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1572601
1958,2017-12-11,삼성바이오로직스3공장으로성장기대저가매수노려야한국,http://news.hankyung.com/article/2017121186076
1959,2017-12-11,삼성바이오로직스3공장시대성장기대한국,http://biz.chosun.com/site/data/html_dir/2017/12/11/2017121100407.html
1960,2017-12-11,삼성바이오로직스4분기실적기대매수기회한국투자,http://www.ebn.co.kr/news/view/921136
1961,2017-12-11,한국투자증권삼성바이오로직스최근주가하락매수기회4분기도영업이익기대치상회예상”,http://www.g-enews.com/ko-kr/news/article/news_all/201712110818159853c642673384_1/article.html
1962,2017-12-11,삼성바이오로직스제3공장준공업계1위생산능력보유,http://www.asiatoday.co.kr/view.php?key=20171211010004822
1963,2017-12-11,삼성바이오로직스3공장준공CMO생산능력세계1위로한국투자,http://www.newstomato.com/ReadNews.aspx?no=793824
1964,2017-12-11,삼성증권삼성바이오로직스추가공장건설가능성주목”,http://www.newsway.co.kr/view.php?tp=1&ud=2017121108415608446
1965,2017-12-11,한국투자증권삼성바이오로직스3공장준공주가하락매수기회로활용해야”,http://www.newsway.co.kr/view.php?tp=1&ud=2017121108492017166
1966,2017-12-11,한국투자증권삼성바이오로직스4분기호실적전망추가매수기회”,http://www.viva100.com/main/view.php?key=20171211010003381
1967,2017-12-11,HotLine삼성바이오로직스3공장준공으로글로벌CMO1위등극,http://news.mk.co.kr/newsRead.php?year=2017&no=817902
1968,2017-12-11,삼성바이오로직스주가더오른다최근하락은매수기회,http://www.businesspost.co.kr/BP?command=article_view&num=66520
1969,2017-12-11,오늘의종목삼성바이오로직스3공장준공CMO1위등극,http://www.sedaily.com/NewsView/1OOTBGPDC5
1970,2017-12-11,아주종목분석삼성바이오로직스3공장완공으로성장본격화,http://www.ajunews.com/view/20171211091213570
1971,2017-12-11,특징주삼성바이오로직스세계1위CMO생산능력저평가에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01662966616157536
1972,2017-12-11,ET투자뉴스삼성바이오로직스3공장준공향후매수삼성증권,http://www.etnews.com/20171211000031
1973,2017-12-11,특징주삼성바이오로직스세계1위CMO평가에강세,http://news.hankyung.com/article/2017121189946
1974,2017-12-11,ET투자뉴스삼성바이오로직스3공장시대의개막매수유지한국투자증권,http://www.etnews.com/20171211000042
1975,2017-12-11,특징주삼성바이오로직스제3공장준공으로세계1위CMO업체등극에강세,http://www.cstimes.com/?mod=news&act=articleView&idxno=262650
1976,2017-12-11,특징주삼성바이오로직스제3공장준공기대감에강세,http://www.ekn.kr/news/article.html?no=330313
1977,2017-12-11,특징주삼성바이오로직스제3공장준공기대감에강세,http://www.newstomato.com/ReadNews.aspx?no=793855
1978,2017-12-11,특징주삼성바이오로직스세계1위CMO생산능력갖춰4↑,http://www.asiae.co.kr/news/view.htm?idxno=2017121109491832457
1979,2017-12-11,삼성바이오로직스CMO생산능력세계1위주가강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=304572
1980,2017-12-11,특징주삼성바이오로직스3공장시대개막,http://www.sisaon.co.kr/news/articleView.html?idxno=66799
1981,2017-12-11,수급골든타임실시간수급시그널종목삼성바이오로직스대한유화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017121111162179554
1982,2017-12-11,ET투자뉴스제약주테마삼성바이오로직스한미약품중심으로강세,http://www.etnews.com/20171211000137
1983,2017-12-11,마감코스피기관사자에상승삼성바이오로직스6급등,http://www.edaily.co.kr/news/newspath.asp?newsid=03063526616157536
1984,2017-12-11,현대車3인방삼성전자하락vs셀트리온3인방삼성바이오로직스급등왜,http://www.choicenews.co.kr/news/articleView.html?idxno=37951
1985,2017-12-11,코스피기관매수에상승삼성바이오로직스6급등,https://cnbc.sbs.co.kr/article_hub/10000884740?division=NAVER
1986,2017-12-12,셀트리온삼성바이오로직스진검승부코스피바이오대장주바뀌나,http://www.asiatoday.co.kr/view.php?key=20171211010005380
1987,2017-12-12,신라젠삼성바이오로직스임직원우리사주대박,http://www.mdtoday.co.kr/mdtoday/index.html?no=304704
1988,2017-12-12,한투증권삼성바이오로직스3공장준공매출성장기대,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171212034500008&did=1195m
1989,2017-12-12,삼성바이오로직스3공장준공세계1위CMO생산력한투증권,http://www.sedaily.com/NewsView/1OOTRC3JTY
1990,2017-12-12,삼성바이오로직스3공장준공돼바이오의약품위탁생산확대청신호,http://www.businesspost.co.kr/BP?command=article_view&num=66660
1991,2017-12-12,내일장멘토링3공장준공에생산력도UP기대감도UP관심주삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017121216404172146
1992,2017-12-13,삼성바이오로직스2공장첫EMA인증획득,http://www.asiae.co.kr/news/view.htm?idxno=2017121308500035705
1993,2017-12-13,삼성바이오로직스유럽의약품청2공장제조승인획득,http://www.fnnews.com/news/201712130853340871
1994,2017-12-13,삼성바이오로직스2공장제품美이어유럽제조허가,http://www.edaily.co.kr/news/newspath.asp?newsid=01633446616158192
1995,2017-12-13,삼성바이오로직스2공장첫EMA인증,http://www.mdtoday.co.kr/mdtoday/index.html?no=304880
1996,2017-12-13,오늘의종목삼성바이오로직스2공장제품유럽의약품청제조승인,http://www.sedaily.com/NewsView/1OOU8WQS7H
1997,2017-12-13,삼성바이오로직스2공장EMA인증획득품질스피드경쟁력입증,http://www.ebn.co.kr/news/view/921494
1998,2017-12-13,삼성바이오로직스2공장EMA인증획득,http://news.mt.co.kr/mtview.php?no=2017121309064655788
1999,2017-12-13,삼성바이오로직스2공장첫EMA인증획득,http://www.dt.co.kr/contents.html?article_no=2017121302109976029001&ref=naver
2000,2017-12-13,삼성바이오로직스2공장EMA인증획득,http://www.medigatenews.com/news/546572839
2001,2017-12-13,삼성바이오로직스2공장첫EMA인증획득,http://www.asiatoday.co.kr/view.php?key=20171213010006350
2002,2017-12-13,삼성바이오로직스2공장첫EMA인증획득,http://www.dailian.co.kr/news/view/680228/?sc=naver
2003,2017-12-13,삼성바이오로직스2공장유럽의약품청인증획득,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201712130052
2004,2017-12-13,삼성바이오로직스2공장EMA인증획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017121309002481915
2005,2017-12-13,삼성바이오로직스2공장유럽의약품청인증획득,http://news.einfomax.co.kr/news/articleView.html?idxno=3425607
2006,2017-12-13,삼성바이오로직스2공장첫유럽의약청EMA승인,http://news.hankyung.com/article/201712136975f
2007,2017-12-13,삼성바이오로직스2공장유럽의약품청인증획득,http://www.newsis.com/view/?id=NISX20171213_0000174889&cID=13001&pID=13000
2008,2017-12-13,삼성바이오로직스2공장유럽의약품청제조승인획득,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171213055400017&did=1195m
2009,2017-12-13,삼성바이오로직스2공장첫EMA인증획득,http://news1.kr/articles/?3178615
2010,2017-12-13,삼성바이오로직스2공장유럽의약품청EMA인증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=213103
2011,2017-12-13,삼성바이오로직스2공장유럽의약품청첫제조승인글로벌CMO시장공략속도,http://biz.chosun.com/site/data/html_dir/2017/12/13/2017121301095.html
2012,2017-12-13,삼성바이오로직스2공장첫EMA인증획득,http://www.dailian.co.kr/news/view/680264/?sc=naver
2013,2017-12-13,삼성바이오로직스미FDA이어유럽EMA서2공장인증획득,http://daily.hankooki.com/lpage/economy/201712/dh20171213104811138080.htm
2014,2017-12-13,삼성바이오로직스2공장첫EMA인증의약품공급탄력”,http://www.sisajournal-e.com/biz/article/177164
2015,2017-12-13,의료바이오삼성바이오로직스2공장EMA인증획득,http://www.ciobiz.co.kr/news/article.html?id=20171213120010
2016,2017-12-13,삼성바이오로직스2공장유럽인증획득,http://www.newstomato.com/ReadNews.aspx?no=794400
2017,2017-12-13,삼성바이오로직스2공장도유럽의제조승인얻어,http://www.businesspost.co.kr/BP?command=article_view&num=66765
2018,2017-12-13,삼성바이오로직스제2공장유럽의약품청인증,http://www.sedaily.com/NewsView/1OOU8URVA7
2019,2017-12-13,삼성바이오로직스2공장EMA인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1136790
2020,2017-12-13,뉴투분석삼성바이오로직스2공장품질인증으로세계최대실현,http://www.news2day.co.kr/96298
2021,2017-12-13,삼성바이오로직스2공장유럽의약품청제조승인획득,http://www.metroseoul.co.kr/news/newsview?newscd=2017121300071
2022,2017-12-13,삼성바이오로직스2공장유럽의약품청승인획득,http://www.kpinews.co.kr/news/articleView.html?idxno=61495
2023,2017-12-13,삼성바이오로직스2공장첫EMA인증획득,http://www.m-i.kr/news/articleView.html?idxno=369139
2024,2017-12-13,삼성바이오로직스2공장美이어유럽제조승인획득글로벌경쟁력확보,http://biz.newdaily.co.kr/news/article.html?no=10148518
2025,2017-12-13,삼성바이오로직스2공장유럽제조승인획득,http://www.fnnews.com/news/201712131808314974
2026,2017-12-13,삼성바이오로직스2공장첫EMA인증,http://news.hankyung.com/article/2017121397881
2027,2017-12-13,삼성바이오로직스2공장유럽인증받았다,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=728453
2028,2017-12-13,삼성바이오로직스2공장유럽의약품청EMA제조승인획득,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1423252
2029,2017-12-13,삼성바이오로직스EMA제조인증획득,http://www.joongboo.com/?mod=news&act=articleView&idxno=1214159
2030,2017-12-14,삼성바이오로직스2공장EMA인증획득,http://www.ajunews.com/view/20171213092349254
2031,2017-12-14,삼성바이오로직스2공장유럽제조승인획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1050279
2032,2017-12-14,HotLine삼성바이오로직스2공장의EUGMP획득에따른성장기대,http://news.mk.co.kr/newsRead.php?year=2017&no=826852
2033,2017-12-14,삼성바이오로직스2공장유럽의약품청서제조승인획득,http://www.kukinews.com/news/article.html?no=509385
2034,2017-12-15,삼성바이오로직스2공장유럽EMA인증획득,http://news.heraldcorp.com/view.php?ud=20171215000107
2035,2017-12-16,핫클릭리포트2018년바이오삼성바이오로직스셀트리온주목,http://www.asiatoday.co.kr/view.php?key=20171216010008121
2036,2017-12-18,참여연대삼성바이오로직스분식회계의혹규명재촉구,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171218100600008&did=1195m
2037,2017-12-18,참여연대금감원에삼성바이오로직스분식회계의혹조사재촉구,http://www.mdtoday.co.kr/mdtoday/index.html?no=305457
2038,2017-12-18,참여연대삼성바이오로직스분식회계의혹재감리촉구,http://www.tfnews.co.kr/news/article.html?no=41433
2039,2017-12-18,참여연대삼성바이오로직스분식회계의혹규명요구,http://www.intn.co.kr/news/articleView.html?idxno=866388
2040,2017-12-18,삼성바이오로직스특별감리깜깜무소식,http://www.kyeongin.com/main/view.php?key=20171218010005624
2041,2017-12-21,삼성바이오로직스유럽제약사와451억규모위탁생산계약체결,http://www.newsis.com/view/?id=NISX20171221_0000183735&cID=10401&pID=10400
2042,2017-12-21,공시삼성바이오로직스451억원규모의약품위탁생산계약체결,http://www.newsway.co.kr/view.php?tp=1&ud=2017122118190651356
2043,2017-12-21,삼성바이오로직스유럽제약사와451억에생산본계약,http://news1.kr/articles/?3187150
2044,2017-12-21,삼성바이오로직스451억규모의약품위탁생산계약체결,http://www.newstomato.com/ReadNews.aspx?no=796483
2045,2017-12-21,ET투자뉴스삼성바이오로직스207940수주공급계약유럽소재제약사,http://www.etnews.com/20171221000425
2046,2017-12-21,삼성바이오로직스451억규모공급계약체결,http://news.mt.co.kr/mtview.php?no=2017122119060948409
2047,2017-12-21,삼성바이오로직스유럽제약사와451억원생산계약체결,http://www.dt.co.kr/contents.html?article_no=2017122102109976029010&ref=naver
2048,2017-12-21,삼성바이오로직스451억원의약품위탁생산계약,http://www.asiatoday.co.kr/view.php?key=20171221010011532
2049,2017-12-21,삼성바이오로직스유럽제약사와451억위탁생산계약,http://news.hankyung.com/article/201712217067i
2050,2017-12-21,삼성바이오로직스유럽제약사와451억규모위탁생산계약,http://www.businesspost.co.kr/BP?command=article_view&num=67629
2051,2017-12-22,르포바이오의약품생산량1위시동건삼성바이오로직스제3공장,http://www.asiatoday.co.kr/view.php?key=20171221010011303
2052,2017-12-22,주요공시삼성바이오로직스유럽제약사와451억위탁생산계약,http://www.cstimes.com/?mod=news&act=articleView&idxno=263705
2053,2017-12-22,전일21일주요공시삼성바이오로직스外,http://www.newsway.co.kr/view.php?tp=1&ud=2017122208133287884
2054,2017-12-22,삼성바이오로직스451억원규모위탁생산계약,http://www.ebn.co.kr/news/view/922826
2055,2017-12-22,주요공시SK하이닉스삼성바이오로직스유앤아이등,http://www.intn.co.kr/news/articleView.html?idxno=866454
2056,2017-12-22,삼성바이오로직스451억규모의약품위탁생산계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=306021
2057,2017-12-22,특징주삼성바이오로직스유럽제약사위탁생산계약체결주가반전주목,http://www.g-enews.com/ko-kr/news/article/news_all/201712220922322782c642673384_1/article.html
2058,2017-12-24,삼성바이오로직스모금회에2000만원전달,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=792618
2059,2017-12-25,삼성바이오로직스임직원기부동참저소득취약층의료비2000만원지원,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=730137
2060,2017-12-25,나누면커진다삼성바이오로직스공동모금회에2천만원의료비지원,http://www.kyeongin.com/main/view.php?key=20171225010007588
2061,2017-12-25,삼성바이오로직스인천복지공동모금회성금전달,http://www.joongboo.com/?mod=news&act=articleView&idxno=1217039
2062,2017-12-26,삼성바이오로직스저소득취약계층의료비지원을위한성금2000만원전달,http://www.nbnnews.co.kr/news/view.php?idx=121266
2063,2017-12-27,셀트리온이전상장삼성바이오로직스와본격대결구도신호탄,http://www.mdtoday.co.kr/mdtoday/index.html?no=306338
2064,2017-12-27,ET투자뉴스삼성바이오로직스_지수하락에도불구하고종목흐름은좋아현재348,http://www.etnews.com/20171227000022
2065,2017-12-27,더벨삼성바이오로직스1년만에사모채발행,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201712210100036590002202
2066,2017-12-28,2017년화려했던바이오시밀러기업셀트리온삼성바이오로직스,http://www.mdtoday.co.kr/mdtoday/index.html?no=306473
2067,2017-12-29,회계부정휘말린삼성바이오로직스위배사항없어,http://news1.kr/articles/?3193508
2068,2017-12-29,삼성바이오로직스분식회계의혹회계규정위반없어,http://www.ebn.co.kr/news/view/923778
2069,2017-12-29,삼성바이오로직스분식회계의혹에적정의견받았다”,http://www.dt.co.kr/contents.html?article_no=2017122902109976029006&ref=naver
2070,2017-12-29,금감원삼성바이오로직스감리내년6월까지마무리”,http://www.econovill.com/news/articleView.html?idxno=329312
2071,2017-12-29,분식회계의혹삼성바이오로직스회계규정위반없다,http://www.edaily.co.kr/news/newspath.asp?newsid=02709286616163440
